Submitted URL: http://mailview.bulletinhealthcare.com/mailview.aspx?m=2019102201ashp&r=9372293-e4bb&l=00e-325&t=c
Effective URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-fai...
Submission: On October 22 via api from US

Summary

This website contacted 89 IPs in 10 countries across 58 domains to perform 307 HTTP transactions. The main IP is 143.204.101.128, located in Seattle, United States and belongs to AMAZON-02 - Amazon.com, Inc., US. The main domain is www.reuters.com.
TLS certificate: Issued by Amazon on April 2nd 2019. Valid for: a year.
This is the only time www.reuters.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

IP Address AS Autonomous System
1 1 69.174.55.131 3257 (GTT-BACKB...)
3 143.204.101.128 16509 (AMAZON-02)
10 13.225.78.91 16509 (AMAZON-02)
2 2600:9000:215... 16509 (AMAZON-02)
1 2600:9000:200... 16509 (AMAZON-02)
1 2a00:1450:400... 15169 (GOOGLE)
3 143.204.101.13 16509 (AMAZON-02)
6 2a00:1450:400... 15169 (GOOGLE)
1 2 2a00:1450:400... 15169 (GOOGLE)
1 2a04:4e42:3::714 54113 (FASTLY)
1 2a00:1450:400... 15169 (GOOGLE)
1 54.217.204.244 16509 (AMAZON-02)
7 23.45.108.200 20940 (AKAMAI-ASN1)
1 143.204.99.83 16509 (AMAZON-02)
4 143.204.101.7 16509 (AMAZON-02)
10 104.18.136.13 13335 (CLOUDFLAR...)
1 147.75.101.51 54825 (PACKET)
3 2606:4700:20:... 13335 (CLOUDFLAR...)
3 2606:4700::68... 13335 (CLOUDFLAR...)
1 2600:9000:20e... 16509 (AMAZON-02)
3 52.72.190.3 14618 (AMAZON-AES)
2 2a03:2880:f01... 32934 (FACEBOOK)
1 2600:9000:21f... 16509 (AMAZON-02)
1 147.75.85.103 54825 (PACKET)
1 52.85.183.93 16509 (AMAZON-02)
1 2600:1f18:624... 14618 (AMAZON-AES)
1 52.87.16.121 14618 (AMAZON-AES)
2 5 2.19.43.224 20940 (AKAMAI-ASN1)
1 35.201.93.216 15169 (GOOGLE)
1 147.75.84.99 54825 (PACKET)
1 2606:4700::68... 13335 (CLOUDFLAR...)
2 52.27.125.121 16509 (AMAZON-02)
2 2a03:2880:f11... 32934 (FACEBOOK)
1 1 2a00:1450:400... 15169 (GOOGLE)
1 1 2a00:1450:400... 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
1 54.171.105.8 16509 (AMAZON-02)
1 2600:9000:215... 16509 (AMAZON-02)
1 52.22.183.200 14618 (AMAZON-AES)
1 2600:9000:20e... 16509 (AMAZON-02)
2 34.243.82.109 16509 (AMAZON-02)
1 136.243.25.83 24940 (HETZNER-AS)
8 2.18.235.93 16625 (AKAMAI-AS)
1 13.225.78.96 16509 (AMAZON-02)
1 66.81.204.228 40034 (CONFLUENC...)
4 23.62.140.165 16625 (AKAMAI-AS)
11 2a00:1450:400... 15169 (GOOGLE)
3 2a00:1450:400... 15169 (GOOGLE)
15 216.58.208.34 15169 (GOOGLE)
11 199.166.0.26 7415 (ADSAFE-1)
3 2a00:1450:400... 15169 (GOOGLE)
3 52.85.183.90 16509 (AMAZON-02)
6 2.18.235.40 16625 (AKAMAI-AS)
7 2.18.232.7 16625 (AKAMAI-AS)
1 1 35.177.169.46 16509 (AMAZON-02)
8 152.195.39.46 15133 (EDGECAST)
1 1 54.235.136.175 14618 (AMAZON-AES)
1 52.216.136.5 16509 (AMAZON-02)
3 2600:9000:215... 16509 (AMAZON-02)
2 35.177.181.185 16509 (AMAZON-02)
6 199.166.0.32 7415 (ADSAFE-1)
1 143.204.101.90 16509 (AMAZON-02)
1 2a02:26f0:6c0... 20940 (AKAMAI-ASN1)
1 3.224.94.188 14618 (AMAZON-AES)
7 35.174.181.134 14618 (AMAZON-AES)
4 2a00:1450:400... 15169 (GOOGLE)
2 143.204.101.40 16509 (AMAZON-02)
1 34.239.9.60 14618 (AMAZON-AES)
22 104.244.36.20 7415 (ADSAFE-1)
4 13.224.196.127 16509 (AMAZON-02)
1 216.58.205.230 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
2 216.58.205.226 15169 (GOOGLE)
2 2a00:1450:400... 15169 (GOOGLE)
4 13.225.78.59 16509 (AMAZON-02)
2 24 34.95.120.147 15169 (GOOGLE)
4 2.18.233.180 16625 (AKAMAI-AS)
1 185.64.189.115 62713 (AS-PUBMATIC)
1 185.64.189.111 62713 (AS-PUBMATIC)
4 104.16.87.26 13335 (CLOUDFLAR...)
7 208.100.17.183 32748 (STEADFAST)
4 104.16.38.14 13335 (CLOUDFLAR...)
2 208.100.17.180 32748 (STEADFAST)
3 208.100.17.185 32748 (STEADFAST)
7 185.33.223.203 29990 (ASN-APPNEXUS)
2 208.100.17.178 32748 (STEADFAST)
7 216.52.2.48 29791 (VOXEL-DOT...)
1 2600:9000:20e... 16509 (AMAZON-02)
1 18.196.104.43 16509 (AMAZON-02)
1 8.41.222.100 26120 (RHYTHMONE)
1 185.64.189.112 62713 (AS-PUBMATIC)
4 6 152.199.21.89 15133 (EDGECAST)
1 185.86.138.32 201081 (SMARTADSE...)
307 89
Apex Domain
Subdomains
Transfer
40 adsafeprotected.com
cdn.adsafeprotected.com
pixel.adsafeprotected.com
static.adsafeprotected.com
dt.adsafeprotected.com
268 KB
24 openx.net
carambola-d.openx.net
eu-u.openx.net
33across-d.openx.net
367 KB
18 carambo.la
route.carambo.la
cdata.carambo.la
logging.carambo.la
inimage.carambo.la
analytics.carambo.la
xtr.carambo.la
media.carambo.la
246 KB
17 doubleclick.net
stats.g.doubleclick.net
securepubads.g.doubleclick.net
ad.doubleclick.net
googleads4.g.doubleclick.net
291 KB
17 reuters.com
www.reuters.com
static.reuters.com
wireapi.reuters.com
601 KB
14 tynt.com
cdn.tynt.com
sc.tynt.com
ic.tynt.com
de.tynt.com
15 KB
12 media.net
contextual.media.net
cdneast2-xch.media.net
149 KB
10 dianomi.com
www.dianomi.com
17 KB
8 33across.com
cdn-sic.33across.com
sic.33across.com
ssc.33across.com
258 KB
8 brid.tv
services.brid.tv
p.brid.tv
stats-dev.brid.tv
92 KB
8 googlesyndication.com
pagead2.googlesyndication.com
tpc.googlesyndication.com
ade.googlesyndication.com
71 KB
8 evidon.com
c.evidon.com
iabmap.evidon.com
36 KB
7 lijit.com
ap.lijit.com
40 KB
7 adnxs.com
ib.adnxs.com
5 KB
7 pubmatic.com
ads.pubmatic.com
image6.pubmatic.com
sshowads.pubmatic.com
aktrack.pubmatic.com
hbopenbid.pubmatic.com
17 KB
7 teads.tv
a.teads.tv
t.teads.tv
sync.teads.tv
186 KB
6 advertising.com
adserver-us.adtech.advertising.com
1 KB
6 s-onetag.com
get.s-onetag.com
beacon.s-onetag.com
dfp-gateway.s-onetag.com
onetag-geo.s-onetag.com
21 KB
6 google-analytics.com
www.google-analytics.com
63 KB
5 moatads.com
z.moatads.com
geo.moatads.com
298 KB
5 googletagservices.com
www.googletagservices.com
130 KB
5 scorecardresearch.com
sb.scorecardresearch.com
3 KB
5 reutersmedia.net
s3.reutersmedia.net
s2.reutersmedia.net
static.reutersmedia.net
102 KB
4 adlightning.com
tagan.adlightning.com
79 KB
4 googleapis.com
fonts.googleapis.com
4 KB
4 google.de
www.google.de
adservice.google.de
1 KB
4 google.com
www.google.com
adservice.google.com
845 B
3 moatpixel.com
reutersdfpcw319687550988.s.moatpixel.com
1 KB
3 demdex.net
dpm.demdex.net
reuters.demdex.net
5 KB
3 consensu.org
vendorlist.consensu.org
evidon.mgr.consensu.org
cmp.teads.mgr.consensu.org
17 KB
3 betrad.com
l.betrad.com
360 B
3 tinypass.com
experience.tinypass.com
cdn.tinypass.com
118 KB
3 tru.am
tru.am
beacon.tru.am
13 KB
3 hotjar.com
static.hotjar.com
script.hotjar.com
vars.hotjar.com
77 KB
3 chartbeat.com
static.chartbeat.com
mab.chartbeat.com
31 KB
2 gstatic.com
fonts.gstatic.com
20 KB
2 2mdn.net
gcdn.2mdn.net
r4---sn-4g5ednee.c.2mdn.net
2 MB
2 facebook.com
www.facebook.com
247 B
2 segment.io
api.segment.io
282 B
2 facebook.net
connect.facebook.net
87 KB
2 reuters.tv
queso-cdn.prod.reuters.tv
sope.prod.reuters.tv
26 KB
1 smartadserver.com
prg.smartadserver.com
1 KB
1 1rx.io
tag.1rx.io
270 B
1 emxdgt.com
hb.emxdgt.com
307 B
1 amazonaws.com
s3.amazonaws.com
2 KB
1 pixel.watch
pixel.watch
322 B
1 mnet-ad.net
s.mnet-ad.net
355 B
1 utoumine.net
utoumine.net
422 B
1 chartbeat.net
ping.chartbeat.net
168 B
1 cloudflare.com
cdnjs.cloudflare.com
2 KB
1 globalwebindex.net
gwiqcdn.globalwebindex.net
15 KB
1 native.ai
cdn.native.ai
43 KB
1 segment.com
cdn.segment.com
71 KB
1 admantx.com
async01.admantx.com
437 B
1 ytimg.com
s.ytimg.com
9 KB
1 youtube.com
www.youtube.com
1 KB
1 googletagmanager.com
www.googletagmanager.com
74 KB
1 bulletinhealthcare.com
mailview.bulletinhealthcare.com
452 B
307 58
Domain Requested by
22 dt.adsafeprotected.com
14 securepubads.g.doubleclick.net www.googletagservices.com
securepubads.g.doubleclick.net
www.reuters.com
tagan.adlightning.com
12 33across-d.openx.net tagan.adlightning.com
33across-d.openx.net
11 pixel.adsafeprotected.com cdn.adsafeprotected.com
www.reuters.com
10 www.dianomi.com static.reuters.com
www.dianomi.com
www.reuters.com
10 static.reuters.com www.reuters.com
8 eu-u.openx.net 1 redirects tagan.adlightning.com
8 contextual.media.net static.reuters.com
contextual.media.net
7 ap.lijit.com www.reuters.com
ap.lijit.com
7 ib.adnxs.com tagan.adlightning.com
www.reuters.com
7 ic.tynt.com
7 analytics.carambo.la cdata.carambo.la
7 c.evidon.com static.reuters.com
c.evidon.com
6 adserver-us.adtech.advertising.com 4 redirects
6 static.adsafeprotected.com pixel.adsafeprotected.com
www.reuters.com
6 www.google-analytics.com www.googletagmanager.com
www.google-analytics.com
www.reuters.com
5 www.googletagservices.com contextual.media.net
securepubads.g.doubleclick.net
5 sb.scorecardresearch.com 2 redirects www.reuters.com
4 cdn-sic.33across.com tagan.adlightning.com
4 carambola-d.openx.net 1 redirects cdata.carambo.la
www.reuters.com
4 tagan.adlightning.com cdata.carambo.la
4 stats-dev.brid.tv
4 fonts.googleapis.com cdata.carambo.la
4 cdata.carambo.la www.reuters.com
cdata.carambo.la
4 cdneast2-xch.media.net
4 wireapi.reuters.com static.reuters.com
3 de.tynt.com cdn.tynt.com
3 ads.pubmatic.com cdata.carambo.la
tagan.adlightning.com
3 reutersdfpcw319687550988.s.moatpixel.com
3 media.carambo.la www.reuters.com
3 t.teads.tv
3 dfp-gateway.s-onetag.com get.s-onetag.com
3 a.teads.tv www.reuters.com
a.teads.tv
3 z.moatads.com securepubads.g.doubleclick.net
3 services.brid.tv securepubads.g.doubleclick.net
services.brid.tv
3 tpc.googlesyndication.com securepubads.g.doubleclick.net
tagan.adlightning.com
3 pagead2.googlesyndication.com securepubads.g.doubleclick.net
3 adservice.google.com www.googletagservices.com
tagan.adlightning.com
3 adservice.google.de www.googletagservices.com
tagan.adlightning.com
3 l.betrad.com www.reuters.com
3 www.reuters.com static.reuters.com
www.googletagmanager.com
2 ssc.33across.com cdn-sic.33across.com
2 sic.33across.com tagan.adlightning.com
2 sc.tynt.com tagan.adlightning.com
2 cdn.tynt.com tagan.adlightning.com
2 fonts.gstatic.com cdata.carambo.la
2 ade.googlesyndication.com
2 static.reutersmedia.net cdata.carambo.la
2 geo.moatads.com z.moatads.com
2 reuters.demdex.net www.reuters.com
2 www.facebook.com www.reuters.com
www.googletagmanager.com
2 api.segment.io cdn.segment.com
2 connect.facebook.net cdn.segment.com
connect.facebook.net
2 experience.tinypass.com www.reuters.com
cdn.tinypass.com
2 tru.am www.googletagmanager.com
tru.am
2 s3.reutersmedia.net www.reuters.com
2 static.chartbeat.com www.reuters.com
1 prg.smartadserver.com www.reuters.com
1 hbopenbid.pubmatic.com www.reuters.com
1 tag.1rx.io www.reuters.com
1 hb.emxdgt.com www.reuters.com
1 onetag-geo.s-onetag.com beacon.s-onetag.com
1 aktrack.pubmatic.com tagan.adlightning.com
1 sshowads.pubmatic.com tagan.adlightning.com
1 image6.pubmatic.com tagan.adlightning.com
1 googleads4.g.doubleclick.net
1 r4---sn-4g5ednee.c.2mdn.net
1 gcdn.2mdn.net 1 redirects
1 ad.doubleclick.net services.brid.tv
1 sync.teads.tv a.teads.tv
1 xtr.carambo.la cdata.carambo.la
1 inimage.carambo.la cdata.carambo.la
1 logging.carambo.la cdata.carambo.la
1 cmp.teads.mgr.consensu.org a.teads.tv
1 p.brid.tv services.brid.tv
1 s3.amazonaws.com www.reuters.com
1 pixel.watch 1 redirects
1 route.carambo.la 1 redirects
1 s.mnet-ad.net
1 cdn.adsafeprotected.com contextual.media.net
1 utoumine.net
1 s2.reutersmedia.net
1 beacon.s-onetag.com get.s-onetag.com
1 ping.chartbeat.net
1 get.s-onetag.com www.googletagmanager.com
1 dpm.demdex.net www.reuters.com
1 www.google.de www.reuters.com
1 www.google.com 1 redirects
1 stats.g.doubleclick.net 1 redirects
1 cdnjs.cloudflare.com www.dianomi.com
1 vars.hotjar.com static.hotjar.com
1 gwiqcdn.globalwebindex.net www.reuters.com
1 beacon.tru.am tru.am
1 evidon.mgr.consensu.org c.evidon.com
1 sope.prod.reuters.tv static.reuters.com
1 cdn.native.ai www.reuters.com
1 cdn.tinypass.com experience.tinypass.com
1 script.hotjar.com static.hotjar.com
1 vendorlist.consensu.org c.evidon.com
1 iabmap.evidon.com c.evidon.com
1 static.hotjar.com www.googletagmanager.com
1 cdn.segment.com www.reuters.com
1 async01.admantx.com static.reuters.com
1 s.ytimg.com www.youtube.com
1 mab.chartbeat.com static.chartbeat.com
1 www.youtube.com www.reuters.com
1 www.googletagmanager.com www.reuters.com
1 queso-cdn.prod.reuters.tv www.reuters.com
1 mailview.bulletinhealthcare.com 1 redirects
307 109
Subject Issuer Validity Valid
www.reuters.com
Amazon
2019-04-02 -
2020-05-02
a year crt.sh
static.reuters.com
Amazon
2018-11-28 -
2019-12-28
a year crt.sh
*.chartbeat.com
Gandi Standard SSL CA 2
2019-04-10 -
2020-04-10
a year crt.sh
*.prod.reuters.tv
Amazon
2019-01-28 -
2020-02-28
a year crt.sh
*.google-analytics.com
GTS CA 1O1
2019-10-03 -
2019-12-26
3 months crt.sh
*.google.com
GTS CA 1O1
2019-10-10 -
2020-01-02
3 months crt.sh
f6.shared.global.fastly.net
GlobalSign CloudSSL CA - SHA256 - G3
2019-10-17 -
2020-08-07
10 months crt.sh
*.admantx.com
SSL.com RSA SSL subCA
2019-03-29 -
2021-06-25
2 years crt.sh
*.evidon.com
DigiCert ECC Secure Server CA
2019-02-01 -
2020-05-02
a year crt.sh
*.segment.com
DigiCert SHA2 Secure Server CA
2019-06-24 -
2020-07-01
a year crt.sh
wireapi.reuters.com
Amazon
2019-01-01 -
2020-02-01
a year crt.sh
ssl424245.cloudflaressl.com
COMODO ECC Domain Validation Secure Server CA 2
2019-08-30 -
2020-03-07
6 months crt.sh
static.hotjar.com
Let's Encrypt Authority X3
2019-10-06 -
2020-01-04
3 months crt.sh
ssl389962.cloudflaressl.com
COMODO ECC Domain Validation Secure Server CA 2
2019-09-11 -
2020-03-19
6 months crt.sh
*.tinypass.com
DigiCert SHA2 Secure Server CA
2019-01-31 -
2020-03-20
a year crt.sh
l.betrad.com
Go Daddy Secure Certificate Authority - G2
2019-04-25 -
2021-06-24
2 years crt.sh
*.facebook.com
DigiCert SHA2 High Assurance Server CA
2019-09-22 -
2019-12-20
3 months crt.sh
vendorlist.consensu.org
Amazon
2019-03-06 -
2020-04-06
a year crt.sh
script.hotjar.com
Let's Encrypt Authority X3
2019-10-06 -
2020-01-04
3 months crt.sh
cdn.native.ai
Amazon
2019-08-26 -
2020-09-26
a year crt.sh
evidon.mgr.consensu.org
Amazon
2019-08-22 -
2020-09-22
a year crt.sh
*.scorecardresearch.com
COMODO RSA Organization Validation Secure Server CA
2018-11-28 -
2019-12-26
a year crt.sh
*.globalwebindex.net
RapidSSL RSA CA 2018
2017-12-13 -
2020-12-19
3 years crt.sh
vars.hotjar.com
Let's Encrypt Authority X3
2019-10-06 -
2020-01-04
3 months crt.sh
ssl412106.cloudflaressl.com
COMODO ECC Domain Validation Secure Server CA 2
2019-08-10 -
2020-02-16
6 months crt.sh
www.google.de
GTS CA 1O1
2019-10-10 -
2020-01-02
3 months crt.sh
*.demdex.net
DigiCert SHA2 High Assurance Server CA
2018-01-09 -
2021-02-12
3 years crt.sh
*.s-onetag.com
Amazon
2019-06-25 -
2020-07-25
a year crt.sh
*.chartbeat.net
Thawte RSA CA 2018
2018-12-20 -
2020-01-01
a year crt.sh
utoumine.net
Let's Encrypt Authority X3
2019-09-05 -
2019-12-04
3 months crt.sh
*.media.net
DigiCert SHA2 Secure Server CA
2018-12-30 -
2020-03-30
a year crt.sh
*.adsafeprotected.com
COMODO RSA Domain Validation Secure Server CA
2018-08-20 -
2020-09-17
2 years crt.sh
*.mnet-ad.net
Sectigo RSA Domain Validation Secure Server CA
2019-04-04 -
2020-04-15
a year crt.sh
*.g.doubleclick.net
GTS CA 1O1
2019-10-03 -
2019-12-26
3 months crt.sh
tpc.googlesyndication.com
GTS CA 1O1
2019-10-03 -
2019-12-26
3 months crt.sh
*.brid.tv
Go Daddy Secure Certificate Authority - G2
2019-01-02 -
2020-03-03
a year crt.sh
moatads.com
DigiCert ECC Secure Server CA
2018-11-10 -
2020-02-09
a year crt.sh
teads.tv
Let's Encrypt Authority X3
2019-08-22 -
2019-11-20
3 months crt.sh
*.carambo.la
DigiCert SHA2 Secure Server CA
2019-02-21 -
2021-02-25
2 years crt.sh
s3.amazonaws.com
DigiCert Baltimore CA-2 G2
2019-09-06 -
2020-12-02
a year crt.sh
*.moatads.com
DigiCert SHA2 Secure Server CA
2019-03-12 -
2021-06-10
2 years crt.sh
teads.mgr.consensu.org
Let's Encrypt Authority X3
2019-09-23 -
2019-12-22
3 months crt.sh
*.googleapis.com
GTS CA 1O1
2019-10-03 -
2019-12-26
3 months crt.sh
*.doubleclick.net
GTS CA 1O1
2019-10-03 -
2019-12-26
3 months crt.sh
*.c.docs.google.com
GTS CA 1O1
2019-10-10 -
2019-12-19
2 months crt.sh
*.adlightning.com
Amazon
2019-08-19 -
2020-09-19
a year crt.sh
*.openx.net
GeoTrust RSA CA 2018
2018-01-04 -
2020-07-09
3 years crt.sh
*.pubmatic.com
DigiCert SHA2 Secure Server CA
2018-12-13 -
2020-03-13
a year crt.sh
*.tynt.com
Sectigo RSA Domain Validation Secure Server CA
2019-10-01 -
2021-09-30
2 years crt.sh
*.33across.com
Sectigo RSA Domain Validation Secure Server CA
2019-10-01 -
2021-09-30
2 years crt.sh
*.adnxs.com
DigiCert ECC Secure Server CA
2019-01-23 -
2021-03-08
2 years crt.sh
*.lijit.com
Go Daddy Secure Certificate Authority - G2
2019-03-11 -
2020-05-10
a year crt.sh
*.emxdgt.com
Go Daddy Secure Certificate Authority - G2
2019-07-17 -
2020-07-17
a year crt.sh
*.1rx.io
Sectigo RSA Domain Validation Secure Server CA
2019-06-28 -
2021-06-27
2 years crt.sh
*.adtech.advertising.com
DigiCert SHA2 High Assurance Server CA
2018-05-22 -
2020-05-26
2 years crt.sh
*.smartadserver.com
Thawte RSA CA 2018
2018-09-07 -
2020-02-17
a year crt.sh

This page contains 41 frames:

Primary Page: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Frame ID: 489368E72C580067D851F0146B3CCF61
Requests: 167 HTTP requests in this frame

Frame: https://vars.hotjar.com/box-74dcf4e32eff343c96838bf3a780ac1d.html
Frame ID: 6D1B2C9153261963865AB33A1D3FC226
Requests: 1 HTTP requests in this frame

Frame: https://www.dianomi.com/smartads.epl?id=4728&num_ads=5&shuffle=0&cf=545.4.Reuters%20v3.1
Frame ID: EDCCEB1EB33528FC578B6352E292E588
Requests: 1 HTTP requests in this frame

Frame: https://www.dianomi.com/recirculation.epl?id=98&cf=545.4.Reuters%20v3.1
Frame ID: 5D8CBF95BF37F84486EA87ADF70C09C2
Requests: 1 HTTP requests in this frame

Frame: https://www.dianomi.com/recirculation.epl?id=99&start=6&cf=545.4.Reuters%20v3.1
Frame ID: EFC86B0F81245E0C2C0D4A1C1D025DB7
Requests: 1 HTTP requests in this frame

Frame: https://reuters.demdex.net/dest5.html?d_nsid=0
Frame ID: 78ECD98C06D082CF66F3A8D57D61E9E0
Requests: 1 HTTP requests in this frame

Frame: https://www.facebook.com/tr/
Frame ID: 23E1392EB841C69B41A5984AD3DFD241
Requests: 1 HTTP requests in this frame

Frame: https://contextual.media.net/checksync.php?&vsSync=1&cs=1&hb=1&cv=37&ndec=1&cid=8CUF1VN4G&prvid=3%2C23%2C28%2C29%2C33%2C38%2C41%2C51%2C54%2C56%2C59%2C69%2C72%2C74%2C76%2C77%2C80%2C82%2C84%2C97%2C106%2C108%2C109%2C113%2C117%2C118%2C122%2C126%2C138%2C139%2C141%2C145%2C147%2C159%2C172%2C173%2C174%2C175%2C178%2C182%2C3004%2C3007%2C3010&rtime=39&https=1&gdpr=1&gdprconsent=0
Frame ID: E06D77444F642602E96CA64FF91A5786
Requests: 1 HTTP requests in this frame

Frame: https://contextual.media.net/checksync.php?&vsSync=1&cs=1&hb=1&cv=37&ndec=1&cid=8CUF1VN4G&prvid=3%2C23%2C28%2C29%2C33%2C38%2C41%2C51%2C54%2C56%2C59%2C69%2C72%2C74%2C76%2C77%2C80%2C82%2C84%2C97%2C106%2C108%2C109%2C113%2C117%2C118%2C122%2C126%2C138%2C139%2C141%2C145%2C147%2C159%2C172%2C173%2C174%2C175%2C178%2C182%2C3004%2C3007%2C3010&rtime=101&https=1&gdpr=1&gdprconsent=0
Frame ID: 8DA8580EBCF0433AD6207F61D60DD605
Requests: 1 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvW06vP1UtUwPeV9aoGYXtVK3TJAnj7-eCm8g_BIMCnbG6UGX196yIRqJBDoF1dv541xLhpHFkOVE9V647ngPwMBHcMxGEgNZH4TOnJBM8C7sjqRZOYvxSsEWtDAhF8YBTnh-BXuWTCW6OGUuoVn9NpxBi0-zhVZ54g6W29PA2ZfITWW-fykM_-BuM93JRcngHehkCeR7SPHkrqG-PxBlv3ZWbP60z9NLrDSR4eofLkKQiydeNjiIE3DJSccA1aOy8TULMS-Wksj7c3k5yONCcEMIGRCjc_1al2Yw&sig=Cg0ArKJSzM-xhtUJHcExEAE&urlfix=1&adurl=
Frame ID: 5877DA3C90976F2113BE026C4B30A0BD
Requests: 17 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjstYYGid8mh1098dQRHGyc4vE5rsUNsSKmwPetKW7iQ3DbLgr6F38leeHONdNuDCGx8ZN-Vb5cLa84etataP20VrWJr4cmHs__k1KW8WhJqstN7Jt3Za2wtWoLhprmNhvFTW5OpVJQugTZmCYHXPBwZSe7Bhi4wjX9QlFljVccvr5o0D1itPV-QZYMl8ftGpHfYW6fRAkt80KXHxMB7uelhpe4ZAAKsIjPI8l13eWOUEVRy2nTnf5SAl-K1xEKLzHyX4ryu1b-wBRya1icMdhkg146q1w3w7M4WU&sig=Cg0ArKJSzOX2_Wf5ALyHEAE&urlfix=1&adurl=
Frame ID: FAF8CAFB4DC30641DF9EBAF54D619766
Requests: 5 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjssXtcrtikyfsTtTOmXHR7O20rdiubRuHnNcY08euuUjU-NoYHs0ehaqLi_w2S_3yMNwdBzeOqxh0avhlxZT_UDUZP6vTTUr7QLH9tJYdgvef5KA2pWiULhSRJMImc5d_fKn_56hOXmRDHZfNAeOHaMOwtTHKYo_RMLwbq4jtPrRZqUHnyn3ybxVjFOwH0kb50rk5Jm91eo8Wk71WK5Z4K6mC665SrZLXxcnLkU9dokxXpfWSncNXPTxqYmVz8LXENw_rKZJdLk6WsJb7Z7YJZtPXc8IXJc&sig=Cg0ArKJSzIWQObs-TQgqEAE&urlfix=1&adurl=
Frame ID: EF323A190D2F40D462D84DB743475C48
Requests: 37 HTTP requests in this frame

Frame: https://pixel.adsafeprotected.com/jload?anId=10764&campId=2x2&pubId=54423312&chanId=37592232&placementId=4741317042&pubCreative=138206523841&pubOrder=2107429564&cb=370275150&custom=canvas&custom2=400&custom3=0&adsafe_par&impId=ded5b646-f4e0-11e9-bb6e-382c4ac630d1
Frame ID: 07DCB72E876871ECF84114E11C728A93
Requests: 2 HTTP requests in this frame

Frame: https://pixel.adsafeprotected.com/jload?anId=10764&campId=300x280&pubId=20159232&chanId=37592232&placementId=139199112&pubCreative=138204787707&pubOrder=277213512&cb=1954337497&custom=bizdev_article_rr2&custom2=20000&custom3=0&adsafe_par&impId=ded54131-f4e0-11e9-98a1-382c4ac63135
Frame ID: 163F8BB8254DCDC7C1DF7939B468B0EF
Requests: 2 HTTP requests in this frame

Frame: https://pixel.adsafeprotected.com/jload?anId=10764&campId=300x250&pubId=4789302609&chanId=37592232&placementId=5189420777&pubCreative=138289622787&pubOrder=2599246982&cb=1797662741&custom=mpu&custom2=400&custom3=0&adsafe_par&impId=ded34561-f4e0-11e9-ba52-70106fb729f4
Frame ID: C0763AAA072295E8B9B0C3BFB3EC2F5E
Requests: 2 HTTP requests in this frame

Frame: https://cmp.teads.mgr.consensu.org/index.html
Frame ID: 94254FB6BE9E1FD0C6C52C338F509E0F
Requests: 1 HTTP requests in this frame

Frame: https://static.adsafeprotected.com/sca.17.4.95.js
Frame ID: 64B0044116AD79B9228F8E48A0008657
Requests: 1 HTTP requests in this frame

Frame: https://static.adsafeprotected.com/sca.17.4.95.js
Frame ID: 80F38E869EE82B73AA9B84939EAC1A8F
Requests: 1 HTTP requests in this frame

Frame: https://static.adsafeprotected.com/sca.17.4.95.js
Frame ID: DE493BE8AA98EC4F7F98E612C8B51765
Requests: 1 HTTP requests in this frame

Frame: https://sync.teads.tv/iframe?pid=78293&userId=897290cb-1056-43ab-aef5-daf7577331f0&gdprIab={%22status%22:23,%22consent%22:%22%22,%22reason%22:230}&env=js-web&1571758227263
Frame ID: F77957F2FF9BA69AD7B4613BD8FF4680
Requests: 1 HTTP requests in this frame

Frame: https://tagan.adlightning.com/carambola/blacklist_script.js
Frame ID: 02452BB11BC1C1A59584C86A1228F36A
Requests: 4 HTTP requests in this frame

Frame: https://tagan.adlightning.com/carambola/blacklist_script.js
Frame ID: 7A621020EB2E3236F3A6C429B258C622
Requests: 17 HTTP requests in this frame

Frame: https://eu-u.openx.net/w/1.0/pd?cc=1&plm=6&ph=c60c4e0c-5442-4600-876b-e4035d01b1eb
Frame ID: 56126EBDF926DB7DD3B9724009864031
Requests: 1 HTTP requests in this frame

Frame: https://ads.pubmatic.com/AdServer/js/showad.js
Frame ID: A9B5DA23922A99E06886BB8C62367CDB
Requests: 1 HTTP requests in this frame

Frame: https://ads.pubmatic.com/AdServer/js/showad.js
Frame ID: 68427A93E273A42DD4F0E0C69D8B314C
Requests: 1 HTTP requests in this frame

Frame: https://cdn.tynt.com/siab.js?uTjYfYoCUQ&_ADTIME_&$RANDOM&%%CACHEBUSTER%%&
Frame ID: D122BCC9445690E81E6777420A171095
Requests: 12 HTTP requests in this frame

Frame: https://aktrack.pubmatic.com/AdServer/AdDisplayTrackerServlet?operId=1&pubId=156612&siteId=251236&adId=2075066&adType=3&adServerId=165&kefact=0.000000&kaxefact=0.000000&kadNetFrequecy=0&kadwidth=300&kadheight=250&kadsizeid=0&kltstamp=1571758230&indirectAdId=1840519&adServerOptimizerId=1&ranreq=0.9121392798281893&kpbmtpfact=0.000000&dcId=3&tldId=0&passback=30&svr=ADS22411U&ekefact=liCvXRXXAABZZPgCAPHzbI87ouO-LwC--RDjOFRl-y3Vzv_K&ekaxefact=liCvXSvXAACxu2yEH2e_sPfuUUDuC_5t784VHEl2Y4wpHizr&ekpbmtpfact=liCvXT_XAABptP7Rgk8K5FOkjHMF_N-P350c-Gt1eLcbugjF&crID=0&campaignId=0&isRTB=0&imprId=733C412A-15E0-49B3-A955-A461CCE0379A&oid=733C412A-15E0-49B3-A955-A461CCE0379A&cntryId=58&domain=reuters.com&pageURL=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-farxiga-fda%2Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&sec=1&pmc=0
Frame ID: 5A680D820AD18631F60CE56719FED7BB
Requests: 1 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/tag/js/gpt.js
Frame ID: 364EA63166B60A211EBF8EEFDA4E6EEB
Requests: 8 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/tag/js/gpt.js
Frame ID: 9B4079359E115ECD91BC72EF12505A78
Requests: 7 HTTP requests in this frame

Frame: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Frame ID: DF30109C2386EEAE4A63F7C283BE834E
Requests: 2 HTTP requests in this frame

Frame: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Frame ID: 1A4A6E4FB8F0227CFDBCA532D4B4BEEB
Requests: 2 HTTP requests in this frame

Frame: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Frame ID: 3D305EB86FF1736DFE4DDA68B3AB8C17
Requests: 2 HTTP requests in this frame

Frame: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Frame ID: BFEB5275453F26D25899A2C2EC94386A
Requests: 2 HTTP requests in this frame

Frame: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Frame ID: DE48C8073C55A4CE679F2A08D67C10F4
Requests: 2 HTTP requests in this frame

Frame: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Frame ID: 2FCEC09D1054F7DB55E15F2FB542854A
Requests: 2 HTTP requests in this frame

Frame: https://eu-u.openx.net/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
Frame ID: E7E59A70CC5785DF25E2A86DAAC3A3A7
Requests: 1 HTTP requests in this frame

Frame: https://eu-u.openx.net/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
Frame ID: A96F16BFDF9E4F776474B353EE8A78FE
Requests: 1 HTTP requests in this frame

Frame: https://eu-u.openx.net/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
Frame ID: 298846F3C3DA0FF0FB998307D644FAF0
Requests: 1 HTTP requests in this frame

Frame: https://eu-u.openx.net/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
Frame ID: CE610881FD0C24853B9ADC9537D2DC8D
Requests: 1 HTTP requests in this frame

Frame: https://eu-u.openx.net/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
Frame ID: 7275EF93A3CFEDE64073825130D7466F
Requests: 1 HTTP requests in this frame

Frame: https://eu-u.openx.net/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
Frame ID: B526211F76F5479D016EDD776C9D70E7
Requests: 1 HTTP requests in this frame

Screenshot


Page URL History Show full URLs

  1. http://mailview.bulletinhealthcare.com/mailview.aspx?m=2019102201ashp&r=9372293-e4bb&l=00e-325&t=c HTTP 302
    https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-fo... Page URL

Detected technologies

Overall confidence: 50%
Detected patterns
  • url /\.aspx?(?:$|\?)/i

Overall confidence: 100%
Detected patterns
  • url /\.aspx?(?:$|\?)/i

Overall confidence: 100%
Detected patterns
  • headers server /nginx(?:\/([\d.]+))?/i

Overall confidence: 100%
Detected patterns
  • headers via /\(CloudFront\)$/i

Overall confidence: 50%
Detected patterns
  • url /\.aspx?(?:$|\?)/i

Overall confidence: 100%
Detected patterns
  • headers via /\(CloudFront\)$/i

Overall confidence: 100%
Detected patterns
  • script /googletagservices\.com\/tag\/js\/gpt(?:_mobile)?\.js/i

Overall confidence: 100%
Detected patterns
  • script /\/\/connect\.facebook\.net\/[^\/]*\/[a-z]*\.js/i

Overall confidence: 100%
Detected patterns
  • script /googlesyndication\.com\//i

Overall confidence: 100%
Detected patterns
  • script /google-analytics\.com\/(?:ga|urchin|analytics)\.js/i

Overall confidence: 100%
Detected patterns
  • html /<!-- (?:End )?Google Tag Manager -->/i

Overall confidence: 100%
Detected patterns
  • script /^\/\/static\.hotjar\.com\/c\/hotjar-/i

Overall confidence: 100%
Detected patterns
  • script /cdn\.segment\.com\/analytics\.js/i

Overall confidence: 100%
Detected patterns
  • html /<iframe[^>]* (?:id="comscore"|scr=[^>]+comscore)|\.scorecardresearch\.com\/beacon\.js|COMSCORE\.beacon/i
  • script /\.scorecardresearch\.com\/beacon\.js|COMSCORE\.beacon/i

Page Statistics

307
Requests

99 %
HTTPS

31 %
IPv6

58
Domains

109
Subdomains

89
IPs

10
Countries

6411 kB
Transfer

15108 kB
Size

4
Cookies

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

  1. http://mailview.bulletinhealthcare.com/mailview.aspx?m=2019102201ashp&r=9372293-e4bb&l=00e-325&t=c HTTP 302
    https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5 Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 58
  • https://sb.scorecardresearch.com/b?c1=2&c2=6035630&ns__t=1571758223775&ns_c=UTF-8&cv=3.1e&c8=FDA%20approves%20AstraZeneca%20diabetes%20drug%20for%20treating%20heart%20failure%20risk%20-%20Reuters&c7=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-farxiga-fda%2Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&c9= HTTP 302
  • https://sb.scorecardresearch.com/b2?c1=2&c2=6035630&ns__t=1571758223775&ns_c=UTF-8&cv=3.1e&c8=FDA%20approves%20AstraZeneca%20diabetes%20drug%20for%20treating%20heart%20failure%20risk%20-%20Reuters&c7=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-farxiga-fda%2Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&c9=
Request Chain 73
  • https://stats.g.doubleclick.net/r/collect?t=dc&aip=1&_r=3&v=1&_v=j79&tid=UA-24152976-22&cid=599101512.1571758223&jid=2010143685&gjid=1080161227&_gid=2001321523.1571758223&_u=aGDAiEAjR~&z=138488704 HTTP 302
  • https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=599101512.1571758223&jid=2010143685&_v=j79&z=138488704 HTTP 302
  • https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=599101512.1571758223&jid=2010143685&_v=j79&z=138488704&slf_rd=1&random=1418846269
Request Chain 128
  • https://route.carambo.la/inimage/getlayer?pid=thms97&did=112441&wid=3&rdn=[RANDOM_NUMBER] HTTP 302
  • https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Request Chain 131
  • https://pixel.watch/q4m9 HTTP 302
  • https://s3.amazonaws.com/scripts-clickmeter-com/js/pixelNew.js
Request Chain 150
  • https://sb.scorecardresearch.com/p?c1=2&c2=17198971&ns_ap_sv=2.1511.10&ns_type=hidden&ns_st_it=a&ns_st_sv=4.0.0&ns_st_ad=1&ns_st_sq=1&ns_st_id=1571758226906&ns_st_ec=1&ns_st_cn=1&ns_st_ev=play&ns_st_ct=va00&ns_st_cl=0&ns_st_pt=0&c3=*null&c4=*null&c6=*null&ns_ts=63909980&cs_ucfr=1 HTTP 302
  • https://sb.scorecardresearch.com/p2?c1=2&c2=17198971&ns_ap_sv=2.1511.10&ns_type=hidden&ns_st_it=a&ns_st_sv=4.0.0&ns_st_ad=1&ns_st_sq=1&ns_st_id=1571758226906&ns_st_ec=1&ns_st_cn=1&ns_st_ev=play&ns_st_ct=va00&ns_st_cl=0&ns_st_pt=0&c3=*null&c4=*null&c6=*null&ns_ts=63909980&cs_ucfr=1
Request Chain 199
  • https://gcdn.2mdn.net/videoplayback/id/a24f93b0836c331a/itag/342/source/doubleclick_dmm/ctier/L/acao/yes/ip/0.0.0.0/ipbits/0/expire/3713879037/sparams/id,itag,source,ctier,acao,ip,ipbits,expire/signature/8B7A8A1C69C9F732DE398CB9822694E23BF26F51.313C9ACCFFAABC44E1BDD3BEDA9B426C2A2904DD/key/ck2/file/file.mp4 HTTP 302
  • https://r4---sn-4g5ednee.c.2mdn.net/videoplayback/id/a24f93b0836c331a/itag/342/source/doubleclick_dmm/ctier/L/acao/yes/ip/0.0.0.0/ipbits/0/expire/3713879037/sparams/acao,ctier,expire,id,ip,ipbits,itag,mip,mm,mn,ms,mv,mvi,pl,source/signature/504A329919287FA4737CA61FA8825DC9DCD2B608.01061AD6F013FE81011F2984E8A39EE5C70E39F9/key/cms1/cms_redirect/yes/mip/2a01:4f8:192:5414::2/mm/42/mn/sn-4g5ednee/ms/onc/mt/1571758061/mv/m/mvi/3/pl/41/file/file.mp4
Request Chain 225
  • https://carambola-d.openx.net/w/1.0/acj?ai=d3a9183f-6e15-4497-bc84-3f6a64323458&o=1839218318&callback=OX_1839218318&ju=https%3A//www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&jr=&auid=540746705&dims=&adxy=&res=1600x1200x24&plg=pm&ch=UTF-8&tz=-120&ws=300x250&ifr=1&tws=1600x1200&mt=1 HTTP 302
  • https://carambola-d.openx.net/w/1.0/acj?cc=1&ai=d3a9183f-6e15-4497-bc84-3f6a64323458&o=1839218318&callback=OX_1839218318&ju=https%3A//www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&jr=&auid=540746705&dims=&adxy=&res=1600x1200x24&plg=pm&ch=UTF-8&tz=-120&ws=300x250&ifr=1&tws=1600x1200&mt=1
Request Chain 226
  • https://eu-u.openx.net/w/1.0/pd?plm=6&ph=c60c4e0c-5442-4600-876b-e4035d01b1eb HTTP 302
  • https://eu-u.openx.net/w/1.0/pd?cc=1&plm=6&ph=c60c4e0c-5442-4600-876b-e4035d01b1eb
Request Chain 309
  • https://adserver-us.adtech.advertising.com/pubapi/3.0/10334.1/4788545/0/1/ADTECH;v=2;cmd=bid;cors=yes;alias=219b494579777dd;misc=1571758235665;bidfloor=0.05; HTTP 302
  • https://adserver-us.adtech.advertising.com/pubapi/3.0/10334.1/4788545/0/1/ADTECH;cfp=1;rndc=1571758235;v=2;cmd=bid;cors=yes;alias=219b494579777dd;misc=1571758235665;bidfloor=0.05 HTTP 302
  • https://adserver-us.adtech.advertising.com/pubapi/3.0/10334.1/4788545/0/1/ADTECH;apid=1Ae4de7574-f4e0-11e9-b9c1-121c10c2940c;cfp=1;rndc=1571758235;v=2;cmd=bid;cors=yes;alias=219b494579777dd;misc=1571758235665;bidfloor=0.05
Request Chain 310
  • https://adserver-us.adtech.advertising.com/pubapi/3.0/10334.1/5126271/0/1/ADTECH;v=2;cmd=bid;cors=yes;alias=228b0c287c48d74;misc=1571758235665;bidfloor=0.05; HTTP 302
  • https://adserver-us.adtech.advertising.com/pubapi/3.0/10334.1/5126271/0/1/ADTECH;cfp=1;rndc=1571758235;v=2;cmd=bid;cors=yes;alias=228b0c287c48d74;misc=1571758235665;bidfloor=0.05 HTTP 302
  • https://adserver-us.adtech.advertising.com/pubapi/3.0/10334.1/5126271/0/1/ADTECH;apid=1Ae4dcfa82-f4e0-11e9-b74f-124c2db8624e;cfp=1;rndc=1571758235;v=2;cmd=bid;cors=yes;alias=228b0c287c48d74;misc=1571758235665;bidfloor=0.05

307 HTTP transactions

Resource
Path
Size
x-fer
Type
MIME-Type
Primary Request fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
www.reuters.com/article/us-astrazeneca-farxiga-fda/
Redirect Chain
  • http://mailview.bulletinhealthcare.com/mailview.aspx?m=2019102201ashp&r=9372293-e4bb&l=00e-325&t=c
  • https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
199 KB
53 KB
Document
General
Full URL
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.128 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-128.fra50.r.cloudfront.net
Software
nginx /
Resource Hash
697be22b2f9f77ecaec9eacb176e73a1f2c4853df2d6865b900baaed2042d3d4

Request headers

:method
GET
:authority
www.reuters.com
:scheme
https
:path
/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
none
accept-encoding
gzip, deflate, br
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
200
content-type
text/html;charset=UTF-8
access-control-allow-headers
Access-Control-Allow-Origin,charset
access-control-allow-origin
http://admin.reuters.com
channel-name
healthNews
content-encoding
gzip
date
Tue, 22 Oct 2019 15:30:22 GMT
expires
Tue, 22 Oct 2019 15:24:59 GMT
last-updateda
Mon, 21 Oct 2019 07:08:10 GMT
server
nginx
vary
Accept-Encoding
x-cache
Miss from cloudfront
via
1.1 32e4d419823b7f8df8417a8b18c9602d.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
ltwxraHdzth3yDlgQBJLJemP68wYGxLg8NMroudG3k4chAvn8SejmA==

Redirect headers

Cache-Control
private
Content-Type
text/html; charset=utf-8
Location
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Server
Microsoft-IIS/10.0
Set-Cookie
ASP.NET_SessionId=g4qzbcnc1zhonoap41wqnnbu; path=/; HttpOnly
X-AspNet-Version
4.0.30319
X-BNN-Server
biapp1
Date
Tue, 22 Oct 2019 15:30:22 GMT
Content-Length
260
article.bundle.css
static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/
149 KB
16 KB
Stylesheet
General
Full URL
https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/article.bundle.css
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.225.78.91 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-225-78-91.fra2.r.cloudfront.net
Software
nginx /
Resource Hash
27f08df1567ca0787d0e9bdfd6dc30cb6d250efdb932e0ac752abbb10cb87f19

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:16:10 GMT
content-encoding
gzip
age
852
x-cache
Hit from cloudfront
status
200
content-length
16097
last-modified
Fri, 18 Oct 2019 18:58:47 GMT
server
nginx
vary
Accept-Encoding
content-type
text/css
via
1.1 90cf045072373c2c671297de3161846f.cloudfront.net (CloudFront)
cache-control
max-age=7200
x-amz-cf-pop
FRA2-C2
accept-ranges
bytes
x-amz-cf-id
gJ0pbhj7Qi9GytM05yC59aDWYPCCFjXvmgOVs5KOqNYjVSd_GG8fng==
expires
Tue, 22 Oct 2019 17:04:14 GMT
common.bundle.css
static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/
480 KB
279 KB
Stylesheet
General
Full URL
https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.css
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.225.78.91 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-225-78-91.fra2.r.cloudfront.net
Software
nginx /
Resource Hash
f789c9224c81ba9c39f3dd523c7d53b289574ecb6e3554bcc63f575ab45652c0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 14:52:56 GMT
content-encoding
gzip
last-modified
Fri, 18 Oct 2019 18:58:51 GMT
server
nginx
age
2246
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
text/css
status
200
cache-control
max-age=7200
x-amz-cf-pop
FRA2-C2
accept-ranges
bytes
x-amz-cf-id
qNOxykE2dz-_-_ClnFFXOQE35qU118nttVN_illGCYTPaLCa0KQ6_g==
via
1.1 90cf045072373c2c671297de3161846f.cloudfront.net (CloudFront)
expires
Tue, 22 Oct 2019 15:03:02 GMT
chartbeat_mab.js
static.chartbeat.com/js/
19 KB
8 KB
Script
General
Full URL
https://static.chartbeat.com/js/chartbeat_mab.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2156:b800:18:1fcd:349:ca21 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
nginx /
Resource Hash
c1acfa727754dab58bedc79995a642e235c6fde6449824c4fba4318fc060c91c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:08:06 GMT
content-encoding
gzip
last-modified
Wed, 14 Aug 2019 01:44:12 GMT
server
nginx
age
1336
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/x-javascript
status
200
cache-control
max-age=7200
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
hEPHJmxBnj_8zJZZLZwFL_JoArrtC8hhz-PdfKlJblA4z13rilCvxw==
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
expires
Tue, 22 Oct 2019 17:08:06 GMT
embedder.bundle.js
queso-cdn.prod.reuters.tv/new/assets/
50 KB
13 KB
Script
General
Full URL
https://queso-cdn.prod.reuters.tv/new/assets/embedder.bundle.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:200d:3200:1e:ef1b:aa40:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
nginx/1.14.0 (Ubuntu) /
Resource Hash
3ad6849c327eac0d747d48c9e8d0430e5599933b668c944154f8228ec48b19ac

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:22 GMT
content-encoding
gzip
x-origin
i-001de507f23474502.queso.prod.us.reuters.tv
server
nginx/1.14.0 (Ubuntu)
x-amz-cf-pop
FRA50
status
200
vary
Accept-Encoding
access-control-allow-methods
GET, POST, OPTIONS
content-type
application/javascript
access-control-allow-origin
*
last-modified
Thu, 21 Mar 2019 19:00:31 GMT
x-cache
Hit from cloudfront
access-control-allow-headers
connection, range, accept-encoding, user-agent, referer, content-type
x-amz-cf-id
IXunj2fEHYgvmKkudaaiuiVZu-f6Tkvip23JIFf87snQ5EP71K6m-g==
via
1.1 a436b6df4b0d1bd189edf722b5d2a523.cloudfront.net (CloudFront)
gtm.js
www.googletagmanager.com/
286 KB
74 KB
Script
General
Full URL
https://www.googletagmanager.com/gtm.js?id=GTM-W9SLGS
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:815::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
e5b5d63adc886c996f55c3cd74fab30fbd7769f9a2023b4ae83709ea44d75ab1
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:22 GMT
content-encoding
br
server
Google Tag Manager
access-control-allow-headers
Cache-Control
status
200
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
http://www.googletagmanager.com
cache-control
private, max-age=900
access-control-allow-credentials
true
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
75404
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:22 GMT
3aae9fd5da3557fba61d6444cb943643.png
static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/
1 KB
2 KB
Image
General
Full URL
https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/3aae9fd5da3557fba61d6444cb943643.png
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.225.78.91 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-225-78-91.fra2.r.cloudfront.net
Software
nginx /
Resource Hash
6346ee09058d555984eb04aac881775c926b5d9d4f73ca91493f7cb708ed90df

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 19:05:29 GMT
content-encoding
gzip
age
73493
x-cache
Hit from cloudfront
status
200
content-length
1539
last-modified
Fri, 18 Oct 2019 18:58:44 GMT
server
nginx
vary
Accept-Encoding
content-type
image/png
via
1.1 90cf045072373c2c671297de3161846f.cloudfront.net (CloudFront)
cache-control
max-age=86400
x-amz-cf-pop
FRA2-C2
accept-ranges
bytes
x-amz-cf-id
uUGGBr8b-rPFw_4ehc6wwSdUkeB3Md8HNQSXIsuZcqtPWDMzuyEMUg==
expires
Sat, 19 Oct 2019 19:05:11 GMT
/
s3.reutersmedia.net/resources/r/
754 B
1 KB
Image
General
Full URL
https://s3.reutersmedia.net/resources/r/?m=02&d=20191021&t=2&i=1443247775&r=LYNXMPEF9K0CN&w=20
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.13 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-13.fra50.r.cloudfront.net
Software
nginx /
Resource Hash
5df1b4e6904954a6b9f4d34dea0d936bc238ad066f6a747f9b84551bd53050cc

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 06:44:09 GMT
via
1.1 1d87c34bb2f20fda8e0841bc33179769.cloudfront.net (CloudFront)
x-amz-expiration
expiry-date="Thu, 21 Nov 2019 00:00:00 GMT", rule-id="ExpiraIn30Days"
last-modified
Mon, 21 Oct 2019 06:38:12 GMT
server
nginx
x-amz-cf-pop
FRA50-C1
etag
"59f199cc7bcdc96d1d4574106fa1495b"
x-cache
Hit from cloudfront
x-amz-version-id
s7_Wy8zFxJzNPs_L8DAtv1S0XxXxXGib
status
200
content-type
image/jpeg
content-length
754
x-amz-cf-id
s2HF2fRBs6yJszwIMidvHI5Fegg7kGI2SAcWYcsKYd0i_U2UaaCENg==
common.bundle.js
static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/
731 KB
175 KB
Script
General
Full URL
https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.225.78.91 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-225-78-91.fra2.r.cloudfront.net
Software
nginx /
Resource Hash
d62e1ce4a06c3bc837907935917e23462591f87162a171c0cdf5be61c7dcd04e

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:17 GMT
content-encoding
gzip
last-modified
Fri, 18 Oct 2019 18:58:51 GMT
server
nginx
age
5
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
status
200
cache-control
max-age=7200
x-amz-cf-pop
FRA2-C2
accept-ranges
bytes
x-amz-cf-id
PCVwsqC_gV2GZUCsovf_2jBPExlY0zY_Eav0AcvUeixffnAe-57a7A==
via
1.1 90cf045072373c2c671297de3161846f.cloudfront.net (CloudFront)
expires
Tue, 22 Oct 2019 17:06:07 GMT
article.bundle.js
static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/
360 KB
52 KB
Script
General
Full URL
https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/article.bundle.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.225.78.91 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-225-78-91.fra2.r.cloudfront.net
Software
nginx /
Resource Hash
c35c41a7ff7df6d6d0d3e1ba8382602098f32fe9018ee20c827d8b82f7d390e7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:16:10 GMT
content-encoding
gzip
age
852
x-cache
Hit from cloudfront
status
200
content-length
52458
last-modified
Fri, 18 Oct 2019 18:58:47 GMT
server
nginx
vary
Accept-Encoding
content-type
application/javascript
via
1.1 90cf045072373c2c671297de3161846f.cloudfront.net (CloudFront)
cache-control
max-age=7200
x-amz-cf-pop
FRA2-C2
accept-ranges
bytes
x-amz-cf-id
IgOenzyRnnBX37AUvYMfqBN3eNXlBn_1mv7m5byj4t4xJKF09-5rGQ==
expires
Tue, 22 Oct 2019 17:07:43 GMT
analytics.js
www.google-analytics.com/
43 KB
17 KB
Script
General
Full URL
https://www.google-analytics.com/analytics.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-W9SLGS
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:808::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
dbb67c620eaabf6679a314db18d3ae43037aef71ab27422e6feec08ee987cc0a
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=10886400; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Mon, 19 Aug 2019 17:22:41 GMT
server
Golfe2
age
5773
date
Tue, 22 Oct 2019 13:54:09 GMT
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
public, max-age=7200
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
17803
expires
Tue, 22 Oct 2019 15:54:09 GMT
js
www.google-analytics.com/gtm/
60 KB
23 KB
Script
General
Full URL
https://www.google-analytics.com/gtm/js?id=GTM-TBBXQQ&t=gtm1&cid=599101512.1571758223
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:808::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
9e223d43450fc3a047c5eb120c7b38d5ae9b3cf337ffb18352820727dff5dc33
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:23 GMT
content-encoding
br
last-modified
Tue, 22 Oct 2019 15:00:00 GMT
server
Google Tag Manager
access-control-allow-headers
Cache-Control
status
200
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
http://www.googletagmanager.com
cache-control
private, max-age=900
access-control-allow-credentials
true
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
22753
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:23 GMT
iframe_api
www.youtube.com/
859 B
1 KB
Script
General
Full URL
https://www.youtube.com/iframe_api
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
YouTube Frontend Proxy /
Resource Hash
16dd54686a3ed4ca169cba44af157ea072d91930a6b5ad3690b4651820e5e0b2
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:23 GMT
x-content-type-options
nosniff
server
YouTube Frontend Proxy
content-type
application/javascript
status
200
cache-control
no-cache
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
859
x-xss-protection
0
expires
Tue, 27 Apr 1971 19:44:06 EST
truncated
/
49 KB
49 KB
Font
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
f01d25f7a76e0682a7a43230c32bef653eaf28b8a6f7a683ebb88bf8c6aa4f50

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Origin
https://www.reuters.com

Response headers

Content-Type
application/font-woff
truncated
/
49 KB
49 KB
Font
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
d7d62426c6b87d35cef5c2c873355aa44edffcf4a7f927f1c51b10694ea4f6ed

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Origin
https://www.reuters.com

Response headers

Content-Type
application/font-woff
truncated
/
71 KB
71 KB
Font
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
ee0768f9d2def8b13df284410776f5d755109e77b5c0ca17d8895f65b343a0cd

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Origin
https://www.reuters.com

Response headers

Content-Type
application/font-woff
/
mab.chartbeat.com/mab_strategy/headline_testing/get_strategy/
202 B
488 B
XHR
General
Full URL
https://mab.chartbeat.com/mab_strategy/headline_testing/get_strategy/?host=reuters.com&domain=reuters.com&path=%2Farticle%2Fus-astrazeneca-farxiga-fda-idUSKBN1X00J5
Requested by
Host: static.chartbeat.com
URL: https://static.chartbeat.com/js/chartbeat_mab.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2a04:4e42:3::714 , Ascension Island, ASN54113 (FASTLY - Fastly, US),
Reverse DNS
Software
/
Resource Hash
0d0f896b06d22803e904df2f434d27a79cd4b0f3964e12020527f2022cf6fbb3

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:23 GMT
content-encoding
gzip
age
0
x-cache
MISS
status
200
x-cache-hits
0
content-length
167
x-served-by
cache-fra19157-FRA
access-control-allow-origin
*
x-timer
S1571758223.172315,VS0,VE145
vary
Origin, Access-Control-Request-Headers, Access-Control-Request-Method, Accept-Encoding
content-type
application/json
via
1.1 varnish (Varnish/6.0), 1.1 varnish
cache-control
no-store, no-cache, must-revalidate, max-age=0, s-maxage=0
accept-ranges
bytes
expires
Sun, 20 Oct 2019 15:30:23 GMT
www-widgetapi.js
s.ytimg.com/yts/jsbin/www-widgetapi-vfloS5Wsk/
23 KB
9 KB
Script
General
Full URL
https://s.ytimg.com/yts/jsbin/www-widgetapi-vfloS5Wsk/www-widgetapi.js
Requested by
Host: www.youtube.com
URL: https://www.youtube.com/iframe_api
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81e::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
b631fccbe48b26dccef2b6eedeed2d6fb9020daf34dbc8010e587e280b6f498e
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 11:18:24 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
15119
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
8680
x-xss-protection
0
last-modified
Mon, 21 Oct 2019 15:44:35 GMT
server
sffe
vary
Accept-Encoding, Origin
content-type
text/javascript
cache-control
public, max-age=691200
accept-ranges
bytes
timing-allow-origin
https://www.youtube.com
expires
Wed, 30 Oct 2019 11:18:24 GMT
service
async01.admantx.com/admantx/
241 B
437 B
Script
General
Full URL
https://async01.admantx.com/admantx/service?request=%7B%22key%22%3A%22234330834c41105ad5ed794fa036e085b40225c44f9228bb9e2692f427917605%22%2C%20%22decorator%22%3A%22template.reuters%22%2C%20%22filter%22%3A%5B%22default%22%5D%2C%20%22method%22%3A%22descriptor%22%2C%20%22mode%22%3A%22async%22%2C%20%22type%22%3A%22URL%22%2C%20%22body%22%3A%22https%253A%252F%252Fwww.reuters.com%252Farticle%252Fus-astrazeneca-farxiga-fda%252Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5%22%7D
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.217.204.244 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-54-217-204-244.eu-west-1.compute.amazonaws.com
Software
nginx/1.12.2 /
Resource Hash
d416c90f2c8c91b27e8c11d75da2f8e3940198b6b53a40c2731858b20c7bbfd3

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Access-Control-Allow-Origin
*
Date
Tue, 22 Oct 2019 15:30:23 GMT
Server
nginx/1.12.2
Connection
keep-alive
Content-Length
241
Content-Type
text/plain; charset=UTF-8
evidon-sitenotice-tag.js
c.evidon.com/sitenotice/
44 KB
12 KB
Script
General
Full URL
https://c.evidon.com/sitenotice/evidon-sitenotice-tag.js
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
23.45.108.200 , Netherlands, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a23-45-108-200.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
311f7c035bd8e2e36fdef1962231c004e48199087b73427a87499997210bfe16

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:23 GMT
content-encoding
gzip
vary
Accept-Encoding
status
200
content-length
11996
last-modified
Wed, 16 Oct 2019 16:58:44 GMT
server
AkamaiNetStorage
etag
"b42c671932dcdded523f9b56fb2dc206:1571245124"
access-control-max-age
86400
access-control-allow-methods
GET,OPTIONS,POST
content-type
application/x-javascript
access-control-allow-origin
cache-control
max-age=86400, private;max-age=86400
accept-ranges
bytes
access-control-allow-headers
*
expires
Wed, 23 Oct 2019 15:30:23 GMT
country.js
c.evidon.com/geo/
260 B
512 B
Script
General
Full URL
https://c.evidon.com/geo/country.js
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
23.45.108.200 , Netherlands, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a23-45-108-200.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
f9784f57729f84391b084eed9e944e048f771129d65e9b58f34095fdfba86473

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:23 GMT
last-modified
Wed, 30 May 2018 22:23:16 GMT
server
AkamaiNetStorage
status
200
etag
"c1e367d098d326049811561575dbda4a:1527718996"
access-control-max-age
86400
access-control-allow-methods
GET,OPTIONS,POST
content-type
application/x-javascript
access-control-allow-origin
accept-ranges
bytes
access-control-allow-headers
*
content-length
260
snthemes.js
c.evidon.com/sitenotice/1237/
47 KB
4 KB
Script
General
Full URL
https://c.evidon.com/sitenotice/1237/snthemes.js
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
23.45.108.200 , Netherlands, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a23-45-108-200.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
9acfa6b6f02010f813de948aa45812ab104fcbfd5a75d11b71574d0654b6edff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:23 GMT
content-encoding
gzip
vary
Accept-Encoding
status
200
content-length
3321
last-modified
Tue, 22 Oct 2019 14:50:17 GMT
server
AkamaiNetStorage
etag
"f9ff12f5449c57350ebacf667963ce79:1571755817"
access-control-max-age
86400
access-control-allow-methods
GET,OPTIONS,POST
content-type
application/x-javascript
access-control-allow-origin
cache-control
max-age=86400, private;max-age=86400
accept-ranges
bytes
access-control-allow-headers
*
expires
Wed, 23 Oct 2019 15:30:23 GMT
settings.js
c.evidon.com/sitenotice/1237/reuters/
7 KB
2 KB
Script
General
Full URL
https://c.evidon.com/sitenotice/1237/reuters/settings.js
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
23.45.108.200 , Netherlands, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a23-45-108-200.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
d317a796ec71a426b54a0d428e6f89ac3a593e4c95a9083d648ff3b59a561834

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:23 GMT
content-encoding
gzip
vary
Accept-Encoding
status
200
content-length
1856
last-modified
Tue, 22 Oct 2019 14:23:10 GMT
server
AkamaiNetStorage
etag
"a5a0770f4f82e6e927147e8aa98e9b4f:1571754190"
access-control-max-age
86400
access-control-allow-methods
GET,OPTIONS,POST
content-type
application/x-javascript
access-control-allow-origin
cache-control
max-age=86400, private;max-age=86400
accept-ranges
bytes
access-control-allow-headers
*
expires
Wed, 23 Oct 2019 15:30:23 GMT
analytics.min.js
cdn.segment.com/analytics.js/v1/IEWBqQ8VWHijTQxb7lEBGFGS9uIJzigZ/
332 KB
71 KB
Script
General
Full URL
https://cdn.segment.com/analytics.js/v1/IEWBqQ8VWHijTQxb7lEBGFGS9uIJzigZ/analytics.min.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.99.83 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-99-83.fra50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
b5eb1036a718795af24a1b9aaba0ce2cf74384aea489fac422467c3b6066e7e4

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-version-id
GWwT2wYzPv7nRke6aNi9WO4FQDe2D3uI
content-encoding
gzip
etag
"c858c6d81fad609f6cf9c6b955a2eeed"
x-amz-cf-pop
FRA50-C1
x-cache
Hit from cloudfront
status
200
x-amz-replication-status
COMPLETED
content-length
71907
access-control-allow-origin
*
last-modified
Mon, 21 Oct 2019 21:55:19 GMT
server
AmazonS3
date
Tue, 22 Oct 2019 15:16:45 GMT
access-control-max-age
3000
access-control-allow-methods
GET, HEAD
content-type
text/javascript; charset=utf-8
via
1.1 ea2e21f6a5c3ec2f96b0dac1b769e00e.cloudfront.net (CloudFront)
cache-control
public, max-age=300
accept-ranges
bytes
x-amz-cf-id
MQaYl3PKdOPjOqzccsDfJngBqc05D1FYxv8o9FXyo2RHLpuQIdNn9Q==
finance
wireapi.reuters.com/v7/feed/rcom/us/top-nav/
50 B
510 B
Fetch
General
Full URL
https://wireapi.reuters.com/v7/feed/rcom/us/top-nav/finance?count=7
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.7 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-7.fra50.r.cloudfront.net
Software
/
Resource Hash
eedaddf9c2b920f335c7c9830059d625f4251143e4b3fee53043f80c83663037

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:27:29 GMT
via
1.1 linkerd, 1.1 cdb2dba3874dd4d7b53213b8c63a0997.cloudfront.net (CloudFront)
x-amzn-remapped-server
nginx
x-amzn-remapped-date
Tue, 22 Oct 2019 15:27:29 GMT
x-amz-cf-pop
FRA50-C1
x-amzn-requestid
70cfa8d6-2461-4281-b8ad-e0a00c1275b8
x-cache
Error from cloudfront
status
404
l5d-success-class
1.0
x-amz-apigw-id
B-HrMH9yjoEFuVw=
content-length
50
vary
Origin
content-type
application/json;charset=UTF-8
access-control-allow-origin
*
x-amz-cf-id
H-LWf25rbws_CnM69DtJGmrxd9h84Or8mZS6iHjE5LLMb7lDymzfpA==
x-amzn-remapped-connection
keep-alive
markets
wireapi.reuters.com/v7/feed/rcom/us/top-nav/finance/
50 B
510 B
Fetch
General
Full URL
https://wireapi.reuters.com/v7/feed/rcom/us/top-nav/finance/markets?count=7
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.7 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-7.fra50.r.cloudfront.net
Software
/
Resource Hash
eedaddf9c2b920f335c7c9830059d625f4251143e4b3fee53043f80c83663037

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:27:29 GMT
via
1.1 linkerd, 1.1 cdb2dba3874dd4d7b53213b8c63a0997.cloudfront.net (CloudFront)
x-amzn-remapped-server
nginx
x-amzn-remapped-date
Tue, 22 Oct 2019 15:27:29 GMT
x-amz-cf-pop
FRA50-C1
x-amzn-requestid
a1e408ea-78e8-4b08-904c-824a50398d39
x-cache
Error from cloudfront
status
404
l5d-success-class
1.0
x-amz-apigw-id
B-HrMEjDIAMF-QA=
content-length
50
vary
Origin
content-type
application/json;charset=UTF-8
access-control-allow-origin
*
x-amz-cf-id
yf0Mb5tkIMnvMUBgkEtraZEUn91tSeA9t5S9OGaCVieW8Q24nyCmAw==
x-amzn-remapped-connection
keep-alive
world
wireapi.reuters.com/v7/feed/rcom/us/top-nav/news/
50 B
511 B
Fetch
General
Full URL
https://wireapi.reuters.com/v7/feed/rcom/us/top-nav/news/world?count=7
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.7 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-7.fra50.r.cloudfront.net
Software
/
Resource Hash
eedaddf9c2b920f335c7c9830059d625f4251143e4b3fee53043f80c83663037

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:27:29 GMT
via
1.1 linkerd, 1.1 cdb2dba3874dd4d7b53213b8c63a0997.cloudfront.net (CloudFront)
x-amzn-remapped-server
nginx
x-amzn-remapped-date
Tue, 22 Oct 2019 15:27:29 GMT
x-amz-cf-pop
FRA50-C1
x-amzn-requestid
f1c793bb-7bd8-4b6c-8bb4-86d5f8b2404f
x-cache
Error from cloudfront
status
404
l5d-success-class
1.0
x-amz-apigw-id
B-HrOFpUoAMF0Kg=
content-length
50
vary
Origin
content-type
application/json;charset=UTF-8
access-control-allow-origin
*
x-amz-cf-id
pSh3xna1sRFVoqiPpovPbCwjdNIAGEn9WwGCbZ6tCbh9uSEN5nBM3Q==
x-amzn-remapped-connection
keep-alive
politics
wireapi.reuters.com/v7/feed/rcom/us/top-nav/
50 B
511 B
Fetch
General
Full URL
https://wireapi.reuters.com/v7/feed/rcom/us/top-nav/politics?count=7
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.7 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-7.fra50.r.cloudfront.net
Software
/
Resource Hash
eedaddf9c2b920f335c7c9830059d625f4251143e4b3fee53043f80c83663037

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:27:29 GMT
via
1.1 linkerd, 1.1 cdb2dba3874dd4d7b53213b8c63a0997.cloudfront.net (CloudFront)
x-amzn-remapped-server
nginx
x-amzn-remapped-date
Tue, 22 Oct 2019 15:27:29 GMT
x-amz-cf-pop
FRA50-C1
x-amzn-requestid
93d23b80-735f-4a4a-aa91-a79ca358c451
x-cache
Error from cloudfront
status
404
l5d-success-class
1.0
x-amz-apigw-id
B-HrMEolIAMF_lA=
content-length
50
vary
Origin
content-type
application/json;charset=UTF-8
access-control-allow-origin
*
x-amz-cf-id
H5jPVBf-8s-SpWIEASS8vos-QQAnG6xtqPagRwDDE2SJyXtHqPVCUg==
x-amzn-remapped-connection
keep-alive
contextfeed.js
www.dianomi.com/js/
9 KB
3 KB
Script
General
Full URL
https://www.dianomi.com/js/contextfeed.js?
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/article.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.136.13 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
7a736b2f2091be24fcca895da408ed1bf5b0a66dbc3e27522864fe29652db3c8
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:23 GMT
content-encoding
br
x-content-type-options
nosniff
cf-cache-status
HIT
age
512
cf-polished
origSize=11527
status
200
x-xss-protection
1; mode=block
last-modified
Wed, 16 Oct 2019 11:34:07 GMT
server
cloudflare
etag
W/"2d07-595057a8e8736"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
expires
Tue, 22 Oct 2019 19:30:23 GMT
cache-control
public, max-age=14400
access-control-allow-credentials
true
cf-ray
529c8320db9dc2db-FRA
cf-bgj
minify
breakingNews
www.reuters.com/assets/
1 B
366 B
Fetch
General
Full URL
https://www.reuters.com/assets/breakingNews?view=json
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.128 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-128.fra50.r.cloudfront.net
Software
nginx /
Resource Hash
01ba4719c80b6fe911b091a7c05124b64eeece964e09c058ef8f9805daca546b

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:23 GMT
via
1.1 32e4d419823b7f8df8417a8b18c9602d.cloudfront.net (CloudFront)
server
nginx
x-amz-cf-pop
FRA50-C1
status
200
x-cache
Miss from cloudfront
content-type
application/json;charset=UTF-8
access-control-allow-origin
http://admin.reuters.com
access-control-allow-headers
Access-Control-Allow-Origin,charset
content-length
1
x-amz-cf-id
blyyEka3ihFWRhDuryhsbn2SjuHEpSNYqVwUmV3eZuNXBnDGRIhhBw==
expires
Tue, 22 Oct 2019 15:27:47 GMT
/
s3.reutersmedia.net/resources/r/
52 KB
52 KB
Image
General
Full URL
https://s3.reutersmedia.net/resources/r/?m=02&d=20191021&t=2&i=1443247775&r=LYNXMPEF9K0CN&w=1280
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.13 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-13.fra50.r.cloudfront.net
Software
nginx /
Resource Hash
544c336e3440df36db51ed958c7ae51a6c51d418b78fa05d2b45db7dbb3ac232

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 06:44:09 GMT
via
1.1 1d87c34bb2f20fda8e0841bc33179769.cloudfront.net (CloudFront)
x-amz-expiration
expiry-date="Thu, 21 Nov 2019 00:00:00 GMT", rule-id="ExpiraIn30Days"
last-modified
Mon, 21 Oct 2019 06:38:12 GMT
server
nginx
age
6664
etag
"5b6c07dc61b8f7179fd4a9f51a946816"
x-cache
Hit from cloudfront
x-amz-version-id
.Nwm_1eW4pZ3vOFkCcr7wuFyII2TLvkd
status
200
x-amz-cf-pop
FRA50-C1
content-type
image/jpeg
content-length
52973
x-amz-cf-id
J1WZij_reFVphSriIpZfXuBLV_YAwcmx8rEBdJfVrJJBwT5qcrKXyQ==
hotjar-65715.js
static.hotjar.com/c/
5 KB
3 KB
Script
General
Full URL
https://static.hotjar.com/c/hotjar-65715.js?sv=5
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-W9SLGS
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
147.75.101.51 Central, Hong Kong, ASN54825 (PACKET - Packet Host, Inc., US),
Reverse DNS
pkt-ams-k1-7
Software
openresty /
Resource Hash
7732aecc587b25f4d4b429fa86c05eb183b146476e9a25e6b9f3d5f19b680801
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:23 GMT
content-encoding
gzip
x-content-type-options
nosniff
section-io-tag
hotjar
age
50
status
200
section-io-cache
Hit
vary
Accept-Encoding
content-length
2392
server
openresty
cache-control
max-age=60
x-frame-options
SAMEORIGIN
etag
W/d8c24d1ea75f723b71d94adbd6348cbd
access-control-max-age
600
section-io-origin-status
304
access-control-allow-origin
*
x-cache-hit
1
section-io-origin-time-seconds
0.079
section-io-id
6aa5973d52a0005a13b28b1b454e8c83
accept-ranges
bytes
content-type
application/javascript
reuters.js
tru.am/scripts/custom/
1 KB
787 B
Script
General
Full URL
https://tru.am/scripts/custom/reuters.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-W9SLGS
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:a322 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6f23d93c9b8e3ca26f6fcc6be6a8d087e43a3f5795daa3c61017071642f66f3c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:23 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Thu, 14 Jun 2018 18:27:56 GMT
server
cloudflare
age
924
etag
W/"40b7d4de06dae04ec0d6537ef2f54db8"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=86400
cf-ray
529c83213fe05970-VIE
expires
Wed, 23 Oct 2019 15:30:23 GMT
load
experience.tinypass.com/xbuilder/experience/
4 KB
1 KB
Script
General
Full URL
https://experience.tinypass.com/xbuilder/experience/load?aid=TIDovF4cqC
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6810:4b33 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
bd1dc64fac45e75fffefbd76f176c6ea118ab79b88b3efddc5642d4e7c76d4fe

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:23 GMT
content-encoding
br
cf-cache-status
HIT
age
1512
p3p
CP="NON DSP COR OUR IND"
status
200
x-forwarded-https
on
x-request-id
Cj77szpYpRz
wn
prod-exp-10-0-6-10
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
accept-encoding
content-type
application/javascript;charset=utf-8
cache-control
public, max-age=1800
cf-ray
529c83212caf5a1e-VIE
expires
Tue, 22 Oct 2019 16:00:23 GMT
en.js
c.evidon.com/sitenotice/1237/translations/
55 KB
5 KB
Script
General
Full URL
https://c.evidon.com/sitenotice/1237/translations/en.js
Requested by
Host: c.evidon.com
URL: https://c.evidon.com/sitenotice/evidon-sitenotice-tag.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
23.45.108.200 , Netherlands, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a23-45-108-200.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
42ebce48f38ca99ec71f9cdc53e4555d4d0fbd8bdd1a0740e123e32d1b58502d

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:23 GMT
content-encoding
gzip
vary
Accept-Encoding
status
200
content-length
4709
last-modified
Mon, 14 Oct 2019 18:54:07 GMT
server
AkamaiNetStorage
etag
"bcc188e94557debbc19be771b7b3cee8:1571079247"
access-control-max-age
86400
access-control-allow-methods
GET,OPTIONS,POST
content-type
application/x-javascript
access-control-allow-origin
cache-control
max-age=86400, private;max-age=86400
accept-ranges
bytes
access-control-allow-headers
*
expires
Wed, 23 Oct 2019 15:30:23 GMT
iabevidonmapping.js
iabmap.evidon.com/
7 KB
3 KB
Script
General
Full URL
https://iabmap.evidon.com/iabevidonmapping.js
Requested by
Host: c.evidon.com
URL: https://c.evidon.com/sitenotice/evidon-sitenotice-tag.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:20eb:3000:10:27b4:f500:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
a092021e174c55591059b1000001f762a8f9dfb2620a5ab7a402ded82046192b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 22:34:12 GMT
content-encoding
gzip
last-modified
Tue, 08 Oct 2019 17:18:25 GMT
server
AmazonS3
age
73558
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
status
200
x-amz-cf-pop
FRA2-C1
x-amz-cf-id
qmOYDKIF82aYB8-Kh_5vh-iy0t0I5CFzt8T0jCYvqU6UOrgnVkasFw==
via
1.1 2ec3090d74e200e4acdb2780da3c3c44.cloudfront.net (CloudFront)
evidon-cmp.js
c.evidon.com/sitenotice/
23 KB
7 KB
Script
General
Full URL
https://c.evidon.com/sitenotice/evidon-cmp.js
Requested by
Host: c.evidon.com
URL: https://c.evidon.com/sitenotice/evidon-sitenotice-tag.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
23.45.108.200 , Netherlands, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a23-45-108-200.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
2c0255dc71491f7eb909fabf7c2a4111eb30b4373097086c5bf04e93804057dc

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:23 GMT
content-encoding
gzip
vary
Accept-Encoding
status
200
content-length
6652
last-modified
Wed, 16 Oct 2019 16:58:46 GMT
server
AkamaiNetStorage
etag
"cf000373b0fd7b697588ee13bd7024a8:1571245126"
access-control-max-age
86400
access-control-allow-methods
GET,OPTIONS,POST
content-type
application/x-javascript
access-control-allow-origin
cache-control
max-age=86400, private;max-age=86400
accept-ranges
bytes
access-control-allow-headers
*
expires
Wed, 23 Oct 2019 15:30:23 GMT
evidon-banner.js
c.evidon.com/sitenotice/
10 KB
3 KB
Script
General
Full URL
https://c.evidon.com/sitenotice/evidon-banner.js
Requested by
Host: c.evidon.com
URL: https://c.evidon.com/sitenotice/evidon-sitenotice-tag.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
23.45.108.200 , Netherlands, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a23-45-108-200.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
06d56458db165cd0ede7a6c23b441e81d0269feac7f8793d582253cc63e9db38

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:23 GMT
content-encoding
gzip
vary
Accept-Encoding
status
200
content-length
2958
last-modified
Wed, 16 Oct 2019 16:58:45 GMT
server
AkamaiNetStorage
etag
"119ff1c01eb744dc72c66e4d7f49b38b:1571245125"
access-control-max-age
86400
access-control-allow-methods
GET,OPTIONS,POST
content-type
application/x-javascript
access-control-allow-origin
cache-control
max-age=86400, private;max-age=86400
accept-ranges
bytes
access-control-allow-headers
*
expires
Wed, 23 Oct 2019 15:30:23 GMT
2
l.betrad.com/site/v3/1237/5669/3/1/2/
0
120 B
Image
General
Full URL
https://l.betrad.com/site/v3/1237/5669/3/1/2/2?consent=0
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.72.190.3 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-72-190-3.compute-1.amazonaws.com
Software
/ Express
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
204
date
Tue, 22 Oct 2019 15:30:23 GMT
content-encoding
gzip
x-powered-by
Express
etag
W/"a-bAsFyilMr4Ra1hIU5PyoyFRunpI"
vary
Accept-Encoding
js
www.google-analytics.com/gtm/
60 KB
22 KB
Script
General
Full URL
https://www.google-analytics.com/gtm/js?id=GTM-KBK7743&cid=599101512.1571758223
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:808::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
605b6328846dedec173402f4dadfaf7bc7fb60b8ae0087f2f9cc03fc44248219
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:23 GMT
content-encoding
br
last-modified
Tue, 22 Oct 2019 15:00:00 GMT
server
Google Tag Manager
access-control-allow-headers
Cache-Control
status
200
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
http://www.googletagmanager.com
cache-control
private, max-age=900
access-control-allow-credentials
true
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
22752
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:23 GMT
linkid.js
www.google-analytics.com/plugins/ua/
2 KB
995 B
Script
General
Full URL
https://www.google-analytics.com/plugins/ua/linkid.js
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:808::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
92fca55833f48b4289ac8f1cedd48752b580fce4ec4b5d81670b8193d6e51b54
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 14:59:49 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Thu, 21 Apr 2016 03:17:22 GMT
server
sffe
age
1834
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
public, max-age=3600
accept-ranges
bytes
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
856
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:59:49 GMT
fbevents.js
connect.facebook.net/en_US/
103 KB
22 KB
Script
General
Full URL
https://connect.facebook.net/en_US/fbevents.js
Requested by
Host: cdn.segment.com
URL: https://cdn.segment.com/analytics.js/v1/IEWBqQ8VWHijTQxb7lEBGFGS9uIJzigZ/analytics.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f01c:8012:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
/
Resource Hash
9404cee30e4489a7ed4d6de2dd92aa8e4386fd5ff1c81ebcea77f581952eac31
Security Headers
Name Value
Content-Security-Policy default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self';
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; preload; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
status
200
alt-svc
h3-23=":443"; ma=3600
content-length
22458
x-xss-protection
0
pragma
public
x-fb-debug
7mCLW19I8pZ6guMO7pYzSageUcu2ObVMQOrLTwWj/4GSoqeTN3QkblLeqqNa6qc0rLxpk5njZZ0zM+jBHPXmlw==
x-fb-trip-id
2114237953
x-frame-options
DENY
date
Tue, 22 Oct 2019 15:30:23 GMT
vary
Accept-Encoding
content-type
application/x-javascript; charset=utf-8
cache-control
public, max-age=1200
content-security-policy
default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self';
expires
Sat, 01 Jan 2000 00:00:00 GMT
61500
l.betrad.com/site/v3/1237/5669/3/1/2/2/
0
120 B
Image
General
Full URL
https://l.betrad.com/site/v3/1237/5669/3/1/2/2/61500?consent=0
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.72.190.3 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-72-190-3.compute-1.amazonaws.com
Software
/ Express
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
204
date
Tue, 22 Oct 2019 15:30:23 GMT
content-encoding
gzip
x-powered-by
Express
etag
W/"a-bAsFyilMr4Ra1hIU5PyoyFRunpI"
vary
Accept-Encoding
context.pl
www.dianomi.com/cgi-bin/
2 KB
778 B
XHR
General
Full URL
https://www.dianomi.com/cgi-bin/context.pl?id=4&h=www.reuters.com
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/contextfeed.js?
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.136.13 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
20a6d2b7cfb04122ea4af740a815984fc15ffe7cbde0f298d70301b04fe27ff0
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:23 GMT
content-encoding
br
x-content-type-options
nosniff
cf-cache-status
DYNAMIC
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
content-type
application/json; charset=ISO-8859-1
access-control-allow-origin
https://www.reuters.com
cache-control
private, max-age=600
access-control-allow-credentials
true
cf-ray
529c8321a98197a2-FRA
x-xss-protection
1; mode=block
expires
Tue, 22 Oct 2019 15:31:23 GMT
61500
l.betrad.com/site/v3/1237/5669/3/4/2/2/
0
120 B
Image
General
Full URL
https://l.betrad.com/site/v3/1237/5669/3/4/2/2/61500?consent=0
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.72.190.3 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-72-190-3.compute-1.amazonaws.com
Software
/ Express
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
204
date
Tue, 22 Oct 2019 15:30:23 GMT
content-encoding
gzip
x-powered-by
Express
etag
W/"a-bAsFyilMr4Ra1hIU5PyoyFRunpI"
vary
Accept-Encoding
vendorlist.json
vendorlist.consensu.org/
88 KB
17 KB
XHR
General
Full URL
https://vendorlist.consensu.org/vendorlist.json
Requested by
Host: c.evidon.com
URL: https://c.evidon.com/sitenotice/evidon-cmp.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:21f3:c800:1:af78:4c0:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
3e25214e79eab3cf412ea2fec1eee887baf77be4448461d72f2af47ee093128a

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-version-id
dDurJJk9w9s3FJNGQzpcI8tyg.M9IFSK
content-encoding
gzip
vary
Origin,Access-Control-Request-Headers,Access-Control-Request-Method
age
23314
x-cache
Hit from cloudfront
status
200
access-control-allow-origin
*
last-modified
Fri, 18 Oct 2019 08:50:37 GMT
server
AmazonS3
date
Tue, 22 Oct 2019 09:01:50 GMT
access-control-max-age
86400
access-control-allow-methods
GET
content-type
application/json; charset=utf-8
via
1.1 cc0ab20766d57035422a2c4c69fe0620.cloudfront.net (CloudFront)
cache-control
max-age=259200
x-amz-cf-pop
FRA2-C2
x-amz-cf-id
NrKSml1qJWKArLKzt2066s-_gduCBZt6VWNZTVC5pDofiTq-MBMSaA==
modules.cf993f1180b3bef0c641.js
script.hotjar.com/
436 KB
74 KB
Script
General
Full URL
https://script.hotjar.com/modules.cf993f1180b3bef0c641.js
Requested by
Host: static.hotjar.com
URL: https://static.hotjar.com/c/hotjar-65715.js?sv=5
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
147.75.85.103 Parsippany, United States, ASN54825 (PACKET - Packet Host, Inc., US),
Reverse DNS
pkt-ams-k1-11
Software
/
Resource Hash
2a87d714442a06af96c943556506ce28717d07ad7142535cf4701848aa8895ac

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:23 GMT
content-encoding
br
last-modified
Tue, 22 Oct 2019 09:13:46 GMT
status
200
etag
"aa85afd469cc0ddf58f41b335baa4d85"
vary
Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
max-age=31536000
section-io-origin-time-seconds
0.042
section-io-origin-status
200
accept-ranges
bytes
section-io-id
56d5327341929236baeb290397fa4a4d
content-length
75465
tinypass.min.js
cdn.tinypass.com/api/
366 KB
116 KB
Script
General
Full URL
https://cdn.tinypass.com/api/tinypass.min.js
Requested by
Host: experience.tinypass.com
URL: https://experience.tinypass.com/xbuilder/experience/load?aid=TIDovF4cqC
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6810:4b33 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
249eca16ce578de148647856386d86fe20acbfa3a02b6618c90a1d5faedbbeb7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:23 GMT
content-encoding
br
cf-cache-status
HIT
age
157
p3p
CP="NON DSP COR OUR IND"
status
200
wn
prod-dash-10-0-1-142
last-modified
Mon, 21 Oct 2019 15:16:06 GMT
server
cloudflare
etag
W/"374421-1571670966000-gzip"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
cache-control
public, max-age=300
cf-ray
529c8321bd115a1e-VIE
expires
Tue, 22 Oct 2019 15:35:23 GMT
ta-pagesocial-sdk.js
tru.am/scripts/
35 KB
12 KB
Script
General
Full URL
https://tru.am/scripts/ta-pagesocial-sdk.js
Requested by
Host: tru.am
URL: https://tru.am/scripts/custom/reuters.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:a322 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
2b8d8ef7fec86e16424f0c6be7f0471a0c29256e074e1336d92876ddb4bc09ff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:23 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Thu, 18 Apr 2019 03:51:14 GMT
server
cloudflare
age
5813
etag
W/"942d5ae1e512ccdf18813550428dd002"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=86400
cf-ray
529c8321a8095970-VIE
expires
Wed, 23 Oct 2019 15:30:23 GMT
nativeai.js
cdn.native.ai/js/current/
130 KB
43 KB
Script
General
Full URL
https://cdn.native.ai/js/current/nativeai.js?1571270400000
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.85.183.93 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-52-85-183-93.fra50.r.cloudfront.net
Software
nginx / ASP.NET
Resource Hash
bfcea73208d9a1f1a1f89d306cdff89c8d4a8740f0e7ab8b84501c1b86f3fd94

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:20:23 GMT
Content-Encoding
gzip
Connection
keep-alive
Last-Modified
Fri, 12 Jul 2019 21:55:34 GMT
Server
nginx
Age
259
X-Powered-By
ASP.NET
Vary
Accept-Encoding
X-Cache
RefreshHit from cloudfront
Content-Type
application/javascript
Via
1.1 74f98ee8547ec50a6b9a4c3d010e1e0d.cloudfront.net (CloudFront)
Cache-Control
max-age=0,must-revalidate
Transfer-Encoding
chunked
X-Amz-Cf-Pop
FRA50
X-Amz-Cf-Id
KDk5bPa4UzJ4gkwuYk0p0Cdv9wpS6039tItTGIwULRfqbJtv4Sun5w==
ads.js
www.reuters.com/
112 B
514 B
Script
General
Full URL
https://www.reuters.com/ads.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-W9SLGS
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.128 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-128.fra50.r.cloudfront.net
Software
nginx /
Resource Hash
7464555aae6d8d87b77f7170fba1698ff64f7454ded58627ca1819246e9a9969

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:23 GMT
content-encoding
gzip
server
nginx
x-amz-cf-pop
FRA50-C1
status
200
vary
Accept-Encoding
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
http://admin.reuters.com
access-control-allow-headers
Access-Control-Allow-Origin,charset
content-length
116
via
1.1 32e4d419823b7f8df8417a8b18c9602d.cloudfront.net (CloudFront)
x-amz-cf-id
5igreO64IVVQevM8D3dTgp0W-s6fPqw5i5p5HHQiQosvA7oWtpD1rA==
expires
Tue, 22 Oct 2019 15:28:13 GMT
312961195854690
connect.facebook.net/signals/config/
280 KB
65 KB
Script
General
Full URL
https://connect.facebook.net/signals/config/312961195854690?v=2.9.5&r=stable
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f01c:8012:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
/
Resource Hash
f0accb42c769145b6d141864835eba045063021590a01aa8bcce348573ebb188
Security Headers
Name Value
Content-Security-Policy default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; preload; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
status
200
alt-svc
h3-23=":443"; ma=3600
content-length
66234
x-xss-protection
0
pragma
public
x-fb-debug
51cv88GEbYFwvn6JY3QKD57kvQjCJ/S9/rdYffFONLUlW05shCr4qpwa3H5bPXUZqjY+FVMZqTlnvG/RDbRrTg==
x-fb-trip-id
2114237953
x-frame-options
DENY
date
Tue, 22 Oct 2019 15:30:23 GMT
vary
Accept-Encoding
content-type
application/x-javascript; charset=utf-8
cache-control
public, max-age=1200
content-security-policy
default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
expires
Sat, 01 Jan 2000 00:00:00 GMT
article-recirc
sope.prod.reuters.tv/program/rcom/v1/
13 KB
13 KB
Fetch
General
Full URL
https://sope.prod.reuters.tv/program/rcom/v1/article-recirc?edition=us&pageid=USKBN1X00J5&modules=rightrail,ribbon,bottom
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f18:624f:b000:4319:b1c8:f4e4:70ed Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
Software
nginx/1.14.0 (Ubuntu) /
Resource Hash
5926373e0f7c2b519fa3d0fe502ee7e87b172046d83127b040cfa1a2685550d6

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
seq
bbcda71e-61ba-4ac2-ab5a-f6741cc03441

Response headers

date
Tue, 22 Oct 2019 15:30:23 GMT
x-origin
i-0593a16bfc5146c6e.sope.prod.us.reuters.tv
server
nginx/1.14.0 (Ubuntu)
x-amzn-trace-id
Root=1-5daf208f-ff05006dc6a4f44c7d7fae95
status
200
content-type
application/json
access-control-allow-origin
*
access-control-allow-headers
connection, range, accept-encoding, user-agent, referer, seq
content-length
12868
getcookie
evidon.mgr.consensu.org/iab/
169 B
380 B
Script
General
Full URL
https://evidon.mgr.consensu.org/iab/getcookie
Requested by
Host: c.evidon.com
URL: https://c.evidon.com/sitenotice/evidon-cmp.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.87.16.121 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-87-16-121.compute-1.amazonaws.com
Software
/
Resource Hash
9b133863146a5f391e8cee0842cafc7498ae89b6f79edbecfc842055342c1fe2

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:23 GMT
x-amzn-requestid
27bd5f71-d0e4-4aef-9aa2-2e3a1a5476d3
status
200
content-type
text/javascript
access-control-allow-origin
*
x-amzn-trace-id
Root=1-5daf208f-45be68b07a8b4020d543a12c;Sampled=0
x-amz-apigw-id
B-IGfETpoAMF3sA=
content-length
169
beacon
beacon.tru.am/
0
352 B
Fetch
General
Full URL
https://beacon.tru.am/beacon
Requested by
Host: tru.am
URL: https://tru.am/scripts/ta-pagesocial-sdk.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:a322 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
application/x-www-form-urlencoded;charset=UTF-8

Response headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:23 GMT
via
1.1 google
cf-cache-status
DYNAMIC
server
cloudflare
status
200
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Origin
access-control-allow-origin
https://www.reuters.com
cache-control
no-cache, private, max-age=0
cf-ray
529c83222d5c8cb6-VIE
content-length
0
expires
Thu, 01 Jan 1970 00:00:00 UTC
beacon.js
sb.scorecardresearch.com/
1 KB
1 KB
Script
General
Full URL
https://sb.scorecardresearch.com/beacon.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.19.43.224 , Ascension Island, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a2-19-43-224.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
76c393f564f53c19e795307e622edc8657a603f7a816c2646385697286d11313

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:23 GMT
Content-Encoding
gzip
Vary
Accept-Encoding
Content-Type
application/x-javascript
Cache-Control
private, no-transform, max-age=86400
Connection
keep-alive
Content-Length
902
Expires
Wed, 23 Oct 2019 15:30:23 GMT
gwiq.js
gwiqcdn.globalwebindex.net/gwiq/
14 KB
15 KB
Script
General
Full URL
https://gwiqcdn.globalwebindex.net/gwiq/gwiq.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.201.93.216 , Ascension Island, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
216.93.201.35.bc.googleusercontent.com
Software
UploadServer /
Resource Hash
2f78a9f3d1d4b5078213d39c3f51ea1f5b72d91793a9e3fa14612e9d1add543d

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:15:59 GMT
age
864
x-guploader-uploadid
AEnB2UoXz7VFff2CqRn6vRTrwc7f-s672hkD1aw9p_8Wz6fmmCCJCcfJ_wjE3r2IFkzuE_e2YI4GaR4ghCQdThoFo06fnUBx2g
x-goog-storage-class
MULTI_REGIONAL
status
200
x-goog-metageneration
3
x-goog-stored-content-encoding
identity
alt-svc
clear
content-length
14561
last-modified
Fri, 22 Mar 2019 17:21:14 GMT
server
UploadServer
etag
"7bb2a0f8543ca52adc2740318f3b8331"
x-goog-hash
crc32c=CMb65Q==, md5=e7Kg+FQ8pSrcJ0AxjzuDMQ==
x-goog-generation
1553275274038866
cache-control
public, max-age=3600
x-goog-stored-content-length
14561
accept-ranges
bytes
content-type
application/javascript
expires
Tue, 22 Oct 2019 16:15:59 GMT
box-74dcf4e32eff343c96838bf3a780ac1d.html
vars.hotjar.com/ Frame 6D1B
0
0
Document
General
Full URL
https://vars.hotjar.com/box-74dcf4e32eff343c96838bf3a780ac1d.html
Requested by
Host: static.hotjar.com
URL: https://static.hotjar.com/c/hotjar-65715.js?sv=5
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
147.75.84.99 Parsippany, United States, ASN54825 (PACKET - Packet Host, Inc., US),
Reverse DNS
Software
/
Resource Hash

Request headers

:method
GET
:authority
vars.hotjar.com
:scheme
https
:path
/box-74dcf4e32eff343c96838bf3a780ac1d.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
accept-encoding
gzip, deflate, br
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5

Response headers

status
200
date
Tue, 22 Oct 2019 15:30:23 GMT
content-type
text/html
content-length
808
cache-control
max-age=31536000
content-encoding
br
last-modified
Tue, 22 Oct 2019 14:07:08 GMT
etag
"e97b43816dfbff056689db51ae5cdfc7"
section-io-origin-status
200
section-io-origin-time-seconds
0.029
vary
Accept-Encoding
accept-ranges
bytes
section-io-id
edcdf8fee3037c3d7bb519ffea700de3
execute
experience.tinypass.com/xbuilder/experience/
2 KB
1 KB
XHR
General
Full URL
https://experience.tinypass.com/xbuilder/experience/execute?aid=TIDovF4cqC
Requested by
Host: cdn.tinypass.com
URL: https://cdn.tinypass.com/api/tinypass.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6810:4b33 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
a21cb36693b3b20fbd65056a6a5712808171f78551c8994a58bcfd7b85305f4c

Request headers

Accept
*/*
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

date
Tue, 22 Oct 2019 15:30:23 GMT
content-encoding
br
cf-cache-status
DYNAMIC
p3p
CP="NON DSP COR OUR IND"
status
200
x-forwarded-https
on
x-request-id
Cne8szpGjeH
pragma
no-cache
wn
prod-exp-10-0-1-192
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
access-control-allow-methods
POST, GET, OPTIONS
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.reuters.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cf-ray
529c83225d6d5a1e-VIE
expires
Thu, 01 Jan 1970 00:00:00 GMT
b2
sb.scorecardresearch.com/
Redirect Chain
  • https://sb.scorecardresearch.com/b?c1=2&c2=6035630&ns__t=1571758223775&ns_c=UTF-8&cv=3.1e&c8=FDA%20approves%20AstraZeneca%20diabetes%20drug%20for%20treating%20heart%20failure%20risk%20-%20Reuters&c...
  • https://sb.scorecardresearch.com/b2?c1=2&c2=6035630&ns__t=1571758223775&ns_c=UTF-8&cv=3.1e&c8=FDA%20approves%20AstraZeneca%20diabetes%20drug%20for%20treating%20heart%20failure%20risk%20-%20Reuters&...
0
248 B
Image
General
Full URL
https://sb.scorecardresearch.com/b2?c1=2&c2=6035630&ns__t=1571758223775&ns_c=UTF-8&cv=3.1e&c8=FDA%20approves%20AstraZeneca%20diabetes%20drug%20for%20treating%20heart%20failure%20risk%20-%20Reuters&c7=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-farxiga-fda%2Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&c9=
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.19.43.224 , Ascension Island, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a2-19-43-224.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:23 GMT
Cache-Control
private, no-cache, no-cache=Set-Cookie, no-store, proxy-revalidate
Connection
keep-alive
Content-Length
0
Expires
Mon, 01 Jan 1990 00:00:00 GMT

Redirect headers

Location
https://sb.scorecardresearch.com/b2?c1=2&c2=6035630&ns__t=1571758223775&ns_c=UTF-8&cv=3.1e&c8=FDA%20approves%20AstraZeneca%20diabetes%20drug%20for%20treating%20heart%20failure%20risk%20-%20Reuters&c7=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-farxiga-fda%2Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&c9=
Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:23 GMT
Cache-Control
private, no-cache, no-cache=Set-Cookie, no-store, proxy-revalidate
Connection
keep-alive
Content-Length
0
Expires
Mon, 01 Jan 1990 00:00:00 GMT
dianomi-context.css
www.dianomi.com/partner/dianomi/css/
169 B
246 B
Stylesheet
General
Full URL
https://www.dianomi.com/partner/dianomi/css/dianomi-context.css?v=1.1
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/contextfeed.js?
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.136.13 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
99781410070a5dd4d753fdb8a46f4272082b5be64541dcfcb1b2d3c4aea09c6c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:23 GMT
content-encoding
br
x-content-type-options
nosniff
cf-cache-status
HIT
age
515
cf-polished
origSize=199
status
200
x-xss-protection
1; mode=block
last-modified
Mon, 21 Jan 2019 12:43:41 GMT
server
cloudflare
etag
W/"c7-57ff735e16ce7"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/css; charset=utf-8
access-control-allow-origin
*
expires
Tue, 22 Oct 2019 19:30:23 GMT
cache-control
public, max-age=14400
access-control-allow-credentials
true
cf-ray
529c8322b96cc2db-FRA
cf-bgj
minify
smartads.epl
www.dianomi.com/ Frame EDCC
0
0
Document
General
Full URL
https://www.dianomi.com/smartads.epl?id=4728&num_ads=5&shuffle=0&cf=545.4.Reuters%20v3.1
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/contextfeed.js?
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.136.13 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

:method
GET
:authority
www.dianomi.com
:scheme
https
:path
/smartads.epl?id=4728&num_ads=5&shuffle=0&cf=545.4.Reuters%20v3.1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
accept-encoding
gzip, deflate, br
cookie
__cfduid=dcc86932d6156a42ad2cf4a2b60c282d71571758223
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5

Response headers

status
200
date
Tue, 22 Oct 2019 15:30:23 GMT
content-type
text/html; charset=UTF-8
x-content-type-options
nosniff
x-xss-protection
1; mode=block
access-control-allow-origin
*
access-control-allow-credentials
true
expires
now
pragma
no-cache
cache-control
no-cache,no-store,private
link
</img/a/pss/2649/23.css>;rel=preload;as=style
vary
Accept-Encoding, User-Agent
cf-cache-status
DYNAMIC
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
server
cloudflare
cf-ray
529c8322c992c2db-FRA
content-encoding
br
cf-h2-pushed
</img/a/pss/2649/23.css>
videofeed-combined.js
www.dianomi.com/js/
15 KB
4 KB
Script
General
Full URL
https://www.dianomi.com/js/videofeed-combined.js?id=33
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/contextfeed.js?
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.136.13 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
d31b1f947a51cfdc97520d53eb6610e8abf104e48569fb8069e917ffe5c7a617
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:23 GMT
content-encoding
br
x-content-type-options
nosniff
cf-cache-status
HIT
age
515
cf-polished
origSize=20718
status
200
x-xss-protection
1; mode=block
last-modified
Wed, 09 Oct 2019 10:58:47 GMT
server
cloudflare
etag
W/"50ee-594782b536c0d"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
expires
Tue, 22 Oct 2019 19:30:23 GMT
cache-control
public, max-age=14400
access-control-allow-credentials
true
cf-ray
529c8322c98fc2db-FRA
cf-bgj
minify
recirculation.epl
www.dianomi.com/ Frame 5D8C
0
0
Document
General
Full URL
https://www.dianomi.com/recirculation.epl?id=98&cf=545.4.Reuters%20v3.1
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/contextfeed.js?
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.136.13 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

:method
GET
:authority
www.dianomi.com
:scheme
https
:path
/recirculation.epl?id=98&cf=545.4.Reuters%20v3.1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
accept-encoding
gzip, deflate, br
cookie
__cfduid=dcc86932d6156a42ad2cf4a2b60c282d71571758223
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5

Response headers

status
200
date
Tue, 22 Oct 2019 15:30:23 GMT
content-type
text/html; charset=utf-8
x-content-type-options
nosniff
x-xss-protection
1; mode=block
access-control-allow-origin
*
access-control-allow-credentials
true
vary
Accept-Encoding, User-Agent
cf-cache-status
DYNAMIC
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
server
cloudflare
cf-ray
529c8322c994c2db-FRA
content-encoding
br
recirculation.epl
www.dianomi.com/ Frame EFC8
0
0
Document
General
Full URL
https://www.dianomi.com/recirculation.epl?id=99&start=6&cf=545.4.Reuters%20v3.1
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/contextfeed.js?
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.136.13 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

:method
GET
:authority
www.dianomi.com
:scheme
https
:path
/recirculation.epl?id=99&start=6&cf=545.4.Reuters%20v3.1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
accept-encoding
gzip, deflate, br
cookie
__cfduid=dcc86932d6156a42ad2cf4a2b60c282d71571758223
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5

Response headers

status
200
date
Tue, 22 Oct 2019 15:30:23 GMT
content-type
text/html; charset=utf-8
x-content-type-options
nosniff
x-xss-protection
1; mode=block
access-control-allow-origin
*
access-control-allow-credentials
true
vary
Accept-Encoding, User-Agent
cf-cache-status
DYNAMIC
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
server
cloudflare
cf-ray
529c8322c998c2db-FRA
content-encoding
br
lazyload.iife.min.js
cdnjs.cloudflare.com/ajax/libs/vanilla-lazyload/10.20.1/
5 KB
2 KB
Script
General
Full URL
https://cdnjs.cloudflare.com/ajax/libs/vanilla-lazyload/10.20.1/lazyload.iife.min.js
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/contextfeed.js?
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6813:c797 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
3c514d4fb8244af230a89d2203522c6a67a55a3f161cfd4fca9f53301c0588ff
Security Headers
Name Value
Strict-Transport-Security max-age=15780000; includeSubDomains

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:23 GMT
content-encoding
br
vary
Accept-Encoding
cf-cache-status
HIT
age
16392077
status
200
alt-svc
h3-23=":443"; ma=86400
served-in-seconds
0.028
timing-allow-origin
*
last-modified
Sun, 17 Feb 2019 22:45:49 GMT
server
cloudflare
etag
W/"5c69e41d-14cf"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
strict-transport-security
max-age=15780000; includeSubDomains
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
public, max-age=30672000
cf-ray
529c8322c9a859b2-VIE
expires
Sun, 11 Oct 2020 15:30:23 GMT
dianomi-max-200x38.png
www.dianomi.com/img/
9 KB
9 KB
Image
General
Full URL
https://www.dianomi.com/img/dianomi-max-200x38.png
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.136.13 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
e4ec107483b9a2de4a043bad835b700257cfac8308ec6d00f760f1ff6eccfc6e
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:23 GMT
x-content-type-options
nosniff
cf-cache-status
HIT
age
22131
cf-polished
origFmt=png, origSize=31456
status
200
content-disposition
inline; filename="dianomi-max-200x38.webp"
content-length
8976
x-xss-protection
1; mode=block
last-modified
Tue, 23 May 2017 10:48:47 GMT
server
cloudflare
etag
"7ae0-5502ebb78747a"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept
content-type
image/webp
access-control-allow-origin
*
expires
Fri, 22 Nov 2019 01:30:23 GMT
cache-control
public, max-age=2628000
access-control-allow-credentials
true
accept-ranges
bytes
cf-ray
529c8322c99cc2db-FRA
cf-bgj
imgq:85
pixeltrack.pl
www.dianomi.com/cgi-bin/
77 B
184 B
Image
General
Full URL
https://www.dianomi.com/cgi-bin/pixeltrack.pl?cf=545.4.Reuters%20v3.1
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.136.13 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
d4fa79afcf5a5cc5a0f12dedaf825f11530e6397d723fe7044cd37ba3c248e57
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:23 GMT
x-content-type-options
nosniff
cf-cache-status
DYNAMIC
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
content-type
image/gif; charset=ISO-8859-1
access-control-allow-origin
*
access-control-allow-credentials
true
cf-ray
529c8322c99fc2db-FRA
content-length
77
x-xss-protection
1; mode=block
expires
Mon, 21 Oct 2019 15:30:23 GMT
truncated
/
49 KB
49 KB
Font
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
45610b21279531a97f9566b0f0f8a1d287a45ae4bc6bc545971af5cd7e393cc6

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Origin
https://www.reuters.com

Response headers

Content-Type
application/font-woff
truncated
/
38 B
38 B
Other
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
52dc24c0429ea6ccc5b579a6da8bb79bf41e471fe5108a62009f3c2e195551c0

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/webp
smartads_video_json.pl
www.dianomi.com/cgi-bin/
3 B
148 B
XHR
General
Full URL
https://www.dianomi.com/cgi-bin/smartads_video_json.pl?id=4729&cf=545.4.Reuters%20v3.1
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/videofeed-combined.js?id=33
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.136.13 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
ca3d163bab055381827226140568f3bef7eaac187cebd76878e0b63e9e442356
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:23 GMT
content-encoding
br
x-content-type-options
nosniff
cf-cache-status
DYNAMIC
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.reuters.com
cache-control
private, no-cache, no-store, must-revalidate, max-age=0, pre-check=0, post-check=0
access-control-allow-credentials
true
cf-ray
529c83230b6b97a2-FRA
x-xss-protection
1; mode=block
p
api.segment.io/v1/
21 B
141 B
XHR
General
Full URL
https://api.segment.io/v1/p
Requested by
Host: cdn.segment.com
URL: https://cdn.segment.com/analytics.js/v1/IEWBqQ8VWHijTQxb7lEBGFGS9uIJzigZ/analytics.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.27.125.121 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-52-27-125-121.us-west-2.compute.amazonaws.com
Software
/
Resource Hash
12f71cb993958eefc4bdb41d7dbbda490779a9c7aba448f7be52bb63912e0254

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

status
200
date
Tue, 22 Oct 2019 15:30:24 GMT
access-control-allow-origin
https://www.reuters.com
content-length
21
vary
Origin
content-type
application/json
/
www.facebook.com/tr/
44 B
247 B
Image
General
Full URL
https://www.facebook.com/tr/?id=312961195854690&ev=PageView&dl=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-farxiga-fda%2Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&rl=&if=false&ts=1571758224097&sw=1600&sh=1200&v=2.9.5&r=stable&a=seg&ec=0&o=30&fbp=fb.1.1571758224096.1184693481&it=1571758223622&coo=false&rqm=GET
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f11c:8183:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
10d8d42d73a02ddb877101e72fbfa15a0ec820224d97cedee4cf92d571be5caa
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:24 GMT
last-modified
Fri, 21 Dec 2012 00:00:01 GMT
server
proxygen-bolt
strict-transport-security
max-age=31536000; includeSubDomains
content-type
image/gif
status
200
cache-control
no-cache, must-revalidate, max-age=0
alt-svc
h3-23=":443"; ma=3600
content-length
44
expires
Tue, 22 Oct 2019 15:30:24 GMT
collect
www.google-analytics.com/
35 B
99 B
Image
General
Full URL
https://www.google-analytics.com/collect?v=1&_v=j79&a=1172262690&t=pageview&_s=1&dl=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-farxiga-fda%2Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&dp=%2Farticle%2Fus-astrazeneca-farxiga-fda%2Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&ul=en-us&de=UTF-8&dt=FDA%20approves%20AstraZeneca%20diabetes%20drug%20for%20treating%20heart%20failure%20risk&sd=24-bit&sr=1600x1200&vp=1585x1200&je=0&_u=aGDAiEAjR~&jid=2010143685&gjid=1080161227&cid=599101512.1571758223&tid=UA-24152976-22&_gid=2001321523.1571758223&cd2=Homepage&cd11=us-astrazeneca-farxiga-fda%2Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk&cd4=News&cd8=0&cd10=False&cd9=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-farxiga-fda%2Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&cd19=Page%20Load&cd7=Desktop&cd14=USKBN1X00J5&cd6=U.S.&cd5=Article&cd17=Reuters%20Editorial&cd3=Homepage%20-%20Homepage&cd1=Homepage&cd13=268&cd18=FDA%20approves%20AstraZeneca%20diabetes%20drug%20for%20treating%20heart%20failure%20risk&z=67957859
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:808::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
8337212354871836e6763a41e615916c89bac5b3f1f0adf60ba43c7c806e1015
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Wed, 09 Oct 2019 13:15:43 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
age
1131281
status
200
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
35
expires
Mon, 01 Jan 1990 00:00:00 GMT
ga-audiences
www.google.de/ads/
Redirect Chain
  • https://stats.g.doubleclick.net/r/collect?t=dc&aip=1&_r=3&v=1&_v=j79&tid=UA-24152976-22&cid=599101512.1571758223&jid=2010143685&gjid=1080161227&_gid=2001321523.1571758223&_u=aGDAiEAjR~&z=138488704
  • https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=599101512.1571758223&jid=2010143685&_v=j79&z=138488704
  • https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=599101512.1571758223&jid=2010143685&_v=j79&z=138488704&slf_rd=1&random=1418846269
42 B
109 B
Image
General
Full URL
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=599101512.1571758223&jid=2010143685&_v=j79&z=138488704&slf_rd=1&random=1418846269
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:24 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
cache-control
no-cache, no-store, must-revalidate
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:24 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
302
content-type
text/html; charset=UTF-8
location
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=599101512.1571758223&jid=2010143685&_v=j79&z=138488704&slf_rd=1&random=1418846269
cache-control
no-cache, no-store, must-revalidate
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
0b9ae0631dc9cb1d12dd2eb240ef07bb.png
static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/
22 KB
9 KB
Image
General
Full URL
https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/0b9ae0631dc9cb1d12dd2eb240ef07bb.png
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.225.78.91 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-225-78-91.fra2.r.cloudfront.net
Software
nginx /
Resource Hash
9f9104dee58871cdb561e4f139fcf095a2fc1fcb0a7778a964975e6b12059c6a

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/article.bundle.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 19:00:24 GMT
content-encoding
gzip
age
73800
x-cache
Hit from cloudfront
status
200
content-length
9050
last-modified
Fri, 18 Oct 2019 18:58:43 GMT
server
nginx
vary
Accept-Encoding
content-type
image/png
via
1.1 90cf045072373c2c671297de3161846f.cloudfront.net (CloudFront)
cache-control
max-age=86400
x-amz-cf-pop
FRA2-C2
accept-ranges
bytes
x-amz-cf-id
7Od7IYEC59i1Ll19C8t1E0CCaGUOmj9TDlbi6ivQMVyDBk-dlPBQeg==
expires
Tue, 22 Oct 2019 19:00:24 GMT
/
static.reuters.com/resources/r/
3 KB
4 KB
Image
General
Full URL
https://static.reuters.com/resources/r/?m=02&d=20191021&t=2&i=1443416505&r=LYNXMPEF9K1AY&w=120
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.225.78.91 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-225-78-91.fra2.r.cloudfront.net
Software
nginx /
Resource Hash
d90d7d5ced0f4fbd1be3ac5c73c3a1be826082e352fd219e987682de3ba00f95

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 16:39:50 GMT
via
1.1 90cf045072373c2c671297de3161846f.cloudfront.net (CloudFront)
x-amz-expiration
expiry-date="Thu, 21 Nov 2019 00:00:00 GMT", rule-id="ExpiraIn30Days"
last-modified
Mon, 21 Oct 2019 16:27:57 GMT
server
nginx
age
82195
etag
"6244ccc53daab6e1fa861e036141b20f"
x-cache
Hit from cloudfront
x-amz-version-id
x7oZbTHICwJXx3ZIIj1ETtPTIJL_W4UD
status
200
x-amz-cf-pop
FRA2-C2
content-type
image/jpeg
content-length
3389
x-amz-cf-id
ZVG7TZnW9wVbZ2JHa9ShvN0_0AeuXfGiDS-N1Yc5ahkRTbVq_qdRzQ==
/
static.reuters.com/resources/r/
2 KB
3 KB
Image
General
Full URL
https://static.reuters.com/resources/r/?m=02&d=20191022&t=2&i=1443692184&r=LYNXMPEF9L0UM&w=120
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.225.78.91 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-225-78-91.fra2.r.cloudfront.net
Software
nginx /
Resource Hash
5d4679a9bd79e6cae720fe200458a84f582ef16845e1cbe8945bdea7bb789ac4

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 14:05:23 GMT
via
1.1 90cf045072373c2c671297de3161846f.cloudfront.net (CloudFront)
x-amz-expiration
expiry-date="Fri, 22 Nov 2019 00:00:00 GMT", rule-id="ExpiraIn30Days"
last-modified
Tue, 22 Oct 2019 14:05:23 GMT
server
nginx
age
5081
etag
"6d285dc553b8d459e9aaefed5ea11da8"
x-cache
Hit from cloudfront
x-amz-version-id
pKVedSiyPoMfBB_rADxt1ursJGrWuxu8
status
200
x-amz-cf-pop
FRA2-C2
content-type
image/jpeg
content-length
2234
x-amz-cf-id
NZUyEB1P6jr2TN3fuKxNLvGrK__hg9MbXgQvgZehgRtZEIWe-ivsGw==
/
static.reuters.com/resources/r/
2 KB
2 KB
Image
General
Full URL
https://static.reuters.com/resources/r/?m=02&d=20191021&t=2&i=1443309572&r=LYNXMPEF9K0O2&w=120
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.225.78.91 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-225-78-91.fra2.r.cloudfront.net
Software
nginx /
Resource Hash
0cc9a65e6796a338995b77f195f6fe62ac4fbceb148bc859748ab517a754b102

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-version-id
iPD74NC9v1UM8wE_DMT0wTkXnsxCMWAd
via
1.1 90cf045072373c2c671297de3161846f.cloudfront.net (CloudFront)
x-amz-expiration
expiry-date="Thu, 21 Nov 2019 00:00:00 GMT", rule-id="ExpiraIn30Days"
last-modified
Mon, 21 Oct 2019 10:36:12 GMT
server
nginx
age
17626
etag
"a4086eba2f12a0644e7f0606dcb3a060"
x-cache
Hit from cloudfront
content-type
image/jpeg
status
200
date
Tue, 22 Oct 2019 10:36:38 GMT
x-amz-cf-pop
FRA2-C2
content-length
1724
x-amz-cf-id
2oRubSx-St8stN-9p3fDw-Acj2LHiapM1nuhs_n8hvZ_Fd5ckYI-sA==
/
static.reuters.com/resources/r/
3 KB
3 KB
Image
General
Full URL
https://static.reuters.com/resources/r/?m=02&d=20191021&t=2&i=1443509558&r=LYNXMPEF9K12A&w=120
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.225.78.91 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-225-78-91.fra2.r.cloudfront.net
Software
nginx /
Resource Hash
c961286c83894d917256687b9b1ec26ac25240eac083b4ae762030e9dd98ca33

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 22:32:33 GMT
via
1.1 90cf045072373c2c671297de3161846f.cloudfront.net (CloudFront)
x-amz-expiration
expiry-date="Thu, 21 Nov 2019 00:00:00 GMT", rule-id="ExpiraIn30Days"
last-modified
Mon, 21 Oct 2019 22:31:37 GMT
server
nginx
age
61000
etag
"97012a762769a6ac0dcb6b41ab930023"
x-cache
Hit from cloudfront
x-amz-version-id
xEiGlSXL8MjPfhu2Tf9Uam2Pj9.bwjaU
status
200
x-amz-cf-pop
FRA2-C2
content-type
image/jpeg
content-length
2866
x-amz-cf-id
blaQ-rTUjODDx367F78rbmZuTeAspjxYRRhTUU7c136fbCYW1ukruQ==
chartbeat_video.js
static.chartbeat.com/js/
66 KB
23 KB
Script
General
Full URL
https://static.chartbeat.com/js/chartbeat_video.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2156:b800:18:1fcd:349:ca21 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
nginx /
Resource Hash
88762480fb084c0725cf9c3abde10e540ebf64884fd50a86789b5eb661c38cdd

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:13:34 GMT
content-encoding
gzip
last-modified
Thu, 01 Aug 2019 01:36:07 GMT
server
nginx
age
1009
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/x-javascript
status
200
cache-control
max-age=7200
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
USyU98WIPiQ7KYcDGM0yzm3sLx8-c101HcWfTgtFluA5bhjC7Sr_jQ==
via
1.1 c6702f5f3b6e77da6f394e67ef1a6aab.cloudfront.net (CloudFront)
expires
Tue, 22 Oct 2019 17:13:34 GMT
id
dpm.demdex.net/
3 KB
2 KB
XHR
General
Full URL
https://dpm.demdex.net/id?d_visid_ver=4.4.0&d_fieldgroup=MC&d_rtbd=json&d_ver=2&d_orgid=4579BF7A580A3C6A0A495DAF%40AdobeOrg&d_nsid=0&ts=1571758224195
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.171.105.8 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-54-171-105-8.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash
38cb0ec02cf04c56ad199afc61967bb8c4df07fdd78eddd2776ac968411f6039
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
application/x-www-form-urlencoded

Response headers

DCS
dcs-prod-irl1-v048-02df97f51.edge-irl1.demdex.com 5.61.0.20191015084456 2ms (+1ms)
Pragma
no-cache
Strict-Transport-Security
max-age=31536000; includeSubDomains
Content-Encoding
gzip
X-TID
14BW8fe7Qcc=
Vary
Origin, Accept-Encoding, User-Agent
P3P
policyref="/w3c/p3p.xml", CP="NOI NID CURa ADMa DEVa PSAa PSDa OUR SAMa BUS PUR COM NAV INT"
Access-Control-Allow-Origin
https://www.reuters.com
Cache-Control
no-cache,no-store,must-revalidate,max-age=0,proxy-revalidate,no-transform,private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json;charset=utf-8
Content-Length
962
Expires
Thu, 01 Jan 1970 00:00:00 GMT
tag.min.js
get.s-onetag.com/4ed1416f-67eb-4d50-8a45-916a5921fee8/
41 KB
13 KB
Script
General
Full URL
https://get.s-onetag.com/4ed1416f-67eb-4d50-8a45-916a5921fee8/tag.min.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-W9SLGS
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2156:b600:1f:287:d20a:ce1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
a5537aed93100c34cdea277b5b092c37b6de90f11339384634a76a035030f7f0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-version-id
B0GnU21j5XMDwAuNEC12S2upHRxtcWd0
content-encoding
gzip
last-modified
Mon, 09 Sep 2019 10:39:51 GMT
server
AmazonS3
age
2844
date
Tue, 22 Oct 2019 14:43:01 GMT
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
text/javascript
status
200
cache-control
max-age=3600
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
Wpk_kszQj5Sx-s-_NpBmVf5mellmAlF8KWV7NVa9B3xiK_ftyz-D3w==
via
1.1 32c8da10203574baccb74b8f771a7ffb.cloudfront.net (CloudFront)
collect
www.google-analytics.com/
35 B
93 B
Image
General
Full URL
https://www.google-analytics.com/collect?v=1&_v=j79&a=1172262690&t=timing&_s=2&dl=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-farxiga-fda%2Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&dp=%2Farticle%2Fus-astrazeneca-farxiga-fda%2Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&ul=en-us&de=UTF-8&dt=FDA%20approves%20AstraZeneca%20diabetes%20drug%20for%20treating%20heart%20failure%20risk&sd=24-bit&sr=1600x1200&vp=1585x1200&je=0&plt=1619&pdt=13&dns=1&rrt=194&srt=109&tcp=15&dit=843&clt=843&_gst=416&_gbt=512&_cst=329&_cbt=405&_u=aGDAiEAjR~&jid=&gjid=&cid=599101512.1571758223&tid=UA-24152976-22&_gid=2001321523.1571758223&cd2=Homepage&cd11=us-astrazeneca-farxiga-fda%2Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk&cd4=News&cd8=0&cd10=False&cd9=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-farxiga-fda%2Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&cd19=Page%20Load&cd7=Desktop&cd14=USKBN1X00J5&cd6=U.S.&cd5=Article&cd17=Reuters%20Editorial&cd3=Homepage%20-%20Homepage&cd1=Homepage&cd13=268&cd18=FDA%20approves%20AstraZeneca%20diabetes%20drug%20for%20treating%20heart%20failure%20risk&z=1515491682
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:808::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
8337212354871836e6763a41e615916c89bac5b3f1f0adf60ba43c7c806e1015
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Wed, 09 Oct 2019 13:15:43 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
age
1131281
status
200
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
35
expires
Mon, 01 Jan 1990 00:00:00 GMT
i
api.segment.io/v1/
21 B
141 B
XHR
General
Full URL
https://api.segment.io/v1/i
Requested by
Host: cdn.segment.com
URL: https://cdn.segment.com/analytics.js/v1/IEWBqQ8VWHijTQxb7lEBGFGS9uIJzigZ/analytics.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.27.125.121 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-52-27-125-121.us-west-2.compute.amazonaws.com
Software
/
Resource Hash
12f71cb993958eefc4bdb41d7dbbda490779a9c7aba448f7be52bb63912e0254

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

status
200
date
Tue, 22 Oct 2019 15:30:24 GMT
access-control-allow-origin
https://www.reuters.com
content-length
21
vary
Origin
content-type
application/json
ping
ping.chartbeat.net/
43 B
168 B
Image
General
Full URL
https://ping.chartbeat.net/ping?h=reuters.com&p=reuters.com%2Farticle%2Fus-astrazeneca-farxiga-fda-idUSKBN1X00J5&u=DiWHbyBglesXDjfSPS&d=reuters.com&g=52639&g0=Homepage&g1=Reuters%20Editorial&g4=Article&n=1&f=00001&c=0&x=0&m=0&y=5917&o=1600&w=1200&j=45&R=1&W=0&I=0&E=0&e=0&r=&b=1619&t=BBFRUKDKnkuJDdFlXZC1H72XCa1cYh&V=116&i=FDA%20approves%20AstraZeneca%20diabetes%20drug%20for%20treating%20heart%20failure%20risk%20-%20Reuters&tz=-120&sn=1&sv=BRtqpbD6J53oBOxZ5-BgpXm_BVLZEE&sd=1&im=06679cf0&_
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.22.183.200 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-22-183-200.compute-1.amazonaws.com
Software
/
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
200
pragma
no-cache
date
Tue, 22 Oct 2019 15:30:24 GMT
cache-control
no-cache, no-store, must-revalidate
content-type
image/gif
content-length
43
expires
0
beacon.min.js
beacon.s-onetag.com/
18 KB
6 KB
Script
General
Full URL
https://beacon.s-onetag.com/beacon.min.js
Requested by
Host: get.s-onetag.com
URL: https://get.s-onetag.com/4ed1416f-67eb-4d50-8a45-916a5921fee8/tag.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:20eb:3000:5:9a4c:9b00:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
662fa6bcdf71d8f92e29010d3e2e270e0071e5d19b1d14ce205654a78aa0a7a9

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-version-id
dQ2IPgbwW_sArXQW0CBb3eN5W57SqoQ0
content-encoding
gzip
last-modified
Thu, 04 Apr 2019 09:35:05 GMT
server
AmazonS3
age
1237
date
Tue, 22 Oct 2019 15:09:49 GMT
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
status
200
cache-control
max-age=3600
x-amz-cf-pop
FRA2-C1
x-amz-cf-id
PJ3sIpvbgvUtEb5wsk3XFZhBxxMpVfKH4x4K3fsLXighnciEyAEAAQ==
via
1.1 41f60102fc29156bc5001d6646f75c02.cloudfront.net (CloudFront)
Cookie set dest5.html
reuters.demdex.net/ Frame 78EC
0
0
Document
General
Full URL
https://reuters.demdex.net/dest5.html?d_nsid=0
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.243.82.109 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-34-243-82-109.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Host
reuters.demdex.net
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
Sec-Fetch-Site
cross-site
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Accept-Encoding
gzip, deflate, br
Cookie
demdex=26600977127131900062340524685145456624
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5

Response headers

Accept-Ranges
bytes
Cache-Control
max-age=21600
Content-Encoding
gzip
Content-Type
text/html
Expires
Thu, 01 Jan 1970 00:00:00 GMT
Last-Modified
Wed, 16 Oct 2019 08:54:15 GMT
P3P
policyref="/w3c/p3p.xml", CP="NOI NID CURa ADMa DEVa PSAa PSDa OUR SAMa BUS PUR COM NAV INT"
Pragma
no-cache
Set-Cookie
demdex=26600977127131900062340524685145456624;Path=/;Domain=.demdex.net;Expires=Sun, 19-Apr-2020 15:30:24 GMT;Max-Age=15552000
Strict-Transport-Security
max-age=31536000; includeSubDomains
Vary
Accept-Encoding, User-Agent
X-TID
XMHHGTVORPY=
Content-Length
2764
Connection
keep-alive
/
s2.reutersmedia.net/resources/r/
68 B
458 B
Image
General
Full URL
https://s2.reutersmedia.net/resources/r/?f=15&m=19&d=20151015&t=6&i=6772432951&w=001&r=RSXIOcuPKkgbZ
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.13 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-13.fra50.r.cloudfront.net
Software
ADFCDN/5.2.3 / AdDefend GmbH
Resource Hash
adfa0c7de03bc3bea3de80b4a4514881c8b6296568f43a5acd5cd7a16fffd1c9

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:24 GMT
via
1.1 1d87c34bb2f20fda8e0841bc33179769.cloudfront.net (CloudFront)
server
ADFCDN/5.2.3
x-amz-cf-pop
FRA50-C1
x-powered-by
AdDefend GmbH
x-cache
Miss from cloudfront
content-type
image/png
status
200
cache-control
max-age=0, max-stale=0, must-revalidate, no-cache, no-store, no-transform, post-check=0, pre-check=0, private
accept-ranges
bytes
content-length
68
x-amz-cf-id
5sYlT8fo8RoUY5bvDUuYS1fQbFcNNCsXni6uF5h1Za-d8qDcDgaibw==
expires
0
/
utoumine.net/s/ad-time/
68 B
422 B
Image
General
Full URL
https://utoumine.net/s/ad-time/?e=16&m=16&d=20180627&t=6&i=4975384967&w=001&r=IWVZJcuPKkgbZ.jpg
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
136.243.25.83 , Germany, ASN24940 (HETZNER-AS, DE),
Reverse DNS
api.addefend.com
Software
ADFCDN/5.2.3 / AdDefend GmbH
Resource Hash
adfa0c7de03bc3bea3de80b4a4514881c8b6296568f43a5acd5cd7a16fffd1c9

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:24 GMT
Server
ADFCDN/5.2.3
X-Powered-By
AdDefend GmbH
Content-Type
image/png
Cache-Control
max-age=0, max-stale=0, must-revalidate, no-cache, no-store, no-transform, post-check=0, pre-check=0, private
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
68
Expires
0
/
www.facebook.com/tr/ Frame 23E1
0
0
Document
General
Full URL
https://www.facebook.com/tr/
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-W9SLGS
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f11c:8183:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

:method
POST
:authority
www.facebook.com
:scheme
https
:path
/tr/
content-length
3030
pragma
no-cache
cache-control
no-cache
origin
https://www.reuters.com
upgrade-insecure-requests
1
content-type
application/x-www-form-urlencoded
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
accept-encoding
gzip, deflate, br
cookie
fr=0WSVOcEpfiLxI0S3O..BdryCQ...1.0.BdryCQ.
Origin
https://www.reuters.com
Upgrade-Insecure-Requests
1
Content-Type
application/x-www-form-urlencoded
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5

Response headers

status
200
content-type
text/plain
access-control-allow-origin
https://www.reuters.com
access-control-allow-credentials
true
strict-transport-security
max-age=31536000; includeSubDomains
content-length
0
server
proxygen-bolt
alt-svc
h3-23=":443"; ma=3600
date
Tue, 22 Oct 2019 15:30:24 GMT
event
reuters.demdex.net/
3 KB
3 KB
XHR
General
Full URL
https://reuters.demdex.net/event?d_dil_ver=9.3&_ts=1571758224691
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.243.82.109 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-34-243-82-109.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash
22dced6e2bb156aa4edbab4ed8ee1a4c6f0362153a45ebaa23743d251b20e367
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
application/x-www-form-urlencoded

Response headers

DCS
dcs-prod-irl1-v048-051377cf8.edge-irl1.demdex.com 5.61.0.20191015084456 5ms (+0ms)
Pragma
no-cache
Strict-Transport-Security
max-age=31536000; includeSubDomains
X-TID
jjY+WMbTT1s=
Vary
Origin
P3P
policyref="/w3c/p3p.xml", CP="NOI NID CURa ADMa DEVa PSAa PSDa OUR SAMa BUS PUR COM NAV INT"
Access-Control-Allow-Origin
https://www.reuters.com
Cache-Control
no-cache,no-store,must-revalidate,max-age=0,proxy-revalidate,no-transform,private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json;charset=utf-8
Content-Length
2670
Expires
Thu, 01 Jan 1970 00:00:00 GMT
bidexchange.js
contextual.media.net/
397 KB
113 KB
Script
General
Full URL
https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=www.reuters.com&version=4.1&https=1
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.235.93 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-93.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
fddff7377de43b0bdcbde2010f53e6037d3dff4a44d1a8731052bc97545d5f0c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:25 GMT
content-encoding
gzip
server
Apache
vary
Accept-Encoding
x-mnet-h
E
content-type
text/javascript; charset=utf-8
status
200
cache-control
max-age=1800
expires
Tue, 22 Oct 2019 16:00:25 GMT
iasPET.1.js
cdn.adsafeprotected.com/
19 KB
6 KB
Script
General
Full URL
https://cdn.adsafeprotected.com/iasPET.1.js
Requested by
Host: contextual.media.net
URL: https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=www.reuters.com&version=4.1&https=1
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.225.78.96 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-225-78-96.fra2.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
0e9324325e7bad86597c91ee8cf9e7f6bc0b83c6e03f29415e48511d19e64856

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 21 Oct 2019 17:06:06 GMT
Content-Encoding
gzip
Connection
keep-alive
Last-Modified
Mon, 21 Oct 2019 17:06:03 GMT
Server
AmazonS3
Age
80660
Vary
Accept-Encoding
X-Cache
Hit from cloudfront
Content-Type
application/javascript
Via
1.1 debe291145dc27044f50d04bac101cd9.cloudfront.net (CloudFront)
Cache-Control
max-age=604800
Transfer-Encoding
chunked
X-Amz-Cf-Pop
FRA2-C2
X-Amz-Cf-Id
2Z4UHXfGUak6tFnmzRNaePbKoAWmddEHYi-dDDp5gg75vD4rFhd9-w==
tc.js
contextual.media.net/
12 KB
7 KB
Script
General
Full URL
https://contextual.media.net/tc.js?&tpkey=TB4M82W&size=300x250&v=17&nat=1&https=1
Requested by
Host: contextual.media.net
URL: https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=www.reuters.com&version=4.1&https=1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.235.93 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-93.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
5d23dafa2c443b2dfaeb848fea20fdfacf73479fa6c6070c01c7f713c40311bd

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:25 GMT
content-encoding
gzip
server
Apache
vary
Accept-Encoding
x-mnet-h
E
content-type
text/javascript; charset=utf-8
status
200
cache-control
max-age=172800
content-length
6675
expires
Thu, 24 Oct 2019 15:30:25 GMT
tc.js
contextual.media.net/
13 KB
7 KB
Script
General
Full URL
https://contextual.media.net/tc.js?&tpkey=T645KQG&size=728x90&v=17&nat=1&https=1
Requested by
Host: contextual.media.net
URL: https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=www.reuters.com&version=4.1&https=1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.235.93 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-93.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
61880e6272da762d94c13369e078e5b16d940c992f64debc61bd56a027cb2638

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:25 GMT
content-encoding
gzip
server
Apache
vary
Accept-Encoding
x-mnet-h
E
content-type
text/javascript; charset=utf-8
status
200
cache-control
max-age=172800
content-length
7433
expires
Thu, 24 Oct 2019 15:30:25 GMT
checksync.php
contextual.media.net/ Frame E06D
0
0
Document
General
Full URL
https://contextual.media.net/checksync.php?&vsSync=1&cs=1&hb=1&cv=37&ndec=1&cid=8CUF1VN4G&prvid=3%2C23%2C28%2C29%2C33%2C38%2C41%2C51%2C54%2C56%2C59%2C69%2C72%2C74%2C76%2C77%2C80%2C82%2C84%2C97%2C106%2C108%2C109%2C113%2C117%2C118%2C122%2C126%2C138%2C139%2C141%2C145%2C147%2C159%2C172%2C173%2C174%2C175%2C178%2C182%2C3004%2C3007%2C3010&rtime=39&https=1&gdpr=1&gdprconsent=0
Requested by
Host: contextual.media.net
URL: https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=www.reuters.com&version=4.1&https=1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.235.93 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-93.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash

Request headers

:method
GET
:authority
contextual.media.net
:scheme
https
:path
/checksync.php?&vsSync=1&cs=1&hb=1&cv=37&ndec=1&cid=8CUF1VN4G&prvid=3%2C23%2C28%2C29%2C33%2C38%2C41%2C51%2C54%2C56%2C59%2C69%2C72%2C74%2C76%2C77%2C80%2C82%2C84%2C97%2C106%2C108%2C109%2C113%2C117%2C118%2C122%2C126%2C138%2C139%2C141%2C145%2C147%2C159%2C172%2C173%2C174%2C175%2C178%2C182%2C3004%2C3007%2C3010&rtime=39&https=1&gdpr=1&gdprconsent=0
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
accept-encoding
gzip, deflate, br
cookie
gdpr_status=1
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5

Response headers

status
200
server
Apache
content-type
text/html; charset=UTF-8
set-cookie
gdpr_status=1; Expires=Fri, 24 Apr 2020 15:30:25 GMT; domain=.media.net; Path=/;
x-mnet-hl2
E
vary
Accept-Encoding
content-encoding
gzip
cache-control
max-age=604800
expires
Tue, 29 Oct 2019 15:30:25 GMT
date
Tue, 22 Oct 2019 15:30:25 GMT
content-length
4592
hmmaster.js
contextual.media.net/
19 KB
7 KB
Script
General
Full URL
https://contextual.media.net/hmmaster.js?cid=8CUF1VN4G&p=hb&v=3.1.3&https=1&adt=1
Requested by
Host: contextual.media.net
URL: https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=www.reuters.com&version=4.1&https=1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.235.93 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-93.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cc11628ee489395e239bc94ea6dc8d5b1908e6b957cc5c9a9e05a64793f77e28

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:25 GMT
content-encoding
gzip
server
Apache
vary
Accept-Encoding
x-mnet-h
E
content-type
text/html; charset=UTF-8
status
200
cache-control
max-age=1800
content-length
7348
expires
Tue, 22 Oct 2019 16:00:25 GMT
px.gif
contextual.media.net/
43 B
193 B
Image
General
Full URL
https://contextual.media.net/px.gif?&ch=1&vn=1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.235.93 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-93.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
8ac1703c1c34b2be426deda409d39258f82fae17f13e645f377f337a954aedde

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:25 GMT
last-modified
Wed, 19 Jul 2017 10:11:12 GMT
server
Apache
content-type
image/gif
status
200
cache-control
max-age=1209600
accept-ranges
bytes
content-length
43
expires
Tue, 05 Nov 2019 15:30:25 GMT
px.gif
s.mnet-ad.net/
43 B
355 B
Image
General
Full URL
https://s.mnet-ad.net/px.gif?&ch=2&vn=1
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_256_GCM
Server
66.81.204.228 , Virgin Islands (British), ASN40034 (CONFLUENCE-NETWORK-INC - Confluence Networks Inc, VG),
Reverse DNS
o1-66-81-204-228.static.o1.com
Software
Apache /
Resource Hash
8ac1703c1c34b2be426deda409d39258f82fae17f13e645f377f337a954aedde

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:26 GMT
Last-Modified
Wed, 19 Jul 2017 10:11:12 GMT
Server
Apache
Content-Type
image/gif
Cache-Control
max-age=1209600
Connection
Keep-Alive
Accept-Ranges
bytes
Keep-Alive
timeout=2, max=92
Content-Length
43
Expires
Tue, 05 Nov 2019 15:30:26 GMT
rtbsspub
cdneast2-xch.media.net/AdExchange/
41 KB
3 KB
EventSource
General
Full URL
https://cdneast2-xch.media.net/AdExchange/rtbsspub?&gdpr=1&gdprconsent=0&cid=8CUF1VN4G&region=nv&ptrid=8PRL4E7N3&requestString=267235141*4%7C300x250%7C8CUD609M7%7C976846895%40267235141*29%7C300x250%7C11384%7C31484_232454_15%40267235141*38%7C300x250%7C8CUF1VN4G%7C267235141_8CUF1VN4G%40267235141*51%7C300x250%7C973973%7C11084976%7C0.07%40267235141*59%7C300x250%7C8CUF1VN4G%7C_112891%7C0.07%40267235141*74%7C300x250%7C1113800%7C12209124%40267235141*97%7C300x250%7C8CUF1VN4G%7C267235141_8CUF1VN4G%40267235141*122%7C300x250%7C8CUF1VN4G%7C8CUF1VN4G_fFuYfaVC4aA86N9xVFo929Yk%7C1.22%40267235141*145%7C300x250%7C100600%7C147215%40267235141*172%7C300x250%7C8CUF1VN4G%7C15331955%7C0.06%40267235141*175%7C300x250%7C8CUF1VN4G%7C267235141_8CUF1VN4G%7C0.01%40267235141*178%7C300x250%7C8CUF1VN4G%7C267235141_8CUF1VN4G%40313743496*4%7C728x90%7C8CUD609M7%7C536231532%40313743496*29%7C728x90~970x250%7C11384%7C31484_232454_2~31484_232454_57%40313743496*38%7C970x250~728x90%7C8CUF1VN4G%7C313743496_8CUF1VN4G~313743496_8CUF1VN4G%40313743496*51%7C728x90%7C973973%7C11084975%7C0.69%40313743496*59%7C728x90~970x250%7C8CUF1VN4G%7C_112891~_112891%7C0.07%40313743496*74%7C728x90~970x250%7C1113800%7C12209125~12209125%40313743496*97%7C728x90~970x250%7C8CUF1VN4G%7C313743496_8CUF1VN4G~313743496_8CUF1VN4G%40313743496*122%7C728x90%7C8CUF1VN4G%7C8CUF1VN4G_LKbKv9hpus2aba7C923hUsFj%7C1.22%40313743496*145%7C970x250~728x90%7C100600%7C147214~147214%40313743496*172%7C728x90~970x250%7C8CUF1VN4G%7C15303527~15303527%7C0.06%40313743496*175%7C728x90%7C8CUF1VN4G%7C313743496_8CUF1VN4G%7C0.01%40313743496*178%7C728x90%7C8CUF1VN4G%7C313743496_8CUF1VN4G%40391166652*4%7C160x600%7C8CUD609M7%7C712281133%40391166652*29%7C300x250~160x600~300x600%7C11384%7C31484_232454_15~31484_232454_9~31484_232454_10%40391166652*38%7C300x600~160x600~300x250%7C8CUF1VN4G%7C391166652_8CUF1VN4G~391166652_8CUF1VN4G~391166652_8CUF1VN4G%40391166652*51%7C300x250~160x600~300x600%7C973973%7C11084976~11084976~11084976%7C0.07%40391166652*59%7C300x250~160x600~300x600%7C8CUF1VN4G%7C_112891~_112891~_112891%7C0.07%40391166652*74%7C300x250~300x600%7C1113800%7C12209124~12209124%40391166652*97%7C300x250~300x600~160x600%7C8CUF1VN4G%7C391166652_8CUF1VN4G~391166652_8CUF1VN4G~391166652_8CUF1VN4G%40391166652*122%7C300x250%7C8CUF1VN4G%7C8CUF1VN4G_fFuYfaVC4aA86N9xVFo929Yk%7C1.22%40391166652*145%7C300x600~160x600~300x250%7C100600%7C147215~147215~147215%40391166652*172%7C160x600~300x250~300x600%7C8CUF1VN4G%7C15331955~15331955~15331955%7C0.06%40391166652*175%7C300x600~160x600~300x250%7C8CUF1VN4G%7C391166652_8CUF1VN4G~391166652_8CUF1VN4G~391166652_8CUF1VN4G%7C0.01%40391166652*178%7C300x600~300x250~160x600%7C8CUF1VN4G%7C391166652_8CUF1VN4G~391166652_8CUF1VN4G~391166652_8CUF1VN4G%40451439109*4%7C300x250%7C8CUD609M7%7C155187763%40451439109*29%7C300x250%7C11384%7C31484_123998_15%40451439109*38%7C300x250%7C8CUF1VN4G%7C451439109_8CUF1VN4G%40451439109*51%7C300x250%7C973973%7C11084979%7C0.07%40451439109*59%7C300x250%7C8CUF1VN4G%7C_112891%7C0.07%40451439109*97%7C300x250%7C8CUF1VN4G%7C451439109_8CUF1VN4G%40451439109*122%7C300x250%7C8CUF1VN4G%7C8CUF1VN4G_fFuYfaVC4aA86N9xVFo929Yk%7C1.22%40451439109*145%7C300x250%7C100600%7C147218%40451439109*172%7C300x250%7C8CUF1VN4G%7C15331958%7C0.06%40451439109*175%7C300x250%7C8CUF1VN4G%7C451439109_8CUF1VN4G%7C0.01%40451439109*178%7C300x250%7C8CUF1VN4G%7C451439109_8CUF1VN4G%40612341223*4%7C728x90%7C8CUD609M7%7C813012502%40612341223*29%7C728x90~970x250%7C11384%7C31484_232454_2~31484_232454_57%40612341223*38%7C970x250~728x90%7C8CUF1VN4G%7C612341223_8CUF1VN4G~612341223_8CUF1VN4G%40612341223*51%7C728x90%7C973973%7C11084975%7C0.69%40612341223*59%7C728x90~970x250%7C8CUF1VN4G%7C_112891~_112891%7C0.07%40612341223*74%7C728x90~970x250%7C1113800%7C12209125~12209125%40612341223*97%7C728x90~970x250%7C8CUF1VN4G%7C612341223_8CUF1VN4G~612341223_8CUF1VN4G%40612341223*122%7C728x90%7C8CUF1VN4G%7C8CUF1VN4G_LKbKv9hpus2aba7C923hUsFj%7C1.22%40612341223*145%7C728x90~970x250%7C100600%7C147214~147214%40612341223*172%7C728x90~970x250%7C8CUF1VN4G%7C15303527~15303527%7C0.06%40612341223*175%7C728x90%7C8CUF1VN4G%7C612341223_8CUF1VN4G%7C0.01%40612341223*178%7C728x90%7C8CUF1VN4G%7C612341223_8CUF1VN4G&crid=267235141%2C313743496%2C391166652%2C451439109%2C612341223&sd=1&requrl=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-farxiga-fda%2Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&bl=1&rt=5&dn=https://www.reuters.com&https=1&act=headerBid&prvReqId=265444742731904871571758225700&erTr=0&hlt=1&ugd=4&adt=desktop&tr=0.023873689874792214&ndec=1&scrsize=1600x1200&taginfo=%7B%7D&pageinfo=%7B%22vw%22%3A1585%2C%22vh%22%3A1200%2C%22ph%22%3A5917%7D&itype=HB&sid=8973&scc=1&tmt=200&section=us.reuters%2Flife%2Fhealth%2Farticle&prid=8PRVCXX19&wo=1&isRefresh=0&switch=1&cc=DE&rc=HE&ct=FRANKFURT
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.62.140.165 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-62-140-165.deploy.static.akamaitechnologies.com
Software
Apache-Coyote/1.1 /
Resource Hash
1b3cab309b16c064adf10195a68a25d85fbdb27e1a6d9bb6151d3ddf78a41ed7

Request headers

Accept
text/event-stream
Cache-Control
no-cache
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:25 GMT
content-encoding
gzip
server
Apache-Coyote/1.1
status
200
vary
Accept-Encoding
content-type
text/event-stream;charset=UTF-8
access-control-allow-origin
https://www.reuters.com
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
timing-allow-origin
*, *
expires
Tue, 22 Oct 2019 15:30:25 GMT
rtbsspub
cdneast2-xch.media.net/AdExchange/
3 KB
1 KB
EventSource
General
Full URL
https://cdneast2-xch.media.net/AdExchange/rtbsspub?&gdpr=1&gdprconsent=0&cid=8CUF1VN4G&region=nv&ptrid=8PRL4E7N3&requestString=267235141*84%7C1x1_TB4M82W_1%7C8CUF1VN4G%7C267235141%40313743496*84%7C1x1_T645KQG_1%7C8CUF1VN4G%7C313743496%40391166652*84%7C1x1_TB4M82W_1%7C8CUF1VN4G%7C391166652%40451439109*84%7C1x1_TB4M82W_1%7C8CUF1VN4G%7C451439109%40612341223*84%7C1x1_T645KQG_1%7C8CUF1VN4G%7C612341223&crid=267235141%2C313743496%2C391166652%2C451439109%2C612341223&sd=1&requrl=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-farxiga-fda%2Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&bl=1&rt=5&dn=https://www.reuters.com&https=1&act=headerBid&prvReqId=453846517047750051571758225705&erTr=0&hlt=1&ugd=4&adt=desktop&tr=0.00976307643844132&ndec=1&scrsize=1600x1200&taginfo=%7B%7D&pageinfo=%7B%22vw%22%3A1585%2C%22vh%22%3A1200%2C%22ph%22%3A5917%7D&itype=HB&sid=8973&scc=1&tmt=200&section=us.reuters%2Flife%2Fhealth%2Farticle&at=3&prid=8PRVCXX19&wo=1&cc=DE&rc=HE&ct=FRANKFURT
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.62.140.165 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-62-140-165.deploy.static.akamaitechnologies.com
Software
Apache-Coyote/1.1 /
Resource Hash
d3edb77c486dbb1ebc6a0ebcb02b4a6191a6abaa5fb68613994fe6c4cfdacb2c

Request headers

Accept
text/event-stream
Cache-Control
no-cache
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:25 GMT
content-encoding
gzip
server
Apache-Coyote/1.1
status
200
vary
Accept-Encoding
content-type
text/event-stream;charset=UTF-8
access-control-allow-origin
https://www.reuters.com
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
timing-allow-origin
*, *
expires
Tue, 22 Oct 2019 15:30:25 GMT
checksync.php
contextual.media.net/ Frame 8DA8
0
0
Document
General
Full URL
https://contextual.media.net/checksync.php?&vsSync=1&cs=1&hb=1&cv=37&ndec=1&cid=8CUF1VN4G&prvid=3%2C23%2C28%2C29%2C33%2C38%2C41%2C51%2C54%2C56%2C59%2C69%2C72%2C74%2C76%2C77%2C80%2C82%2C84%2C97%2C106%2C108%2C109%2C113%2C117%2C118%2C122%2C126%2C138%2C139%2C141%2C145%2C147%2C159%2C172%2C173%2C174%2C175%2C178%2C182%2C3004%2C3007%2C3010&rtime=101&https=1&gdpr=1&gdprconsent=0
Requested by
Host: contextual.media.net
URL: https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=www.reuters.com&version=4.1&https=1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.235.93 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-93.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash

Request headers

:method
GET
:authority
contextual.media.net
:scheme
https
:path
/checksync.php?&vsSync=1&cs=1&hb=1&cv=37&ndec=1&cid=8CUF1VN4G&prvid=3%2C23%2C28%2C29%2C33%2C38%2C41%2C51%2C54%2C56%2C59%2C69%2C72%2C74%2C76%2C77%2C80%2C82%2C84%2C97%2C106%2C108%2C109%2C113%2C117%2C118%2C122%2C126%2C138%2C139%2C141%2C145%2C147%2C159%2C172%2C173%2C174%2C175%2C178%2C182%2C3004%2C3007%2C3010&rtime=101&https=1&gdpr=1&gdprconsent=0
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
accept-encoding
gzip, deflate, br
cookie
gdpr_status=1
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5

Response headers

status
200
server
Apache
content-type
text/html; charset=UTF-8
set-cookie
gdpr_status=1; Expires=Fri, 24 Apr 2020 15:30:25 GMT; domain=.media.net; Path=/;
x-mnet-hl2
E
vary
Accept-Encoding
content-encoding
gzip
cache-control
max-age=604800
expires
Tue, 29 Oct 2019 15:30:25 GMT
date
Tue, 22 Oct 2019 15:30:25 GMT
content-length
4592
gpt.js
www.googletagservices.com/tag/js/
46 KB
15 KB
Script
General
Full URL
https://www.googletagservices.com/tag/js/gpt.js
Requested by
Host: contextual.media.net
URL: https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=www.reuters.com&version=4.1&https=1
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:818::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
13426ba13e9862a0e6f6e2c9af87cce602482e4fd64aa5419bea6d0f449e7c70
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:25 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"314 / 441 of 1000 / last-modified: 1571691975"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
14762
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:25 GMT
integrator.js
adservice.google.de/adsid/
109 B
656 B
Script
General
Full URL
https://adservice.google.de/adsid/integrator.js?domain=www.reuters.com
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:800::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 22 Oct 2019 15:30:25 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status
200
cache-control
private, no-cache, no-store
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
104
x-xss-protection
0
integrator.js
adservice.google.com/adsid/
109 B
323 B
Script
General
Full URL
https://adservice.google.com/adsid/integrator.js?domain=www.reuters.com
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:818::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 22 Oct 2019 15:30:25 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status
200
cache-control
private, no-cache, no-store
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
104
x-xss-protection
0
pubads_impl_2019101401.js
securepubads.g.doubleclick.net/gpt/
156 KB
58 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.208.34 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s12-in-f2.1e100.net
Software
sffe /
Resource Hash
f8800772f0dd827877029d9d634a170a156ff82b6b6bdf251b62c750b73cfe93
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:25 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Mon, 14 Oct 2019 13:08:16 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
58589
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:25 GMT
show_companion_ad.js
pagead2.googlesyndication.com/pagead/
188 KB
70 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/show_companion_ad.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:818::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
1ce29feca8520c47fcbdbb7b8b795314102f36cf2e9f44924f6f07e0796b4343
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:29:23 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
62
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
content-disposition
attachment; filename="f.txt"
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
71218
x-xss-protection
0
server
cafe
etag
17977282172821756952
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=3600
timing-allow-origin
*
expires
Tue, 22 Oct 2019 16:29:23 GMT
pub
pixel.adsafeprotected.com/services/
324 B
709 B
XHR
General
Full URL
https://pixel.adsafeprotected.com/services/pub?anId=10764&slot=%7Bid:dpslot_mpu_5002933_USKBN1X00J5,s:300.250,p:/4735792/us.reuters/life/health/article,t:display%7D&wr=1600.1200&sr=1600.1200&sessionId=89395452-bd87-0d11-fc34-7d0a46811a9c&url=https%253A%252F%252Fwww.reuters.com%252Farticle%252Fus-astrazeneca-farxiga-fda%252Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Requested by
Host: cdn.adsafeprotected.com
URL: https://cdn.adsafeprotected.com/iasPET.1.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
cca5e524e3a1529060aa9d242d43ce09a7f1c38f10e7b3ba25f84b0e8f5d5ff3

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:25 GMT
X-Server-Name
app44ami.ami.303net.pvt
Transfer-Encoding
chunked
Content-Type
application/json;charset=UTF-8
Access-Control-Allow-Origin
https://www.reuters.com
Access-Control-Expose-Headers
X-Server-Name
Access-Control-Allow-Credentials
true
Connection
keep-alive
Timing-Allow-Origin
*
Server
nginx
pub
pixel.adsafeprotected.com/services/
306 B
691 B
XHR
General
Full URL
https://pixel.adsafeprotected.com/services/pub?anId=10764&slot=%7Bid:canvas_leaderboard_8634605569923490_USKBN1X00J5,s:728.90,p:/4735792/us.reuters/life/health/article,t:display%7D&wr=1600.1200&sr=1600.1200&sessionId=89395452-bd87-0d11-fc34-7d0a46811a9c&url=https%253A%252F%252Fwww.reuters.com%252Farticle%252Fus-astrazeneca-farxiga-fda%252Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Requested by
Host: cdn.adsafeprotected.com
URL: https://cdn.adsafeprotected.com/iasPET.1.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
d88e4898306d877fadacfcfee0662548c0074506f2d59f3f24cd39e29a53b754

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:25 GMT
X-Server-Name
app46ami.ami.303net.pvt
Transfer-Encoding
chunked
Content-Type
application/json;charset=UTF-8
Access-Control-Allow-Origin
https://www.reuters.com
Access-Control-Expose-Headers
X-Server-Name
Access-Control-Allow-Credentials
true
Connection
keep-alive
Timing-Allow-Origin
*
Server
nginx
tc.js
contextual.media.net/
15 KB
8 KB
Script
General
Full URL
https://contextual.media.net/tc.js?&tpkey=TF6129H&size=2x2&v=17&nat=1&https=1
Requested by
Host: contextual.media.net
URL: https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=www.reuters.com&version=4.1&https=1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.235.93 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-93.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
1c5f973eb7e9ce2290f6feaeacfaa58f5cf3821175316bba1d3adcb24d133a11

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:25 GMT
content-encoding
gzip
server
Apache
vary
Accept-Encoding
x-mnet-h
E
content-type
text/javascript; charset=utf-8
status
200
cache-control
max-age=172800
content-length
8074
expires
Thu, 24 Oct 2019 15:30:25 GMT
pub
pixel.adsafeprotected.com/services/
312 B
697 B
XHR
General
Full URL
https://pixel.adsafeprotected.com/services/pub?anId=10764&slot=%7Bid:dpslot_canvas_3130230_USKBN1X00J5,s:2.2,p:/4735792/us.reuters/life/health/article,t:display%7D&wr=1600.1200&sr=1600.1200&sessionId=89395452-bd87-0d11-fc34-7d0a46811a9c&url=https%253A%252F%252Fwww.reuters.com%252Farticle%252Fus-astrazeneca-farxiga-fda%252Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Requested by
Host: cdn.adsafeprotected.com
URL: https://cdn.adsafeprotected.com/iasPET.1.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
eff51e3f8ef16413591b1b19715508d0038efe1845e995e2959021e659af7e19

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:25 GMT
X-Server-Name
app36ami.ami.303net.pvt
Transfer-Encoding
chunked
Content-Type
application/json;charset=UTF-8
Access-Control-Allow-Origin
https://www.reuters.com
Access-Control-Expose-Headers
X-Server-Name
Access-Control-Allow-Credentials
true
Connection
keep-alive
Timing-Allow-Origin
*
Server
nginx
pub
pixel.adsafeprotected.com/services/
315 B
700 B
XHR
General
Full URL
https://pixel.adsafeprotected.com/services/pub?anId=10764&slot=%7Bid:dpslot_connatix_14489529_USKBN1X00J5,s:1100.420,p:/4735792/us.reuters/life/health/article,t:display%7D&wr=1600.1200&sr=1600.1200&sessionId=89395452-bd87-0d11-fc34-7d0a46811a9c&url=https%253A%252F%252Fwww.reuters.com%252Farticle%252Fus-astrazeneca-farxiga-fda%252Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Requested by
Host: cdn.adsafeprotected.com
URL: https://cdn.adsafeprotected.com/iasPET.1.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
1ca0313b9966aac73a01e982d7a8e7b983dfba49985cbd6e1bff25b1c4ea2769

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:26 GMT
X-Server-Name
app23ami.ami.303net.pvt
Transfer-Encoding
chunked
Content-Type
application/json;charset=UTF-8
Access-Control-Allow-Origin
https://www.reuters.com
Access-Control-Expose-Headers
X-Server-Name
Access-Control-Allow-Credentials
true
Connection
keep-alive
Timing-Allow-Origin
*
Server
nginx
pub
pixel.adsafeprotected.com/services/
309 B
694 B
XHR
General
Full URL
https://pixel.adsafeprotected.com/services/pub?anId=10764&slot=%7Bid:dpslot_bizdev_article_rr2_7487062_USKBN1X00J5,s:300.280,p:/4735792/us.reuters/life/health/article,t:display%7D&wr=1600.1200&sr=1600.1200&sessionId=89395452-bd87-0d11-fc34-7d0a46811a9c&url=https%253A%252F%252Fwww.reuters.com%252Farticle%252Fus-astrazeneca-farxiga-fda%252Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Requested by
Host: cdn.adsafeprotected.com
URL: https://cdn.adsafeprotected.com/iasPET.1.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
0e8f583b9a2cb34a75594494e2a9cb33c1f7e896b3ce618d39510101d8af2b6b

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:25 GMT
X-Server-Name
app29ami.ami.303net.pvt
Transfer-Encoding
chunked
Content-Type
application/json;charset=UTF-8
Access-Control-Allow-Origin
https://www.reuters.com
Access-Control-Expose-Headers
X-Server-Name
Access-Control-Allow-Credentials
true
Connection
keep-alive
Timing-Allow-Origin
*
Server
nginx
rtbsspub
cdneast2-xch.media.net/AdExchange/
1017 B
926 B
EventSource
General
Full URL
https://cdneast2-xch.media.net/AdExchange/rtbsspub?&gdpr=1&gdprconsent=0&cid=8CUF1VN4G&region=nv&ptrid=8PRL4E7N3&requestString=105651588*141%7C1x1_TF6129H_1%7C8CUF1VN4G%7C105651588_8CUF1VN4G&crid=105651588&sd=1&requrl=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-farxiga-fda%2Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&bl=1&rt=5&dn=https://www.reuters.com&https=1&act=headerBid&prvReqId=420313385498918231571758225939&erTr=0&hlt=1&ugd=4&adt=desktop&tr=0.87066027379665&ndec=1&scrsize=1600x1200&taginfo=%7B%22105651588%22%3A%7B%22xps%22%3A634.5%2C%22yps%22%3A1498%7D%7D&pageinfo=%7B%22vw%22%3A1585%2C%22vh%22%3A1200%2C%22ph%22%3A5917%7D&itype=HB&sid=8973&scc=1&tmt=200&section=us.reuters%2Flife%2Fhealth%2Farticle&at=3&prid=8PRVCXX19&wo=1&cc=DE&rc=HE&ct=FRANKFURT
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.62.140.165 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-62-140-165.deploy.static.akamaitechnologies.com
Software
Apache-Coyote/1.1 /
Resource Hash
267f182076a11fcc0f1c1ee223fbf3b227aa4be0aee1e8f3a94ea7a5c00719f0

Request headers

Accept
text/event-stream
Cache-Control
no-cache
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:26 GMT
content-encoding
gzip
server
Apache-Coyote/1.1
status
200
vary
Accept-Encoding
content-type
text/event-stream;charset=UTF-8
access-control-allow-origin
https://www.reuters.com
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
timing-allow-origin
*, *
expires
Tue, 22 Oct 2019 15:30:26 GMT
rtbsspub
cdneast2-xch.media.net/AdExchange/
1 KB
935 B
EventSource
General
Full URL
https://cdneast2-xch.media.net/AdExchange/rtbsspub?&gdpr=1&gdprconsent=0&cid=8CUF1VN4G&region=nv&ptrid=8PRL4E7N3&requestString=105651588*4%7C2x2%7C8CUD609M7%7C638433813&crid=105651588&sd=1&requrl=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-farxiga-fda%2Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&bl=1&rt=5&dn=https://www.reuters.com&https=1&act=headerBid&prvReqId=145320488099652981571758225939&erTr=0&hlt=1&ugd=4&adt=desktop&tr=0.4070674216082264&ndec=1&scrsize=1600x1200&taginfo=%7B%22105651588%22%3A%7B%22xps%22%3A634.5%2C%22yps%22%3A1498%7D%7D&pageinfo=%7B%22vw%22%3A1585%2C%22vh%22%3A1200%2C%22ph%22%3A5917%7D&itype=HB&sid=8973&scc=1&tmt=200&section=us.reuters%2Flife%2Fhealth%2Farticle&prid=8PRVCXX19&wo=1&isRefresh=0&cc=DE&rc=HE&ct=FRANKFURT
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.62.140.165 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-62-140-165.deploy.static.akamaitechnologies.com
Software
Apache-Coyote/1.1 /
Resource Hash
c7e7eac8db808fa863790e85663311fb143e97f0955a8f7cd261bfd10d6d3cb1

Request headers

Accept
text/event-stream
Cache-Control
no-cache
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:26 GMT
content-encoding
gzip
server
Apache-Coyote/1.1
status
200
vary
Accept-Encoding
content-type
text/event-stream;charset=UTF-8
access-control-allow-origin
https://www.reuters.com
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
timing-allow-origin
*, *
expires
Tue, 22 Oct 2019 15:30:26 GMT
ads
securepubads.g.doubleclick.net/gampad/
20 KB
6 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=1063870379899504&correlator=1605928124791121&output=ldjh&impl=fifs&adsid=NT&eid=21062796%2C21062832%2C370204053%2C21064102&vrg=2019101401&npa=1&guci=1.2.0.0.2.1.0.0&plat=1%3A536903688%2C2%3A536903688%2C8%3A134250504&sc=1&sfv=1-0-35&ecs=20191022&iu_parts=4735792%2Cus.reuters%2Clife%2Chealth%2Carticle&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4%2C%2F0%2F1%2F2%2F3%2F4%2C%2F0%2F1%2F2%2F3%2F4%2C%2F0%2F1%2F2%2F3%2F4%2C%2F0%2F1%2F2%2F3%2F4&prev_iu_szs=300x250%7C300x600%7C1x1%2C728x90%7C970x250%7C970x90%7C1100x100%7C1100x90%7C1100x250%7C1x1%2C320x50%7C2x2%7C1x1%7C1100x375%2C320x50%7C1100x420%7C1100x400%2C300x280&fluid=0%2C0%2Cheight%2Cheight%2C0&prev_scp=type%3Dmpu%26div_id%3D5002933%26pixel_distance%3D400%26articleID%3DUSKBN1X00J5%26storychannel%3Dhealthcare-upclose%253Bmedical-research%253Bcompanies-phar%253BeverythingNews%253BhealthNews%253Bconsolidated-business%26story%3D0%26template%3Darticle%26p_count%3D8%26asset%3Dimage%26id%3Dded34561-f4e0-11e9-ba52-70106fb729f4%26vw%3D40%2C50%2C60%2C70%2C80%26grm%3D40%2C50%2C60%2C70%2C80%26pub%3D40%2C50%2C60%2C70%2C80%26mnetDNB%3D1%26mnetPageID%3D1%26mnetCV%3D3%26mnetCC%3DDE%26mnetUGD%3D4%7Ctype%3Dleaderboard%26div_id%3D8634605569923490%26articleID%3DUSKBN1X00J5%26storychannel%3Dhealthcare-upclose%253Bmedical-research%253Bcompanies-phar%253BeverythingNews%253BhealthNews%253Bconsolidated-business%26story%3D0%26template%3Darticle%26p_count%3D8%26asset%3Dimage%26id%3Dded36c11-f4e0-11e9-9d6c-98f2b3ea1dc8%26vw%3D40%2C50%2C60%26grm%3D40%2C50%2C60%26pub%3D40%2C50%26mnetDNB%3D1%26mnetPageID%3D2%26mnetCV%3D3%26mnetCC%3DDE%26mnetUGD%3D4%7Ctype%3Dcanvas%26div_id%3D3130230%26pixel_distance%3D400%26articleID%3DUSKBN1X00J5%26storychannel%3Dhealthcare-upclose%253Bmedical-research%253Bcompanies-phar%253BeverythingNews%253BhealthNews%253Bconsolidated-business%26story%3D0%26template%3Darticle%26p_count%3D8%26asset%3Dimage%26id%3Dded5b646-f4e0-11e9-bb6e-382c4ac630d1%26vw%3D40%2C50%2C60%2C70%26grm%3D40%2C50%2C60%2C70%26pub%3D40%2C50%2C60%2C70%26mnetDNB%3D1%26mnetPageID%3D6%26mnetCV%3D3%26mnetCC%3DDE%26mnetUGD%3D4%7Ctype%3Dconnatix%26div_id%3D14489529%26pixel_distance%3D20000%26articleID%3DUSKBN1X00J5%26storychannel%3Dhealthcare-upclose%253Bmedical-research%253Bcompanies-phar%253BeverythingNews%253BhealthNews%253Bconsolidated-business%26story%3D0%26template%3Darticle%26p_count%3D8%26asset%3Dimage%26id%3Dded82758-f4e0-11e9-9a00-00259086cbca%26vw%3D40%2C50%2C60%2C70%26grm%3D40%2C50%2C60%2C70%26pub%3D40%2C50%2C60%2C70%7Ctype%3Dbizdev_article_rr2%26div_id%3D7487062%26pixel_distance%3D20000%26articleID%3DUSKBN1X00J5%26storychannel%3Dhealthcare-upclose%253Bmedical-research%253Bcompanies-phar%253BeverythingNews%253BhealthNews%253Bconsolidated-business%26story%3D0%26template%3Darticle%26p_count%3D8%26asset%3Dimage%26id%3Dded54131-f4e0-11e9-98a1-382c4ac63135%26vw%3D40%2C50%2C60%26grm%3D40%2C50%2C60%26pub%3D40%2C50%2C60&cust_params=bidxc%3D1%26ntvPlacement%3D1093478%26aam%3D26600977127131900062340524685145456624%26admant%3DBarclays%252CBarclays_2%252CExxon_Negative%252CFRB%252CFacebook_Neg%252CGeneral_Brand_Safety%252CIBM%252CJLR_Negative%252CJPMorgan_Neg%252CMSFT_Neg%252CNomura_Negative%252CSabic_Negative%252CWorkdayPG_Neg%26fr%3Dtrue%26adt%3DveryLow%26alc%3DveryLow%26dlm%3DveryLow%26drg%3DveryLow%26hat%3DveryLow%26off%3DveryLow%26vio%3Dlow&cookie_enabled=1&bc=31&abxe=1&lmt=1571758226&dt=1571758226050&dlt=1571758222888&idt=3033&frm=20&biw=1585&bih=1200&oid=3&adxs=-12245933%2C-12245933%2C-12245933%2C-12245933%2C-12245933&adys=-12245933%2C-12245933%2C-12245933%2C-12245933%2C-12245933&adks=3358644139%2C1743084964%2C916242984%2C3656410097%2C127435202&ucis=1%7C2%7C3%7C4%7C5&ifi=1&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-farxiga-fda%2Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&dssz=77&icsg=2818575360&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=300x-1%7C0x-1%7C754x0%7C754x0%7C300x-1&msz=300x-1%7C0x-1%7C2x2%7C1100x420%7C300x-1&ga_vid=667762605.1571758226&ga_sid=1571758226&ga_hid=1172262690&fws=132%2C132%2C132%2C132%2C132&ohw=1585%2C1585%2C1585%2C1585%2C1585
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.208.34 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s12-in-f2.1e100.net
Software
cafe /
Resource Hash
b32621e5f3df38d9f70cefef6a23e6e7561136817504be7664f8b391ce2ebf74
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:26 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2,-2,-2,-2,-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
5342
x-xss-protection
0
google-lineitem-id
5189420777,-2,4741317042,-2,139199112
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138289622787,-2,138206523841,-2,138204787707
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.reuters.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
pubads_impl_rendering_2019101401.js
securepubads.g.doubleclick.net/gpt/
64 KB
24 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019101401.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.208.34 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s12-in-f2.1e100.net
Software
sffe /
Resource Hash
f123fae1ceff20dea7ee2ff8895276a22cddecc8e0ef503b5e95419e76909a54
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:26 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Mon, 14 Oct 2019 13:08:16 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
24836
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:26 GMT
container.html
tpc.googlesyndication.com/safeframe/1-0-35/html/
0
0
Other
General
Full URL
https://tpc.googlesyndication.com/safeframe/1-0-35/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:815::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

view
securepubads.g.doubleclick.net/pcs/ Frame 5877
0
151 B
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvW06vP1UtUwPeV9aoGYXtVK3TJAnj7-eCm8g_BIMCnbG6UGX196yIRqJBDoF1dv541xLhpHFkOVE9V647ngPwMBHcMxGEgNZH4TOnJBM8C7sjqRZOYvxSsEWtDAhF8YBTnh-BXuWTCW6OGUuoVn9NpxBi0-zhVZ54g6W29PA2ZfITWW-fykM_-BuM93JRcngHehkCeR7SPHkrqG-PxBlv3ZWbP60z9NLrDSR4eofLkKQiydeNjiIE3DJSccA1aOy8TULMS-Wksj7c3k5yONCcEMIGRCjc_1al2Yw&sig=Cg0ArKJSzM-xhtUJHcExEAE&urlfix=1&adurl=
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.208.34 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s12-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 22 Oct 2019 15:30:26 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:26 GMT
brid.outstream.min.js
services.brid.tv/player/build/ Frame 5877
234 KB
65 KB
Script
General
Full URL
https://services.brid.tv/player/build/brid.outstream.min.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019101401.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.85.183.90 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-52-85-183-90.fra50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
2dd9aa6fe3335b6436351937950a94a47ad3819fa22fb2f074c4b21ebde8ab38

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 13:03:10 GMT
content-encoding
gzip
last-modified
Tue, 22 Oct 2019 08:14:07 GMT
server
AmazonS3
age
318
etag
"e656811ddfb8493924b3e9ed326581c0"
x-cache
Hit from cloudfront
content-type
application/javascript
status
200
cache-control
max-age=1200, public
x-amz-cf-pop
FRA50
accept-ranges
bytes
content-length
65992
via
1.1 bd5652a800046ffa43683320c0e731b4.cloudfront.net (CloudFront)
x-amz-cf-id
eDSOX0jjFmBwg56KNZSNmNTck7tCyWaxGefuPrXbcWgsNw-Zzq28Aw==
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame 5877
78 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019101401.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:818::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
c1c53a4d300ac7532bec2ed085532b2fe66d27f2b592b3a9383aa649e42ed6fb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:26 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1571656559023965"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
29691
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:26 GMT
moatad.js
z.moatads.com/reutersdfpcw319687550988/ Frame 5877
297 KB
99 KB
Script
General
Full URL
https://z.moatads.com/reutersdfpcw319687550988/moatad.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019101401.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
AmazonS3 /
Resource Hash
6b173d87763629cab6332e13f5fce375f0656baff43c8696995f6e42d8470565

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:26 GMT
Content-Encoding
gzip
Last-Modified
Sat, 19 Oct 2019 00:56:56 GMT
Server
AmazonS3
x-amz-request-id
CC87214EF5D132A9
ETag
"2187b9aaeaf01529cfc067f12de264d2"
Vary
Accept-Encoding
Content-Type
application/x-javascript
Cache-Control
max-age=45293
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
101024
x-amz-id-2
WqW+qP2m7ZeBhE7hIFQ+9pkKpIDMNnHK/BJxvlVvj3DHUMNJH9XzSe054NVTgzkA
osd.js
www.googletagservices.com/activeview/js/current/
77 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd.js?cb=%2Fr20100101
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:818::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
a1999737449d990f86a266a62e57fb225dd6e5d5521da2358d967c6bd662b314
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:26 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1571656559023965"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
29155
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:26 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame FAF8
0
142 B
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjstYYGid8mh1098dQRHGyc4vE5rsUNsSKmwPetKW7iQ3DbLgr6F38leeHONdNuDCGx8ZN-Vb5cLa84etataP20VrWJr4cmHs__k1KW8WhJqstN7Jt3Za2wtWoLhprmNhvFTW5OpVJQugTZmCYHXPBwZSe7Bhi4wjX9QlFljVccvr5o0D1itPV-QZYMl8ftGpHfYW6fRAkt80KXHxMB7uelhpe4ZAAKsIjPI8l13eWOUEVRy2nTnf5SAl-K1xEKLzHyX4ryu1b-wBRya1icMdhkg146q1w3w7M4WU&sig=Cg0ArKJSzOX2_Wf5ALyHEAE&urlfix=1&adurl=
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.208.34 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s12-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 22 Oct 2019 15:30:26 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:26 GMT
tag
a.teads.tv/page/46561/ Frame FAF8
3 KB
1 KB
Script
General
Full URL
https://a.teads.tv/page/46561/tag
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.232.7 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-232-7.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
59463000704c1188d8429a1d74ba978634e70fc8fd0bd146e9ce21948cae6c39

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:26 GMT
content-encoding
gzip
status
200
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, must-revalidate, max-age=3600
access-control-allow-credentials
true
content-length
994
expires
Tue, 22 Oct 2019 16:30:26 GMT
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame FAF8
78 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019101401.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:818::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
c1c53a4d300ac7532bec2ed085532b2fe66d27f2b592b3a9383aa649e42ed6fb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:26 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1571656559023965"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
29691
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:26 GMT
moatad.js
z.moatads.com/reutersdfpcw319687550988/ Frame FAF8
297 KB
99 KB
Script
General
Full URL
https://z.moatads.com/reutersdfpcw319687550988/moatad.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019101401.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
AmazonS3 /
Resource Hash
6b173d87763629cab6332e13f5fce375f0656baff43c8696995f6e42d8470565

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:26 GMT
Content-Encoding
gzip
Last-Modified
Sat, 19 Oct 2019 00:56:56 GMT
Server
AmazonS3
x-amz-request-id
CC87214EF5D132A9
ETag
"2187b9aaeaf01529cfc067f12de264d2"
Vary
Accept-Encoding
Content-Type
application/x-javascript
Cache-Control
max-age=45293
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
101024
x-amz-id-2
WqW+qP2m7ZeBhE7hIFQ+9pkKpIDMNnHK/BJxvlVvj3DHUMNJH9XzSe054NVTgzkA
view
securepubads.g.doubleclick.net/pcs/ Frame EF32
0
142 B
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjssXtcrtikyfsTtTOmXHR7O20rdiubRuHnNcY08euuUjU-NoYHs0ehaqLi_w2S_3yMNwdBzeOqxh0avhlxZT_UDUZP6vTTUr7QLH9tJYdgvef5KA2pWiULhSRJMImc5d_fKn_56hOXmRDHZfNAeOHaMOwtTHKYo_RMLwbq4jtPrRZqUHnyn3ybxVjFOwH0kb50rk5Jm91eo8Wk71WK5Z4K6mC665SrZLXxcnLkU9dokxXpfWSncNXPTxqYmVz8LXENw_rKZJdLk6WsJb7Z7YJZtPXc8IXJc&sig=Cg0ArKJSzIWQObs-TQgqEAE&urlfix=1&adurl=
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.208.34 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s12-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 22 Oct 2019 15:30:26 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:26 GMT
Carambola_layer_152.min.js
cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/ Frame EF32
Redirect Chain
  • https://route.carambo.la/inimage/getlayer?pid=thms97&did=112441&wid=3&rdn=[RANDOM_NUMBER]
  • https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
445 KB
112 KB
Script
General
Full URL
https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
152.195.39.46 , United States, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
ECS (fcn/40D8) /
Resource Hash
35ecea6b7f7b94fb88fd898d4af61f64aa7b353fbc8aafafd03a5f3f11fb7204

Request headers

Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:26 GMT
content-encoding
deflate
vary
Accept-Encoding
x-amz-request-id
153409E1BF7FEBEE
x-cache
HIT
status
200
content-length
113841
x-amz-id-2
V865sMdx3k/t3D5lrABPDE+/WuUUQ/8AKIupBflK34tUpj/Ukbfq0kicUK0ioNi4ZtvpZDfsX9I=
last-modified
Mon, 12 Aug 2019 09:30:10 GMT
server
ECS (fcn/40D8)
etag
"e54fd03b3325e7a3cefa8816a52dbd14"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
text/javascript
access-control-allow-origin
*
cache-control
max-age=63072000,s-maxage=63072000
accept-ranges
bytes

Redirect headers

Location
https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Date
Tue, 22 Oct 2019 15:30:26 GMT
Server
nginx/1.14.1
Connection
keep-alive
X-Powered-By
Express
Content-Length
0
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame EF32
78 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019101401.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:818::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
c1c53a4d300ac7532bec2ed085532b2fe66d27f2b592b3a9383aa649e42ed6fb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:26 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1571656559023965"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
29691
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:26 GMT
moatad.js
z.moatads.com/reutersdfpcw319687550988/ Frame EF32
297 KB
99 KB
Script
General
Full URL
https://z.moatads.com/reutersdfpcw319687550988/moatad.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019101401.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
AmazonS3 /
Resource Hash
6b173d87763629cab6332e13f5fce375f0656baff43c8696995f6e42d8470565

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:26 GMT
Content-Encoding
gzip
Last-Modified
Sat, 19 Oct 2019 00:56:56 GMT
Server
AmazonS3
x-amz-request-id
CC87214EF5D132A9
ETag
"2187b9aaeaf01529cfc067f12de264d2"
Vary
Accept-Encoding
Content-Type
application/x-javascript
Cache-Control
max-age=45293
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
101024
x-amz-id-2
WqW+qP2m7ZeBhE7hIFQ+9pkKpIDMNnHK/BJxvlVvj3DHUMNJH9XzSe054NVTgzkA
pixelNew.js
s3.amazonaws.com/scripts-clickmeter-com/js/ Frame EF32
Redirect Chain
  • https://pixel.watch/q4m9
  • https://s3.amazonaws.com/scripts-clickmeter-com/js/pixelNew.js
2 KB
2 KB
Image
General
Full URL
https://s3.amazonaws.com/scripts-clickmeter-com/js/pixelNew.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.216.136.5 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
s3-1.amazonaws.com
Software
AmazonS3 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:29 GMT
Last-Modified
Wed, 17 Dec 2014 10:04:21 GMT
Server
AmazonS3
x-amz-request-id
93D8E8BFA0330D64
ETag
"5ecfcd6d8fa19e88256687ff922f77d0"
Content-Type
application/x-javascript
x-amz-storage-class
REDUCED_REDUNDANCY
Accept-Ranges
bytes
Content-Length
2271
x-amz-id-2
/pRL59FQzSIRvAy3wszoqx5Wqb1nnD3sBQZ8PRyqEv+6A75ZAzPp69KFtm0kZ2l0wbC/b3OiJuc=

Redirect headers

Date
Tue, 22 Oct 2019 15:30:27 GMT
X-Rate-Limit-Limit
20s
X-Rate-Limit-Remaining
299
Location
https://s3.amazonaws.com/scripts-clickmeter-com/js/pixelNew.js
X-Rate-Limit-Reset
2019-10-22T15:30:47.7770830Z
Engine
clickmeter.redirect, version 2.0
Connection
keep-alive
Content-Length
0
5189420777
dfp-gateway.s-onetag.com/1/4735792/
112 B
574 B
XHR
General
Full URL
https://dfp-gateway.s-onetag.com/1/4735792/5189420777
Requested by
Host: get.s-onetag.com
URL: https://get.s-onetag.com/4ed1416f-67eb-4d50-8a45-916a5921fee8/tag.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2156:1000:a:52eb:a100:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
8a4d12e5be972c41fafa90e374ff50d36d59f1a0d15af42e0083ef7b0ed0e25b

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:02:57 GMT
via
1.1 bab8148a65b29113f79cf2725076287d.cloudfront.net (CloudFront), 1.1 1f49a084ca923f375f74b42fa36ef429.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA50-C1, FRA50-C1
x-amzn-requestid
4ed65906-7554-4cd6-8139-29bcc38e0d42
status
200
x-cache
Hit from cloudfront
content-type
application/json
access-control-allow-origin
*
cache-control
max-age=3600, public
x-amzn-trace-id
Root=1-5daf1a21-7c4ceef42f24836018848ba9;Sampled=0
x-amz-apigw-id
B-EFMGrWyK4FfHg=
content-length
112
x-amz-cf-id
JQnwFdkgU4fZvIgSAcJ-ZLVp9gQR10_4pyxwVXPUiyagUZrTGN3ofQ==
4741317042
dfp-gateway.s-onetag.com/1/4735792/
119 B
575 B
XHR
General
Full URL
https://dfp-gateway.s-onetag.com/1/4735792/4741317042
Requested by
Host: get.s-onetag.com
URL: https://get.s-onetag.com/4ed1416f-67eb-4d50-8a45-916a5921fee8/tag.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2156:1000:a:52eb:a100:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
1469ce4dab8ec9f7506ac192f45056e1b3e6ef639247db13752046e111d723c6

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:20:32 GMT
via
1.1 7e6ac12144acebd1fc302708f2ecfad6.cloudfront.net (CloudFront), 1.1 1f49a084ca923f375f74b42fa36ef429.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA2, FRA50-C1
x-amzn-requestid
41fe19f2-e340-41b0-846c-38315dc59c54
status
200
x-cache
Hit from cloudfront
content-type
application/json
access-control-allow-origin
*
cache-control
max-age=3600, public
x-amzn-trace-id
Root=1-5daf1e40-8006d7a02f8e2900880af9e0;Sampled=0
x-amz-apigw-id
B-GqCHoQyK4Fu2w=
content-length
119
x-amz-cf-id
wdJVyF6FGlxqsWlqp2e58l9Y3MRz7eHkudpKESYB7XD2OSSUT3ncJA==
139199112
dfp-gateway.s-onetag.com/1/4735792/
114 B
582 B
XHR
General
Full URL
https://dfp-gateway.s-onetag.com/1/4735792/139199112
Requested by
Host: get.s-onetag.com
URL: https://get.s-onetag.com/4ed1416f-67eb-4d50-8a45-916a5921fee8/tag.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2156:1000:a:52eb:a100:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
58d94b06f15b9a1ea02b26e3a0454a7921cda64a5769657e333cba9d9a0bb485

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:08:53 GMT
via
1.1 ad46d498157a92ab1076f74db460670d.cloudfront.net (CloudFront), 1.1 1f49a084ca923f375f74b42fa36ef429.cloudfront.net (CloudFront)
age
648
x-amzn-requestid
8b99bffd-4f6a-48c9-a8a4-83308c70ebaa
status
200
x-cache
Hit from cloudfront
content-type
application/json
access-control-allow-origin
*
cache-control
max-age=3600, public
x-amzn-trace-id
Root=1-5daf1b85-12891924c50ebcf067f8a804;Sampled=0
x-amz-cf-pop
FRA50-C1, FRA50-C1
x-amz-apigw-id
B-E84HrTSK4FngQ=
content-length
114
x-amz-cf-id
EOydsNPzf_hafGny9p7lSCvsAqML2c10hmNPG2gw1wF5QNv1bqjL0w==
truncated
/ Frame FAF8
214 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
114b744786146f7391ff6ea349204dac55b9da99c97a8463225532f34fb59297

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
jload
pixel.adsafeprotected.com/ Frame 07DC
45 KB
13 KB
Script
General
Full URL
https://pixel.adsafeprotected.com/jload?anId=10764&campId=2x2&pubId=54423312&chanId=37592232&placementId=4741317042&pubCreative=138206523841&pubOrder=2107429564&cb=370275150&custom=canvas&custom2=400&custom3=0&adsafe_par&impId=ded5b646-f4e0-11e9-bb6e-382c4ac630d1
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
790079e617abdbf4d900877b7b810eedd3cbc0eefcb2de979dd2d4b1353c24c1

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:26 GMT
Content-Encoding
gzip
X-Server-Name
app20ami.ami.303net.pvt
Transfer-Encoding
chunked
Content-Type
application/javascript;charset=utf-8
Access-Control-Allow-Origin
pixel.adsafeprotected.com
Cache-Control
no-cache
Access-Control-Allow-Credentials
true
Connection
keep-alive
Server
nginx
Expires
Wed, 31 Dec 1969 23:59:59 GMT
truncated
/ Frame EF32
212 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
786ad32c91ba7579cd25deaec3f702323e9340692fe9552f06bf7b3fa291c932

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
jload
pixel.adsafeprotected.com/ Frame 163F
45 KB
13 KB
Script
General
Full URL
https://pixel.adsafeprotected.com/jload?anId=10764&campId=300x280&pubId=20159232&chanId=37592232&placementId=139199112&pubCreative=138204787707&pubOrder=277213512&cb=1954337497&custom=bizdev_article_rr2&custom2=20000&custom3=0&adsafe_par&impId=ded54131-f4e0-11e9-98a1-382c4ac63135
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
183bb42833ccb16db2a75ae1c753655270539e5ec7bff355df4b4c07dbcf55cc

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:26 GMT
Content-Encoding
gzip
X-Server-Name
app34ami.ami.303net.pvt
Transfer-Encoding
chunked
Content-Type
application/javascript;charset=utf-8
Access-Control-Allow-Origin
pixel.adsafeprotected.com
Cache-Control
no-cache
Access-Control-Allow-Credentials
true
Connection
keep-alive
Server
nginx
Expires
Wed, 31 Dec 1969 23:59:59 GMT
n.js
geo.moatads.com/
111 B
285 B
Script
General
Full URL
https://geo.moatads.com/n.js?e=35&ud=undefined&qn=%604%7BZEYwoqI%24%5BK%2BdLLU)%2CMm~t8!Z.%5BMhS%3A15.sn_003etW6~P6Jn)s)wC%24GL3jX%7BQqDOJ%3Eoy)G3p%2FhFjrR8CL6k%24)m3*%5B%605*mF%40%23b%3DhjdbEW%3C7bNC%3ElaKc%2C%26WLRGt%269RHrOCFxBoocF)uhFAkD%3Dv%3Cy%5Dv%5BLy*hgMcpk%3FqFm%5Dm%22%2Bx%7Co%3Ee%7CwR3yC%7CQ%7DGH%3Ch%2Cqkc!p!ny%7BiY81%22ASYUby%3D(tN%23V.x%3Bm_Qrw5.W%2F84VKp%40i6AKx!f%3EUYoo813_xB%2CN%7CDoD%3DhA&qp=00000&is=hBBnjB7GsBpBBBPY2CEBsCybBqw776Kqi7gBooCvBOCiCOB6sCqGBgiBBs0fW0glMfcxnBBBkB0BYBny6BsNBmB0ziw7pCr6yC6rO24xXmYyBdfEC2BBBBBjzmBktCP97GBBBGwRmmEBBBBBBBBBBBnaBW35CeFaBBBpx0OFiBBBT5392tavKc5KCdzzFs7nBBBBBBBBRcQyRBBBCpjOBBBBBBBBBTLF6GfC6Jn7O0EYkCBB0IofRfBBPCxB7UBbjtBbBBC0dL9TRhq8K55G96Lo0eIRTzBiqeuSBBBBBB&iv=7&qt=0&gz=0&hh=0&hn=0&tw=%3Di%22%3BB.kCrR&qc=0&qd=0&qf=1600&qe=1200&qh=1600&qg=1200&qm=-120&qa=1600&qb=1200&qi=1600&qj=1200&po=1-0020002000002120&vy=&ql=&qo=0&qr=0&i=REUTERSDFPCW3&hp=1&wf=1&vb=5&cm=8&kq=1&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&bq=0&f=0&j=&t=1571758226753&de=703286277034&m=0&ar=6907c9d928-clean&iw=6919a0a&q=2&cb=0&ym=0&cu=1571758226753&ll=2&lm=0&ln=1&r=0&em=0&en=0&d=54423312%3A2107429564%3A4741317042%3A138206523841&zMoatTP=canvas&zMoatStory=0&zMoatAU=%2F4735792%2Fus.reuters%2Flife%2Fhealth%2Farticle&zMoatPixelDistance=400&zMoatRawSlicer1=3735912&zMoatRawSlicer2=37592232&zMoatReutersSlicer1=3735912&zMoatReutersSlicer2=37592232&zMoatOrigSlicer1=3735912&zMoatOrigSlicer2=37592232&zGSRS=1&zGSRC=1&gu=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-farxiga-fda%2Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&id=1&zMoatBlacklist=true&bo=3735912&bd=37592232&dfp=0%2C1&la=37592232&gw=reutersdfpcw319687550988&fd=1&ac=1&it=500&ti=0&ih=1&fs=173050&na=463896576&cs=0&callback=DOMlessLLDcallback_38025097
Requested by
Host: z.moatads.com
URL: https://z.moatads.com/reutersdfpcw319687550988/moatad.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.177.181.185 London, United Kingdom, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-35-177-181-185.eu-west-2.compute.amazonaws.com
Software
TornadoServer/4.5.3 /
Resource Hash
1fb7788a3e7303b8f2a41b199a40f8ec40ae835b0f68c2129b9531549eb366df

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:26 GMT
server
TornadoServer/4.5.3
etag
"fdd7ca58348aead3d44b347cfc8e131ee73cecd2"
content-type
text/html; charset=UTF-8
status
200
cache-control
max-age=900
timing-allow-origin
*
content-length
111
n.js
geo.moatads.com/
111 B
286 B
Script
General
Full URL
https://geo.moatads.com/n.js?e=35&ud=undefined&qn=%604%7BZEYwoqI%24%5BK%2BdLLU)%2CMm~t8!Z.%5BMhS%3A15.sn_003etW6~P6Jn)s)wC%24GL3jX%7BQqDOJ%3Eoy)G3p%2FhFjrR8CL6k%24)m3*%5B%605*mF%40%23b%3DhjdbEW%3C7bNC%3ElaKc%2C%26WLRGt%269RHrOCFxBoocF)uhFAkD%3Dv%3Cy%5Dv%5BLy*hgMcpk%3FqFm%5Dm%22%2Bx%7Co%3Ee%7CwR3yC%7CQ%7DGH%3Ch%2Cqkc!p!ny%7BiY81%22ASYUby%3D(tN%23V.x%3Bm_Qrw5.W%2F84VKp%40i6AKx!f%3EUYoo813_xB%2CN%7CDoD%3DhA&qp=00000&is=hBBnjB7GsBpBBBPY2CEBsCybBqw776Kqi7gBooCvBOCiCOB6sCqGBgiBBs0fW0glMfcxnBBBkB0BYBny6BsNBmB0ziw7pCr6yC6rO24xXmYyBdfEC2BBBBBjzmBktCP97GBBBGwRmmEBBBBBBBBBBBnaBW35CeFaBBBpx0OFiBBBT5392tavKc5KCdzzFs7nBBBBBBBBRcQyRBBBCpjOBBBBBBBBBTLF6GfC6Jn7O0EYkCBB0IofRfBBPCxB7UBbjtBbBBC0dL9TRhq8K55G96Lo0eIRTzBiqeuSBBBBBB&iv=7&qt=0&gz=0&hh=0&hn=0&tw=%3Di%22%3BB.kCrR&qc=0&qd=0&qf=1600&qe=1200&qh=1600&qg=1200&qm=-120&qa=1600&qb=1200&qi=1600&qj=1200&po=1-0020002000002120&vy=&ql=&qo=0&qr=0&i=REUTERSDFPCW3&hp=1&wf=1&vb=5&cm=8&kq=1&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&bq=0&f=0&j=&t=1571758226753&de=703286277034&m=0&ar=6907c9d928-clean&iw=6919a0a&q=3&cb=0&ym=0&cu=1571758226753&ll=2&lm=0&ln=1&r=0&em=0&en=0&d=54423312%3A2107429564%3A4741317042%3A138206523841&zMoatTP=canvas&zMoatStory=0&zMoatAU=%2F4735792%2Fus.reuters%2Flife%2Fhealth%2Farticle&zMoatPixelDistance=400&zMoatRawSlicer1=3735912&zMoatRawSlicer2=37592232&zMoatReutersSlicer1=3735912&zMoatReutersSlicer2=37592232&zMoatOrigSlicer1=3735912&zMoatOrigSlicer2=37592232&zGSRS=1&zGSRC=1&gu=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-farxiga-fda%2Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&id=1&zMoatBlacklist=true&bo=3735912&bd=37592232&dfp=0%2C1&la=37592232&gw=reutersdfpcw319687550988&fd=1&ac=1&it=500&ti=0&ih=1&fs=173050&na=1062128735&cs=0&callback=MoatDataJsonpRequest_38025097
Requested by
Host: z.moatads.com
URL: https://z.moatads.com/reutersdfpcw319687550988/moatad.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.177.181.185 London, United Kingdom, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-35-177-181-185.eu-west-2.compute.amazonaws.com
Software
TornadoServer/4.5.3 /
Resource Hash
e17a7ad3dcd16f397f81f827e1c6f137c961abb1720329b0ec210849c2b27845

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:26 GMT
server
TornadoServer/4.5.3
etag
"be9178d941f0d44293e9f04dd3774e7c9b867b8e"
content-type
text/html; charset=UTF-8
status
200
cache-control
max-age=900
timing-allow-origin
*
content-length
111
adunit.js
services.brid.tv/player/build/plugins/ Frame 5877
30 B
427 B
Script
General
Full URL
https://services.brid.tv/player/build/plugins/adunit.js
Requested by
Host: services.brid.tv
URL: https://services.brid.tv/player/build/brid.outstream.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.85.183.90 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-52-85-183-90.fra50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
9c25c4e240bd28a308851f487711c88680072496bf9865fb73a258dff5ca3fd9

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 08:23:04 GMT
content-encoding
gzip
last-modified
Wed, 06 Jun 2018 07:10:50 GMT
server
AmazonS3
age
25675
etag
"00472f99064e3d4328bd208da8c0b958"
x-cache
Hit from cloudfront
content-type
application/javascript
status
200
cache-control
public, max-age=31536000
x-amz-cf-pop
FRA50
accept-ranges
bytes
content-length
50
via
1.1 bd5652a800046ffa43683320c0e731b4.cloudfront.net (CloudFront)
x-amz-cf-id
1msslWgjpsg0r0IEqsmoWCsNOijAfQfrVQODqMYgBfu6cLHMZeXlRw==
teads-format.min.js
a.teads.tv/media/format/v3/
708 KB
184 KB
Script
General
Full URL
https://a.teads.tv/media/format/v3/teads-format.min.js
Requested by
Host: a.teads.tv
URL: https://a.teads.tv/page/46561/tag
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.232.7 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-232-7.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
db2619c2d7a2c41b123c8bbca1cdade0ae40b5a90023a492926c827e63b18f97

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:26 GMT
content-encoding
gzip
last-modified
Tue, 22 Oct 2019 08:28:03 GMT
x-amz-request-id
EB7C5BA139736512
etag
"6d0b7f09ede83a24467e5090016e8062"
vary
Accept-Encoding
content-type
text/javascript;charset=utf-8
status
200
cache-control
private, must-revalidate, max-age=600
x-bucket
c
accept-ranges
bytes
content-length
187956
x-amz-id-2
5KuLYvDtGdrTSJj0hnMk72SsyKO3ET9BpKWNqIDeFL3tQxW/CvkSaIEHrdGDWi3yO+N+DjRs0CE=
expires
Tue, 22 Oct 2019 15:40:26 GMT
truncated
/ Frame 5877
211 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
ea9ca2a275acbfdf5ad1076942b527fd8269af69deb89f8a7ce189ec91ac533a

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
jload
pixel.adsafeprotected.com/ Frame C076
45 KB
13 KB
Script
General
Full URL
https://pixel.adsafeprotected.com/jload?anId=10764&campId=300x250&pubId=4789302609&chanId=37592232&placementId=5189420777&pubCreative=138289622787&pubOrder=2599246982&cb=1797662741&custom=mpu&custom2=400&custom3=0&adsafe_par&impId=ded34561-f4e0-11e9-ba52-70106fb729f4
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
2e2e0ed672db1b0a18039d645dd3af8b445c176b2ecca563d4948a094f61bdc1

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:26 GMT
Content-Encoding
gzip
X-Server-Name
app20ami.ami.303net.pvt
Transfer-Encoding
chunked
Content-Type
application/javascript;charset=utf-8
Access-Control-Allow-Origin
pixel.adsafeprotected.com
Cache-Control
no-cache
Access-Control-Allow-Credentials
true
Connection
keep-alive
Server
nginx
Expires
Wed, 31 Dec 1969 23:59:59 GMT
11615.json
services.brid.tv/services/unit/ Frame 5877
2 KB
1 KB
XHR
General
Full URL
https://services.brid.tv/services/unit/11615.json
Requested by
Host: services.brid.tv
URL: https://services.brid.tv/player/build/brid.outstream.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.85.183.90 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-52-85-183-90.fra50.r.cloudfront.net
Software
Apache /
Resource Hash
fb2c8395640565b0f734e404d34f7f8d7246bf847a96d0d0ef83f265e6844771

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:17:52 GMT
content-encoding
gzip
age
324
x-cache
Hit from cloudfront
status
200
content-length
825
x-served-by
media-lb-2
access-control-allow-origin
*
server
Apache
vary
Accept-Encoding
access-control-allow-methods
GET, OPTIONS
content-type
application/json; charset=UTF-8
via
1.1 41903dc3828cdce2b3daa3c944827b92.cloudfront.net (CloudFront)
cache-control
no-store, no-cache, must-revalidate, post-check=0, pre-check=0
x-amz-cf-pop
FRA50
access-control-allow-headers
origin, x-requested-with, content-type, accept
x-amz-cf-id
2mxhp6_oOLJTFfVdfxCu2JX5Oi4jwsCmt36i2rlS0oREChfAV3zlAQ==
main.19.8.22.js
static.adsafeprotected.com/ Frame 163F
158 KB
50 KB
Script
General
Full URL
https://static.adsafeprotected.com/main.19.8.22.js
Requested by
Host: pixel.adsafeprotected.com
URL: https://pixel.adsafeprotected.com/jload?anId=10764&campId=300x280&pubId=20159232&chanId=37592232&placementId=139199112&pubCreative=138204787707&pubOrder=277213512&cb=1954337497&custom=bizdev_article_rr2&custom2=20000&custom3=0&adsafe_par&impId=ded54131-f4e0-11e9-98a1-382c4ac63135
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.32 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.static.adsafeprotected.com
Software
nginx /
Resource Hash
5df41461e8c29072a827d5fd000d2506238b77e767a34642d6613b79ce49134c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:26 GMT
Content-Encoding
gzip
Last-Modified
Wed, 09 Oct 2019 16:27:21 GMT
X-Server-Name
app25ami.ami.303net.pvt
ETag
"5d9e0a69-c7d3"
Content-Type
application/javascript
Cache-Control
max-age=315360000
Connection
keep-alive
Content-Length
51155
Server
nginx
Expires
Thu, 31 Dec 2037 23:55:55 GMT
main.19.8.22.js
static.adsafeprotected.com/ Frame 07DC
158 KB
50 KB
Script
General
Full URL
https://static.adsafeprotected.com/main.19.8.22.js
Requested by
Host: pixel.adsafeprotected.com
URL: https://pixel.adsafeprotected.com/jload?anId=10764&campId=2x2&pubId=54423312&chanId=37592232&placementId=4741317042&pubCreative=138206523841&pubOrder=2107429564&cb=370275150&custom=canvas&custom2=400&custom3=0&adsafe_par&impId=ded5b646-f4e0-11e9-bb6e-382c4ac630d1
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.32 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.static.adsafeprotected.com
Software
nginx /
Resource Hash
5df41461e8c29072a827d5fd000d2506238b77e767a34642d6613b79ce49134c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:26 GMT
Content-Encoding
gzip
Last-Modified
Wed, 09 Oct 2019 16:27:21 GMT
X-Server-Name
app14ami.ami.303net.pvt
ETag
"5d9e0a69-c7d3"
Content-Type
application/javascript
Cache-Control
max-age=315360000
Connection
keep-alive
Content-Length
51155
Server
nginx
Expires
Thu, 31 Dec 2037 23:55:55 GMT
brid.parser.min.js
p.brid.tv/player/build/plugins/parser/1.1.42/ Frame 5877
83 KB
24 KB
Script
General
Full URL
https://p.brid.tv/player/build/plugins/parser/1.1.42/brid.parser.min.js
Requested by
Host: services.brid.tv
URL: https://services.brid.tv/player/build/brid.outstream.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.90 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-90.fra50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
37642757d1d414dac352b8cc0869fa65b771300432e518e0e6ac6551b55181d5

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 08:27:05 GMT
content-encoding
gzip
last-modified
Fri, 27 Sep 2019 08:25:48 GMT
server
AmazonS3
age
25464
etag
"b79fb9eed71dd061b0ed7d88150263de"
x-cache
Hit from cloudfront
content-type
application/javascript
status
200
cache-control
max-age=31536000, public, immutable
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
content-length
24072
via
1.1 ea2e21f6a5c3ec2f96b0dac1b769e00e.cloudfront.net (CloudFront)
x-amz-cf-id
urFv1mYbCp5IPhpjNvy5PQoU_MCLMPfQPgOaNn9FaYlYb4OM2Qro_w==
index.html
cmp.teads.mgr.consensu.org/ Frame 9425
0
0
Document
General
Full URL
https://cmp.teads.mgr.consensu.org/index.html
Requested by
Host: a.teads.tv
URL: https://a.teads.tv/media/format/v3/teads-format.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2a02:26f0:6c00:292::2c92 , Ascension Island, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash

Request headers

Host
cmp.teads.mgr.consensu.org
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
Sec-Fetch-Site
cross-site
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Accept-Encoding
gzip, deflate, br
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5

Response headers

x-amz-id-2
eP74N5mDf2mwuUwz6E0m831egGDvXvr6HEIydDhB20yVDuv4ZE6ina8YQaGiXGlfbz2w11Bw+zo=
x-amz-request-id
93A9209AF986CF84
Last-Modified
Fri, 14 Sep 2018 07:42:32 GMT
ETag
"e7d6c2974a38b7ff77a560e83789f66a"
Accept-Ranges
bytes
Content-Type
text/html
Content-Length
583
Server
AmazonS3
Cache-Control
max-age=300
Expires
Tue, 22 Oct 2019 15:35:28 GMT
Date
Tue, 22 Oct 2019 15:30:28 GMT
Connection
keep-alive
p2
sb.scorecardresearch.com/
Redirect Chain
  • https://sb.scorecardresearch.com/p?c1=2&c2=17198971&ns_ap_sv=2.1511.10&ns_type=hidden&ns_st_it=a&ns_st_sv=4.0.0&ns_st_ad=1&ns_st_sq=1&ns_st_id=1571758226906&ns_st_ec=1&ns_st_cn=1&ns_st_ev=play&ns_s...
  • https://sb.scorecardresearch.com/p2?c1=2&c2=17198971&ns_ap_sv=2.1511.10&ns_type=hidden&ns_st_it=a&ns_st_sv=4.0.0&ns_st_ad=1&ns_st_sq=1&ns_st_id=1571758226906&ns_st_ec=1&ns_st_cn=1&ns_st_ev=play&ns_...
43 B
309 B
Image
General
Full URL
https://sb.scorecardresearch.com/p2?c1=2&c2=17198971&ns_ap_sv=2.1511.10&ns_type=hidden&ns_st_it=a&ns_st_sv=4.0.0&ns_st_ad=1&ns_st_sq=1&ns_st_id=1571758226906&ns_st_ec=1&ns_st_cn=1&ns_st_ev=play&ns_st_ct=va00&ns_st_cl=0&ns_st_pt=0&c3=*null&c4=*null&c6=*null&ns_ts=63909980&cs_ucfr=1
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.19.43.224 , Ascension Island, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a2-19-43-224.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
24e480e4659fbae818853a38f8a3036f529f539024dc3e772c0b594ce02ea9db

Request headers

Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:26 GMT
Cache-Control
private, no-cache, no-cache=Set-Cookie, no-store, proxy-revalidate
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Expires
Mon, 01 Jan 1990 00:00:00 GMT

Redirect headers

Location
https://sb.scorecardresearch.com/p2?c1=2&c2=17198971&ns_ap_sv=2.1511.10&ns_type=hidden&ns_st_it=a&ns_st_sv=4.0.0&ns_st_ad=1&ns_st_sq=1&ns_st_id=1571758226906&ns_st_ec=1&ns_st_cn=1&ns_st_ev=play&ns_st_ct=va00&ns_st_cl=0&ns_st_pt=0&c3=*null&c4=*null&c6=*null&ns_ts=63909980&cs_ucfr=1
Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:26 GMT
Cache-Control
private, no-cache, no-cache=Set-Cookie, no-store, proxy-revalidate
Connection
keep-alive
Content-Length
0
Expires
Mon, 01 Jan 1990 00:00:00 GMT
track
t.teads.tv/
23 B
157 B
Image
General
Full URL
https://t.teads.tv/track?action=placementCall&ts=1571758226904&pageId=46561&pid=78293&env=js-web&pfid=[pfid]&f=1&fv=141
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.232.7 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-232-7.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
328e90a318268aea96180cc31666ae6d6f79d90d078c123bc3d98ee08a192fb7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
200
pragma
no-cache
date
Tue, 22 Oct 2019 15:30:26 GMT
cache-control
max-age=0, no-cache, no-store
expires
Tue, 22 Oct 2019 15:30:26 GMT
content-length
23
content-type
image/gif
track
t.teads.tv/
23 B
157 B
Image
General
Full URL
https://t.teads.tv/track?action=slotAvailable&ts=1571758226904&pageId=46561&pid=78293&env=js-web&pfid=[pfid]&f=1&slot=native&fv=141
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.232.7 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-232-7.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
328e90a318268aea96180cc31666ae6d6f79d90d078c123bc3d98ee08a192fb7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
200
pragma
no-cache
date
Tue, 22 Oct 2019 15:30:26 GMT
cache-control
max-age=0, no-cache, no-store
expires
Tue, 22 Oct 2019 15:30:26 GMT
content-length
23
content-type
image/gif
main.19.8.22.js
static.adsafeprotected.com/ Frame C076
158 KB
50 KB
Script
General
Full URL
https://static.adsafeprotected.com/main.19.8.22.js
Requested by
Host: pixel.adsafeprotected.com
URL: https://pixel.adsafeprotected.com/jload?anId=10764&campId=300x250&pubId=4789302609&chanId=37592232&placementId=5189420777&pubCreative=138289622787&pubOrder=2599246982&cb=1797662741&custom=mpu&custom2=400&custom3=0&adsafe_par&impId=ded34561-f4e0-11e9-ba52-70106fb729f4
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.32 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.static.adsafeprotected.com
Software
nginx /
Resource Hash
5df41461e8c29072a827d5fd000d2506238b77e767a34642d6613b79ce49134c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:26 GMT
Content-Encoding
gzip
Last-Modified
Wed, 09 Oct 2019 16:27:21 GMT
X-Server-Name
app14ami.ami.303net.pvt
ETag
"5d9e0a69-c7d3"
Content-Type
application/javascript
Cache-Control
max-age=315360000
Connection
keep-alive
Content-Length
51155
Server
nginx
Expires
Thu, 31 Dec 2037 23:55:55 GMT
AddLogs
logging.carambo.la/ Frame EF32
0
176 B
XHR
General
Full URL
https://logging.carambo.la/AddLogs
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.224.94.188 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-224-94-188.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-type
application/x-www-form-urlencoded

Response headers

Access-Control-Allow-Origin
*
Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:24 GMT
Cache-Control
no-cache
Connection
keep-alive
Expires
-1
a55a5cc119f012cf60f9282206ee7982_71a394c6fd1503f9b8c0a6332ebf6a5fe46e6d5c_incontent_unified_3.json
inimage.carambo.la/1/thms97/112441/ Frame EF32
3 KB
1 KB
XHR
General
Full URL
https://inimage.carambo.la/1/thms97/112441/a55a5cc119f012cf60f9282206ee7982_71a394c6fd1503f9b8c0a6332ebf6a5fe46e6d5c_incontent_unified_3.json
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
152.195.39.46 , United States, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
ECS (fcn/418B) /
Resource Hash
aa3e0470da5393ab2d67b3f4dc2845598699ffb8848d7872d85eeee676b4053d

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:26 GMT
content-encoding
deflate
vary
Accept-Encoding
x-amz-request-id
7048003E6DEB81B9
x-cache
HIT
status
200
content-length
1029
x-amz-id-2
/eIgYobkN245VE/mMeBwhzjdGlEe3qCoDZuiS855KK+3XjhSXE0nonlwiSMxWddG4o6klOWjN0I=
x-amz-expiration
expiry-date="Thu, 24 Oct 2019 00:00:00 GMT", rule-id="delete files after 24 hours"
last-modified
Tue, 22 Oct 2019 01:06:34 GMT
server
ECS (fcn/418B)
etag
"06a061cd4cc04caf835bfc3ddf248fb6"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
application/json; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=0, s-maxage=14400
accept-ranges
bytes
SetPageRequestGeo
analytics.carambo.la/ Frame EF32
35 B
332 B
Fetch
General
Full URL
https://analytics.carambo.la/SetPageRequestGeo
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.174.181.134 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-35-174-181-134.compute-1.amazonaws.com
Software
/
Resource Hash
a3b59cf3c15a5896f4224c367d24e647fe14e411b8024dcc87aa37783e0cf110

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:26 GMT
Content-Type
application/json; charset=utf-8
Access-Control-Allow-Origin
https://www.reuters.com
Cache-Control
no-cache
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
35
Expires
-1
css
fonts.googleapis.com/ Frame EF32
9 KB
780 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Roboto:500,300,700,400
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:821::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
ESF /
Resource Hash
33e2656713e8648323bd5193b2e314db7df61f4d37d5df4ce22ad72b04a1166a
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
br
last-modified
Tue, 22 Oct 2019 15:30:27 GMT
server
ESF
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
status
200
date
Tue, 22 Oct 2019 15:30:27 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:27 GMT
css
fonts.googleapis.com/
9 KB
734 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Roboto:500,300,700,400
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:821::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
ESF /
Resource Hash
33e2656713e8648323bd5193b2e314db7df61f4d37d5df4ce22ad72b04a1166a
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
br
last-modified
Tue, 22 Oct 2019 15:30:27 GMT
server
ESF
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
status
200
date
Tue, 22 Oct 2019 15:30:27 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:27 GMT
css
fonts.googleapis.com/ Frame EF32
24 KB
1 KB
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Open+Sans:300italic,400italic,600italic,700italic,800italic,400,600,300,700,800
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:821::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
ESF /
Resource Hash
0a733c9a259685cf9a9816145434c0087227f35400e16208e7e63e58ccd44538
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
br
last-modified
Tue, 22 Oct 2019 15:30:27 GMT
server
ESF
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
status
200
date
Tue, 22 Oct 2019 15:30:27 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:27 GMT
css
fonts.googleapis.com/
24 KB
1 KB
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Open+Sans:300italic,400italic,600italic,700italic,800italic,400,600,300,700,800
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:821::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
ESF /
Resource Hash
0a733c9a259685cf9a9816145434c0087227f35400e16208e7e63e58ccd44538
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
br
last-modified
Tue, 22 Oct 2019 15:30:27 GMT
server
ESF
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
status
200
date
Tue, 22 Oct 2019 15:30:27 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:27 GMT
Knowledge-Medium.woff
static.reutersmedia.net/resources_v2/fonts/ Frame EF32
24 KB
24 KB
Font
General
Full URL
https://static.reutersmedia.net/resources_v2/fonts/Knowledge-Medium.woff
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.40 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-40.fra50.r.cloudfront.net
Software
nginx /
Resource Hash
ae62fb7dca96004b13d628bf9deaa48d592259489d50369e6998929cfafe590f

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Origin
https://www.reuters.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 20 Oct 2019 01:32:31 GMT
content-encoding
gzip
age
223076
x-cache
Hit from cloudfront
status
200
content-length
24497
access-control-allow-origin
*
last-modified
Wed, 29 Mar 2017 00:52:23 GMT
server
nginx
vary
Accept-Encoding
content-type
application/x-font-woff
via
1.1 80c1ad5f9352d00b95a9da73eb6b6be5.cloudfront.net (CloudFront)
cache-control
max-age=604800
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
zYE7uQpOcLU_7jNYGoSUzkb5iJhXlkz9acBrQFQsskGPQwlxIZOfIQ==
expires
Tue, 08 Oct 2019 18:56:35 GMT
Knowledge-Regular.woff
static.reutersmedia.net/resources_v2/fonts/ Frame EF32
24 KB
24 KB
Font
General
Full URL
https://static.reutersmedia.net/resources_v2/fonts/Knowledge-Regular.woff
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.40 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-40.fra50.r.cloudfront.net
Software
nginx /
Resource Hash
4e75f5bbf505e72bd2fc760536a94e16ee82202ec60757a8815a0273dc5ae85d

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Origin
https://www.reuters.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 20 Oct 2019 00:25:05 GMT
content-encoding
gzip
age
227122
x-cache
Hit from cloudfront
status
200
content-length
24249
access-control-allow-origin
*
last-modified
Wed, 29 Mar 2017 00:52:26 GMT
server
nginx
vary
Accept-Encoding
content-type
application/x-font-woff
via
1.1 80c1ad5f9352d00b95a9da73eb6b6be5.cloudfront.net (CloudFront)
cache-control
max-age=604800
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
Le8wFQyOm3K2USYW6c2KbIP4vIwd6oLqHq2BHtJMY8mv6Qnq4EinKg==
expires
Fri, 25 Oct 2019 19:41:43 GMT
cbolaIcons.woff
cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/css/fonts/ Frame EF32
4 KB
4 KB
Font
General
Full URL
https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/css/fonts/cbolaIcons.woff?phtwnv
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
152.195.39.46 , United States, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
ECS (fcn/40DA) /
Resource Hash
c85a8e7c2d1d0583578b2afd3a1ce469797bfa5c9d5598cba25f51f839348ec8

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Origin
https://www.reuters.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:27 GMT
last-modified
Mon, 12 Aug 2019 09:30:07 GMT
server
ECS (fcn/40DA)
x-amz-request-id
EB7763FE05F63708
status
200
etag
"dae3eb8c820d3bbb16a17610dece1c88"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
application/octet-stream
access-control-allow-origin
*
cache-control
max-age=63072000,s-maxage=63072000
x-cache
HIT
accept-ranges
bytes
content-length
3832
x-amz-id-2
7MUht4mVKz4ngR9jgyvmir1wZGEjO9QI/rIZ/srGx3xO9UJu61r4NOknLMNQ46mu1ltfrbqjbSk=
SetPageElementsRequestNew
analytics.carambo.la/ Frame EF32
0
176 B
Fetch
General
Full URL
https://analytics.carambo.la/SetPageElementsRequestNew
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.174.181.134 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-35-174-181-134.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

Access-Control-Allow-Origin
*
Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:27 GMT
Cache-Control
no-cache
Connection
keep-alive
Expires
-1
GetAds
xtr.carambo.la/ Frame EF32
10 KB
2 KB
Fetch
General
Full URL
https://xtr.carambo.la/GetAds
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.239.9.60 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-239-9-60.compute-1.amazonaws.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
1299e53ba1649682c4f25d89297450860f282b07a71388be8509635f4b991f2d

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:26 GMT
Content-Encoding
deflate
Server
Microsoft-IIS/8.5
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Content-Type
text/html
Access-Control-Allow-Origin
*
Cache-Control
no-cache
Connection
keep-alive
Content-Length
2198
Expires
-1
3412_3_10.jpg
media.carambo.la/Images/ Frame EF32
9 KB
9 KB
Image
General
Full URL
https://media.carambo.la/Images/3412_3_10.jpg
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
152.195.39.46 , United States, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
ECS (fcn/419C) /
Resource Hash
bfcfa9f2fd2f5cc883c40dff1abaca2f3a15409314df5ed1c7b91a5b395d2114

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:27 GMT
last-modified
Thu, 11 May 2017 11:05:45 GMT
server
ECS (fcn/419C)
x-amz-request-id
8B87ED1B9ADDBE68
status
200
etag
"6979adc2837124cdf2a42f972d0be812"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
image/jpeg
access-control-allow-origin
*
x-cache
HIT
accept-ranges
bytes
content-length
9520
x-amz-id-2
dC+1Td3caQtni1eSLGUW8Ql/3dkSY9yoJoiHj9T1NLl5TWFYz7AqX9/fOjaBnD10Rlf58elmpuw=
3416_3_10.jpg
media.carambo.la/Images/ Frame EF32
10 KB
11 KB
Image
General
Full URL
https://media.carambo.la/Images/3416_3_10.jpg
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
152.195.39.46 , United States, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
ECS (fcn/418B) /
Resource Hash
64d149eb162e7815255c1431fb2ba07c00b871f3146bd1c889c89851ec302ff5

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:27 GMT
last-modified
Thu, 11 May 2017 11:05:47 GMT
server
ECS (fcn/418B)
x-amz-request-id
8B29F51538678986
status
200
etag
"dfd485bbfe66d217e73da9de01623ff7"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
image/jpeg
access-control-allow-origin
*
x-cache
HIT
accept-ranges
bytes
content-length
10658
x-amz-id-2
bv5XX/E4EFD5f7+A3/lZ5/NxAxyTgf1q7sfAAaFS/dzXBVIyt3g8GekhOdksgIQtaauQ62O/Ox0=
4702_3_10.jpg
media.carambo.la/Images/ Frame EF32
19 KB
19 KB
Image
General
Full URL
https://media.carambo.la/Images/4702_3_10.jpg
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
152.195.39.46 , United States, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
ECS (fcn/419E) /
Resource Hash
975e6969cc083d374166ad06d0fc6863b4cf2cb7fd90f46314c38ea5d77cd0ec

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:27 GMT
last-modified
Thu, 11 May 2017 11:05:08 GMT
server
ECS (fcn/419E)
x-amz-request-id
FA206A745F654A91
status
200
etag
"a699d560f82b6abf509d48632621e85a"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
image/jpeg
access-control-allow-origin
*
x-cache
HIT
accept-ranges
bytes
content-length
19048
x-amz-id-2
0PPxzuKt6qz8FFMY9oyQKJf7b3kkV2ODpL/itHX7odXjCWjBDfWmvecKnKw3TcbfLdO2CUwE5vY=
sca.17.4.95.js
static.adsafeprotected.com/ Frame 64B0
81 KB
20 KB
Script
General
Full URL
https://static.adsafeprotected.com/sca.17.4.95.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.32 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.static.adsafeprotected.com
Software
nginx /
Resource Hash
149c8d10677f2f6979fa28c078cf832f575ee53c397d791b739e7c4c687fe7bc

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:27 GMT
Content-Encoding
gzip
Last-Modified
Tue, 19 Jun 2018 17:20:43 GMT
X-Server-Name
app14ami.ami.303net.pvt
ETag
"5b293b6b-4fda"
Content-Type
application/javascript
Cache-Control
max-age=315360000
Connection
keep-alive
Content-Length
20442
Server
nginx
Expires
Thu, 31 Dec 2037 23:55:55 GMT
mon
pixel.adsafeprotected.com/
43 B
309 B
Image
General
Full URL
https://pixel.adsafeprotected.com/mon?anId=10764&campId=300x250&pubId=4789302609&chanId=37592232&placementId=5189420777&pubCreative=138289622787&pubOrder=2599246982&cb=1797662741&custom=mpu&custom2=400&custom3=0&adsafe_par&impId=ded34561-f4e0-11e9-ba52-70106fb729f4&adsafe_url=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-farxiga-fda%2Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&adsafe_type=abdfq&adsafe_jsinfo=,id:60312569-8562-65c6-4952-219c4cca5cec,c:rN5Sfx,sl:inView,em:true,fr:true,mn:app20ami,pt:1-5-15,wc:0.0.1600.1200,ac:1140.436.300.250,am:i,cc:1140.436.300.250,piv:100,obst:0,th:0,reas:,br:u,abv:na,an:n,scm:publ1.grpm1,fm:rFDXldT+11|12|13|14|15|16|17|18|19|1a|1b|1c*.10764|1c1|1d1|1e1|1f|1g,idMap:1c*,pl:,rend:1,renddet:DIV.qs.sn,rmeas:1,es:0,sc:1,ha:1,gm:1,tt:jload,thd:1,et:187,oid:df580500-f4e0-11e9-8a21-0025908827f4,v:19.8.22,sp:1,wr:1600.1200,sr:1600.1200,ov:0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:27 GMT
X-Server-Name
app20ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
sca.17.4.95.js
static.adsafeprotected.com/ Frame 80F3
81 KB
20 KB
Script
General
Full URL
https://static.adsafeprotected.com/sca.17.4.95.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.32 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.static.adsafeprotected.com
Software
nginx /
Resource Hash
149c8d10677f2f6979fa28c078cf832f575ee53c397d791b739e7c4c687fe7bc

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:27 GMT
Content-Encoding
gzip
Last-Modified
Tue, 19 Jun 2018 17:20:43 GMT
X-Server-Name
app14ami.ami.303net.pvt
ETag
"5b293b6b-4fda"
Content-Type
application/javascript
Cache-Control
max-age=315360000
Connection
keep-alive
Content-Length
20442
Server
nginx
Expires
Thu, 31 Dec 2037 23:55:55 GMT
mon
pixel.adsafeprotected.com/
43 B
309 B
Image
General
Full URL
https://pixel.adsafeprotected.com/mon?anId=10764&campId=300x280&pubId=20159232&chanId=37592232&placementId=139199112&pubCreative=138204787707&pubOrder=277213512&cb=1954337497&custom=bizdev_article_rr2&custom2=20000&custom3=0&adsafe_par&impId=ded54131-f4e0-11e9-98a1-382c4ac63135&adsafe_url=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-farxiga-fda%2Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&adsafe_type=abdfq&adsafe_jsinfo=,id:b1b94bc0-409a-65b8-d66e-b3b2892c851a,c:rN5SfO,sl:outOfView,em:true,fr:true,mn:app34ami,pt:1-5-15,wc:0.0.1600.1200,ac:1140.3076.300.280,am:i,cc:1140.3076.300.280,piv:0,obst:0,th:0,reas:l,br:u,abv:na,an:n,scm:publ1.grpm1,fm:rFDXlcz+11|12|13|14|15|16|17|18|19|1a|1b|1c1|1c2|1d1|1e*.10764|1e1|1f|1g,idMap:1e*,pl:,rend:0,renddet:DIV,rmeas:0,es:0,sc:1,ha:1,gm:1,tt:jload,thd:1,et:286,oid:df4da4da-f4e0-11e9-9e72-382c4ac63095,v:19.8.22,sp:1,wr:1600.1200,sr:1600.1200,ov:0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:27 GMT
X-Server-Name
app34ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
SetEvent
analytics.carambo.la/ Frame EF32
0
176 B
Fetch
General
Full URL
https://analytics.carambo.la/SetEvent
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.174.181.134 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-35-174-181-134.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

Access-Control-Allow-Origin
*
Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:26 GMT
Cache-Control
no-cache
Connection
keep-alive
Expires
-1
sca.17.4.95.js
static.adsafeprotected.com/ Frame DE49
81 KB
20 KB
Script
General
Full URL
https://static.adsafeprotected.com/sca.17.4.95.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.32 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.static.adsafeprotected.com
Software
nginx /
Resource Hash
149c8d10677f2f6979fa28c078cf832f575ee53c397d791b739e7c4c687fe7bc

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:27 GMT
Content-Encoding
gzip
Last-Modified
Tue, 19 Jun 2018 17:20:43 GMT
X-Server-Name
app25ami.ami.303net.pvt
ETag
"5b293b6b-4fda"
Content-Type
application/javascript
Cache-Control
max-age=315360000
Connection
keep-alive
Content-Length
20442
Server
nginx
Expires
Thu, 31 Dec 2037 23:55:55 GMT
mon
pixel.adsafeprotected.com/
43 B
309 B
Image
General
Full URL
https://pixel.adsafeprotected.com/mon?anId=10764&campId=2x2&pubId=54423312&chanId=37592232&placementId=4741317042&pubCreative=138206523841&pubOrder=2107429564&cb=370275150&custom=canvas&custom2=400&custom3=0&adsafe_par&impId=ded5b646-f4e0-11e9-bb6e-382c4ac630d1&adsafe_url=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-farxiga-fda%2Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&adsafe_type=abdfq&adsafe_jsinfo=,id:35b2bbf3-52b8-a43e-25f5-83fc4deeee50,c:rN5Sg2,sl:inView,em:true,fr:true,mn:app20ami,pt:1-5-15,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,br:u,abv:na,an:n,scm:publ1.grpm1,fm:rFDXlcG+11|12|13|14|15|16|17|18|19|1a|1b|1c1|1c2|1d*.10764|1d1|1e1|1e2|1f|1g,fm2:rFDXlcG+11|12|13|14|15|16|17|18|19|1a|1b|1c1|1c2|1d*.10764|1d1|1e1|1e2|1f|1g,idMap:1d*,pl:,rend:0,renddet:WINDOW,rmeas:0,es:0,sc:1,ha:1,gm:1,tt:jload,thd:1,et:293,oid:df51004b-f4e0-11e9-8106-0025908827f4,v:19.8.22,sp:1,wr:1600.1200,sr:1600.1200,ov:0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:27 GMT
X-Server-Name
app20ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=60312569-8562-65c6-4952-219c4cca5cec&tv={c:rN5SgO,pingTime:0,time:265,type:pf,clog:[{piv:100,vs:i,r:,w:300,h:250,t:186}],es:0,sc:1,ha:1,gm:1,slTimes:{i:265,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:186,wc:0.0.1600.1200,ac:1140.436.300.250,am:i,cc:1140.436.300.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[91~100],as:[91~300.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:0,fm:rFDXldT+11|12|13|14|15|16|17|18|19|1a|1b|1c*.10764|1c1|1d1|1e1|1f|1g,idMap:1c*,rend:1,renddet:DIV.qs.sn,rmeas:1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:27 GMT
X-Server-Name
dt24.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=35b2bbf3-52b8-a43e-25f5-83fc4deeee50&tv={c:rN5SgY,pingTime:0,time:350,type:pf,im:{pBlk:297},clog:[{piv:100,vs:i,r:,w:2,h:2,t:292}],es:0,sc:1,ha:1,gm:1,slTimes:{i:350,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:292,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,bkn:{piv:[65~100],as:[65~2.2]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:0,fm:rFDXlcz+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1d*.10764|1d1|1e.10764|1e1|1e2|1f|1g,fm2:rFDXlcz+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1d*.10764|1d1|1e.10764|1e1|1e2|1f|1g,idMap:1d*,rend:0,renddet:WINDOW,rmeas:0}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:27 GMT
X-Server-Name
dt63.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
ad
a.teads.tv/page/46561/
118 B
335 B
XHR
General
Full URL
https://a.teads.tv/page/46561/ad?windowWidth=1600&windowHeight=1200&windowDepth=1&windowReferrerUrl=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-farxiga-fda%2Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&page=%7B%22id%22%3A46561%2C%22placements%22%3A%5B%7B%22id%22%3A78293%2C%22validity%22%3A%7B%22status%22%3Atrue%2C%22reasons%22%3A%5B%5D%7D%2C%22player%22%3A%7B%22width%22%3A755%2C%22height%22%3A425%7D%2C%22slotType%22%3A%22native%22%7D%5D%2C%22gdpr_iab%22%3A%7B%22status%22%3A23%2C%22consent%22%3A%22%22%2C%22reason%22%3A230%7D%7D&userId=897290cb-1056-43ab-aef5-daf7577331f0&formatVersion=2.22.61&env=js-web&netBw=10&ttfb=109
Requested by
Host: a.teads.tv
URL: https://a.teads.tv/media/format/v3/teads-format.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.232.7 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-232-7.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
f50167bee40cd7fdd6c623efb794e0edddec7de87ef71f48c8b1b1413e1dfc4a

Request headers

Accept
application/json; charset=UTF-8
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:27 GMT
content-encoding
gzip
status
200
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.reuters.com
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
129
expires
Tue, 22 Oct 2019 15:30:27 GMT
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=60312569-8562-65c6-4952-219c4cca5cec&tv={c:rN5Shb,pingTime:-2,time:288,type:a,im:{sf:0,pom:1,prf:{beA:90,beZ:91,mfA:260,cmA:261,inA:261,inZ:265,prA:265,prZ:271,si:276,poA:276,poZ:281,cmZ:281,mfZ:281,loA:355,loZ:358,ltA:377,ltZ:377,mdA:91,mdZ:119}},sca:{dfp:{df:4,sz:300.250,dom:div}},env:{gca:1},clog:[{piv:100,vs:i,r:,w:300,h:250,t:186}],es:0,sc:1,ha:1,gm:1,slTimes:{i:288,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:186,wc:0.0.1600.1200,ac:1140.436.300.250,am:i,cc:1140.436.300.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[114~100],as:[114~300.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:0,fm:rFDXlcz+11|12|13|14|15|16|17|18|19|1a|1b|1c*.10764|1c1|1d.10764|1d1|1e.10764|1e1|1f|1g,idMap:1c*,rend:1,renddet:DIV.qs.sn,rmeas:1,slid:[google_ads_iframe_/4735792/us.reuters/life/health/article_0,google_ads_iframe_/4735792/us.reuters/life/health/article_0__container__,dpslot_mpu_5002933_USKBN1X00J5,USKBN1X00J5],sinceFw:101,readyFired:true}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:27 GMT
X-Server-Name
dt74.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=b1b94bc0-409a-65b8-d66e-b3b2892c851a&tv={c:rN5Shg,pingTime:-2,time:375,type:a,im:{sf:0,pom:1,prf:{beA:100,beZ:101,mfA:374,cmA:374,inA:374,inZ:376,prA:376,prZ:379,si:386,poA:386,poZ:390,cmZ:390,mfZ:390,loA:453,loZ:454,ltA:475,ltZ:475,mdA:102,mdZ:178}},sca:{dfp:{df:4,sz:300.280,dom:body}},env:{gca:1},clog:[{piv:0,vs:o,r:l,w:300,h:280,t:285}],es:0,sc:1,ha:1,gm:1,slTimes:{i:0,o:375,n:0,pp:0,pm:0},slEvents:[{sl:o,t:285,wc:0.0.1600.1200,ac:1140.3076.300.280,am:i,cc:1140.3076.300.280,piv:0,obst:0,th:0,reas:l,bkn:{piv:[100~0],as:[100~300.280]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:0,fm:rFDXlcz+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1d.10764|1d1|1e*.10764|1e1|1f|1g,idMap:1e*,rend:0,renddet:DIV,rmeas:0,slid:[google_ads_iframe_/4735792/us.reuters/life/health/article_4,google_ads_iframe_/4735792/us.reuters/life/health/article_4__container__,dpslot_bizdev_article_rr2_7487062_USKBN1X00J5,USKBN1X00J5],sinceFw:89,readyFired:true}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:27 GMT
X-Server-Name
dt37.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=35b2bbf3-52b8-a43e-25f5-83fc4deeee50&tv={c:rN5Shj,pingTime:-2,time:371,type:a,im:{sf:0,pom:1,prf:{beA:114,beZ:115,mfA:399,cmA:399,inA:399,inZ:400,prA:400,prZ:404,si:406,poA:406,bl:411,poZ:411,cmZ:411,mfZ:411,loA:465,loZ:466,ltA:484,ltZ:484,mdA:115,mdZ:187}},sca:{dfp:{df:4,sz:100.100,dom:div},ha1:{res1:1,ps:1,ts:1571758227198,psfr:1}},env:{gca:1},clog:[{piv:100,vs:i,r:,w:2,h:2,t:292}],es:0,sc:1,ha:1,gm:1,slTimes:{i:371,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:292,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,bkn:{piv:[85~100],as:[85~2.2]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:0,fm:rFDXlcz+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1d*.10764|1d1|1e.10764|1e1|1e2|1f|1g,fm2:rFDXlcz+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1d*.10764|1d1|1e.10764|1e1|1e2|1f|1g,idMap:1d*,rend:0,renddet:WINDOW,rmeas:0,slid:[google_ads_iframe_/4735792/us.reuters/life/health/article_2,google_ads_iframe_/4735792/us.reuters/life/health/article_2__container__,dpslot_canvas_3130230_USKBN1X00J5,USKBN1X00J5],sinceFw:77,readyFired:true}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:27 GMT
X-Server-Name
dt06.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=60312569-8562-65c6-4952-219c4cca5cec&tv={c:rN5ShX,time:336,type:e,env:{ar:self.0},es:0,sc:1,ha:1,gm:1,slTimes:{i:336,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:186,wc:0.0.1600.1200,ac:1140.436.300.250,am:i,cc:1140.436.300.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[162~100],as:[162~300.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:0,fm:rFDXlcz+11|12|13|14|15|16|17|18|19|1a|1b|1c*.10764|1c1|1d.10764|1d1|1e.10764|1e1|1f|1g,idMap:1c*,rend:1,renddet:DIV.qs.sn,rmeas:1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:27 GMT
X-Server-Name
dt66.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=b1b94bc0-409a-65b8-d66e-b3b2892c851a&tv={c:rN5ShY,time:419,type:e,env:{ar:60312569-8562-65c6-4952-219c4cca5cec.1},es:0,sc:1,ha:1,gm:1,slTimes:{i:0,o:419,n:0,pp:0,pm:0},slEvents:[{sl:o,t:285,wc:0.0.1600.1200,ac:1140.3076.300.280,am:i,cc:1140.3076.300.280,piv:0,obst:0,th:0,reas:l,bkn:{piv:[144~0],as:[144~300.280]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:0,fm:rFDXlcz+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1d.10764|1d1|1e*.10764|1e1|1f|1g,idMap:1e*,rend:0,renddet:DIV,rmeas:0}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:27 GMT
X-Server-Name
dt24.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=35b2bbf3-52b8-a43e-25f5-83fc4deeee50&tv={c:rN5ShZ,time:413,type:e,im:{pWait:4},env:{ar:60312569-8562-65c6-4952-219c4cca5cec.2},es:0,sc:1,ha:1,gm:1,slTimes:{i:413,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:292,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,bkn:{piv:[127~100],as:[127~2.2]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:0,fm:rFDXlcz+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1d*.10764|1d1|1e.10764|1e1|1e2|1f|1g,fm2:rFDXlcz+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1d*.10764|1d1|1e.10764|1e1|1e2|1f|1g,idMap:1d*,rend:0,renddet:WINDOW,rmeas:0}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:27 GMT
X-Server-Name
dt74.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
iframe
sync.teads.tv/ Frame F779
0
0
Document
General
Full URL
https://sync.teads.tv/iframe?pid=78293&userId=897290cb-1056-43ab-aef5-daf7577331f0&gdprIab={%22status%22:23,%22consent%22:%22%22,%22reason%22:230}&env=js-web&1571758227263
Requested by
Host: a.teads.tv
URL: https://a.teads.tv/media/format/v3/teads-format.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.232.7 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-232-7.deploy.static.akamaitechnologies.com
Software
akka-http/10.1.5 /
Resource Hash

Request headers

:method
GET
:authority
sync.teads.tv
:scheme
https
:path
/iframe?pid=78293&userId=897290cb-1056-43ab-aef5-daf7577331f0&gdprIab={%22status%22:23,%22consent%22:%22%22,%22reason%22:230}&env=js-web&1571758227263
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
accept-encoding
gzip, deflate, br
cookie
tt_viewer=c050e068-e6e8-4e6c-ae50-c634efd07694
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5

Response headers

status
200
content-type
text/html; charset=UTF-8
server
akka-http/10.1.5
content-length
1844
expires
Tue, 22 Oct 2019 15:30:27 GMT
cache-control
max-age=0, no-cache, no-store
pragma
no-cache
date
Tue, 22 Oct 2019 15:30:27 GMT
set-cookie
tt_exelate=; Expires=Wed, 23 Oct 2019 15:30:27 GMT; Domain=.teads.tv; SameSite=None tt_bluekai=; Expires=Wed, 23 Oct 2019 15:30:27 GMT; Domain=.teads.tv; SameSite=None tt_emetriq=; Expires=Wed, 23 Oct 2019 15:30:27 GMT; Domain=.teads.tv; SameSite=None tt_liveramp=; Expires=Wed, 23 Oct 2019 15:30:27 GMT; Domain=.teads.tv; SameSite=None tt_neustar=; Expires=Wed, 23 Oct 2019 15:30:27 GMT; Domain=.teads.tv; SameSite=None tt_salesforce=; Expires=Wed, 23 Oct 2019 15:30:27 GMT; Domain=.teads.tv; SameSite=None tt_dar=; Expires=Wed, 23 Oct 2019 15:30:27 GMT; Domain=.teads.tv; SameSite=None tt_skp=; Expires=Wed, 23 Oct 2019 15:30:27 GMT; Domain=.teads.tv; SameSite=None
track
t.teads.tv/
23 B
157 B
Image
General
Full URL
https://t.teads.tv/track?action=passback-noAd&ts=1571758226904&pageId=46561&pid=78293&env=js-web&pfid=[pfid]&f=1&slot=native&fv=141
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.232.7 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-232-7.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
328e90a318268aea96180cc31666ae6d6f79d90d078c123bc3d98ee08a192fb7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
200
pragma
no-cache
date
Tue, 22 Oct 2019 15:30:27 GMT
cache-control
max-age=0, no-cache, no-store
expires
Tue, 22 Oct 2019 15:30:27 GMT
content-length
23
content-type
image/gif
pixel.gif
reutersdfpcw319687550988.s.moatpixel.com/
43 B
409 B
Image
General
Full URL
https://reutersdfpcw319687550988.s.moatpixel.com/pixel.gif?m=1&iv=0&tuv=-1&tet=0&fi=0&apd=200&ui=0&uit=0&h=0&th=-1&s=0&ts=-1&bfa=1&d=reuters.com&L1id=20159232&L2id=277213512&L3id=139199112&L4id=138204787707&S1id=3735912&S2id=37592232&ord=1571758226814&r=46490749940&t=meas&bedc=1&q=1&nu=1&ib=0&dc=1&ob=1&oh=0&lt=0&ab=1&n=1&nm=1&sp=0&pt=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:27 GMT
Last-Modified
Fri, 20 May 2016 15:16:00 GMT
Server
Apache
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Tue, 22 Oct 2019 15:30:27 GMT
pixel.gif
reutersdfpcw319687550988.s.moatpixel.com/
43 B
409 B
Image
General
Full URL
https://reutersdfpcw319687550988.s.moatpixel.com/pixel.gif?m=1&iv=0&tuv=-1&tet=0&fi=0&apd=200&ui=0&uit=0&h=0&th=-1&s=0&ts=-1&bfa=1&d=reuters.com&L1id=20159232&L2id=277213512&L3id=139199112&L4id=138204787707&S1id=3735912&S2id=37592232&ord=1571758226814&r=46490749940&t=nht&bedc=1&q=2&nu=1&ib=0&dc=1&ob=1&oh=0&lt=0&ab=1&n=1&nm=1&sp=0&pt=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:27 GMT
Last-Modified
Fri, 20 May 2016 15:16:00 GMT
Server
Apache
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Tue, 22 Oct 2019 15:30:27 GMT
pixel.gif
reutersdfpcw319687550988.s.moatpixel.com/
43 B
409 B
Image
General
Full URL
https://reutersdfpcw319687550988.s.moatpixel.com/pixel.gif?m=1&iv=0&tuv=-1&tet=0&fi=0&apd=237&ui=0&uit=0&h=0&th=-1&s=0&ts=-1&bfa=1&d=reuters.com&L1id=20159232&L2id=277213512&L3id=139199112&L4id=138204787707&S1id=3735912&S2id=37592232&ord=1571758226814&r=46490749940&t=hdn&bedc=1&q=3&nu=1&ib=0&dc=1&ob=1&oh=0&lt=0&ab=1&n=1&nm=1&sp=0&pt=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:27 GMT
Last-Modified
Fri, 20 May 2016 15:16:00 GMT
Server
Apache
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Tue, 22 Oct 2019 15:30:27 GMT
SetConsentStatus
analytics.carambo.la/ Frame EF32
0
176 B
Fetch
General
Full URL
https://analytics.carambo.la/SetConsentStatus
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.174.181.134 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-35-174-181-134.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

Access-Control-Allow-Origin
*
Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:27 GMT
Cache-Control
no-cache
Connection
keep-alive
Expires
-1
prebid.min.js
cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/external/ Frame EF32
205 KB
65 KB
XHR
General
Full URL
https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/external/prebid.min.js
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
152.195.39.46 , United States, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
ECS (fcn/41AF) /
Resource Hash
6249458482797d7ee8be4da01d4f549ba9994927d14ae92404e0c08181b36206

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:26 GMT
content-encoding
deflate
vary
Accept-Encoding
x-amz-request-id
236064E292235027
x-cache
HIT
status
200
content-length
66427
x-amz-id-2
gQOHFoWiQl7MuJsnFumpDKPDx3zkFHuCxg7YTlszlPMNIizc+Re98cyLiaDVBqa77L9vFdeBxPs=
last-modified
Mon, 12 Aug 2019 09:30:09 GMT
server
ECS (fcn/41AF)
etag
"ea1eea13d68e95de7e03abe6a748ad70"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
text/javascript
access-control-allow-origin
*
cache-control
max-age=63072000,s-maxage=63072000
accept-ranges
bytes
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=60312569-8562-65c6-4952-219c4cca5cec&tv={c:rN5SlX,pingTime:-10,time:584,type:s,mvn:ZnNjPTEyLHNkPTMsbm89Nyxhc3A9MQ--,fsc:17.4.95v220002022020220000022002222000022220202020222220222220002222022002222200002220222022222222222000220200000022220222220222222222222202222222222222222222222222222222222222200000022022020020000002002202022022022222222000000000020222202022022222000000020000000000000000000002220002220000022200222202220022200200222022202220022222220020222222000220000222202222202222000002002002222222222220022202200022002220222202,sd:MTcuNC45NXYxMjAwfHwxNjAwfHwxfHwxfHwyNHx8MTIwMHx8MHx8MHx8MXx8bGFuZHNjYXBlLXByaW1hcnl8fDI0fHw0LzN8fDQvM3x8MHx8MTYwMA--,no:MTcuNC45NXZNb3ppbGxhfHxOZXRzY2FwZXx8bnx8MTZ8fG58fDB8fG58fExpbnV4IHg4Nl82NHx8R2Vja298fDIwMDMwMTA3fHwtMTIwfHxNb3ppbGxhLzUuMCAoTWFjaW50b3NoOyBJbnRlbCBNYWMgT1MgWCAxMF8xNF81KSBBcHBsZVdlYktpdC81MzcuMzYgKEtIVE1MLCBsaWtlIEdlY2tvKSBDaHJvbWUvNzQuMC4zNzI5LjE2OSBTYWZhcmkvNTM3LjM2fHwxfHwxfHxHb29nbGUgSW5jLnx8bg--,asp:1571758227504||13399ee9a6a5cd5f1fdc3c0c885d58a6||675c74d5f114ba25a49fb0f4cb02f70f||d30d0cbefcfb7a5ed25df12d97c9897f||2f6ecf2b1a1a04ca5f69ff50c06cb801||26cf9e6ed83eb2a455fd77467f3f08e1||e9b0634d4e15bd64d685e256de07628a||429a1406a10ceefc5f85d1e7ef1cf842||1529428597}
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:27 GMT
X-Server-Name
dt06.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
truncated
/
2 KB
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
9d02d662da8a47fb5fb610b545007507b6017028043dbb63cd09ec897d3b9627

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
truncated
/
715 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
5a3f1dd74233f605e511f1b5b244bedf85ac88ba264caf4d6401bc7ec2017dcd

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
ping.gif
stats-dev.brid.tv/ Frame 5877
0
347 B
Image
General
Full URL
https://stats-dev.brid.tv/ping.gif?p=14815&pr=o&b=c&pid=11615&s=undefined|undefined&apa=0&df=1&os=l&m=0&ow=14120&e=l
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.224.196.127 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-224-196-127.fra2.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 20:33:19 GMT
via
1.1 adb1b226e6965f6206603ba087bd4a0a.cloudfront.net (CloudFront)
last-modified
Tue, 04 Dec 2018 09:25:32 GMT
server
AmazonS3
age
70051
etag
"d41d8cd98f00b204e9800998ecf8427e"
x-cache
Hit from cloudfront
content-type
image/gif
status
200
cache-control
max-age=0, no-cache, no-store
x-amz-cf-pop
FRA2-C1
accept-ranges
bytes
content-length
0
x-amz-cf-id
TLkAYiqLOpvM-9zdkkqsPV2GxPYmQKbvkS7SiPxcXc5Gs6ghoIzvbg==
ping.gif
stats-dev.brid.tv/ Frame 5877
0
345 B
Image
General
Full URL
https://stats-dev.brid.tv/ping.gif?p=14815&pr=o&b=c&pid=11615&s=undefined|undefined&os=l&m=0&apa=0&df=1&ow=14120&pub=p&e=r&aid=9261&par=b&wp=0&at=0
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.224.196.127 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-224-196-127.fra2.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 20:33:19 GMT
via
1.1 adb1b226e6965f6206603ba087bd4a0a.cloudfront.net (CloudFront)
last-modified
Tue, 04 Dec 2018 09:25:32 GMT
server
AmazonS3
age
70051
etag
"d41d8cd98f00b204e9800998ecf8427e"
x-cache
Hit from cloudfront
content-type
image/gif
status
200
cache-control
max-age=0, no-cache, no-store
x-amz-cf-pop
FRA2-C1
accept-ranges
bytes
content-length
0
x-amz-cf-id
Q4Mk1YP2irbHOm1YfLFvaiodc_9Th09e-9Vvd1vGDkHMGFElMq1BHA==
xml;dc_sdk_apis=[APIFRAMEWORKS];dc_omid_p=[OMIDPARTNER]
ad.doubleclick.net/ddm/pfadx/N1181610.3639REUTERS.COM/B23276979.256194050;sz=0x0;ord=1571758227718;dc_lat=;dc_rdid=;tag_for_child_directed_treatment=;tfua=;dcmt=text/ Frame 5877
32 KB
9 KB
XHR
General
Full URL
https://ad.doubleclick.net/ddm/pfadx/N1181610.3639REUTERS.COM/B23276979.256194050;sz=0x0;ord=1571758227718;dc_lat=;dc_rdid=;tag_for_child_directed_treatment=;tfua=;dcmt=text/xml;dc_sdk_apis=[APIFRAMEWORKS];dc_omid_p=[OMIDPARTNER]
Requested by
Host: services.brid.tv
URL: https://services.brid.tv/player/build/brid.outstream.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.205.230 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s24-in-f230.1e100.net
Software
cafe /
Resource Hash
a08816fa1f8e3c0d622bd503558bfb915c115ada237c9ed51ca76a7edbcb2b41
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:27 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
8892
x-xss-protection
0
pragma
no-cache
server
cafe
content-type
text/xml; charset=UTF-8
access-control-allow-origin
https://www.reuters.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=b1b94bc0-409a-65b8-d66e-b3b2892c851a&tv={c:rN5Sq1,time:918,type:e,es:0,sc:1,ha:1,gm:1,slTimes:{i:0,o:918,n:0,pp:0,pm:0},slEvents:[{sl:o,t:285,wc:0.0.1600.1200,ac:1140.3076.300.280,am:i,cc:1140.3076.300.280,piv:0,obst:0,th:0,reas:l,bkn:{piv:[643~0],as:[643~300.280]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:291,fm:rFDXlcz+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1d.10764|1d1|1e*.10764|1e1|1f|1g,idMap:1e*,rend:1,renddet:IMG.qs,rmeas:1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:27 GMT
X-Server-Name
dt06.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
file.mp4
r4---sn-4g5ednee.c.2mdn.net/videoplayback/id/a24f93b0836c331a/itag/342/source/doubleclick_dmm/ctier/L/acao/yes/ip/0.0.0.0/ipbits/0/expire/3713879037/sparams/acao,ctier,expire,id,ip,ipbits,itag,mip,...
Redirect Chain
  • https://gcdn.2mdn.net/videoplayback/id/a24f93b0836c331a/itag/342/source/doubleclick_dmm/ctier/L/acao/yes/ip/0.0.0.0/ipbits/0/expire/3713879037/sparams/id,itag,source,ctier,acao,ip,ipbits,expire/sig...
  • https://r4---sn-4g5ednee.c.2mdn.net/videoplayback/id/a24f93b0836c331a/itag/342/source/doubleclick_dmm/ctier/L/acao/yes/ip/0.0.0.0/ipbits/0/expire/3713879037/sparams/acao,ctier,expire,id,ip,ipbits,i...
2 MB
2 MB
Media
General
Full URL
https://r4---sn-4g5ednee.c.2mdn.net/videoplayback/id/a24f93b0836c331a/itag/342/source/doubleclick_dmm/ctier/L/acao/yes/ip/0.0.0.0/ipbits/0/expire/3713879037/sparams/acao,ctier,expire,id,ip,ipbits,itag,mip,mm,mn,ms,mv,mvi,pl,source/signature/504A329919287FA4737CA61FA8825DC9DCD2B608.01061AD6F013FE81011F2984E8A39EE5C70E39F9/key/cms1/cms_redirect/yes/mip/2a01:4f8:192:5414::2/mm/42/mn/sn-4g5ednee/ms/onc/mt/1571758061/mv/m/mvi/3/pl/41/file/file.mp4
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2a00:1450:4001:45::a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
gvs 1.0 /
Resource Hash
7efb76927b67f50c1411403ed0710462fb8ea3319d2f893067e4a5d342ae7a43
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:28 GMT
X-Content-Type-Options
nosniff
Last-Modified
Wed, 25 Sep 2019 17:03:56 GMT
Server
gvs 1.0
Content-Type
video/mp4
Content-Range
bytes 0-2268496/2268497
Cache-Control
private, max-age=86400
Connection
close
Accept-Ranges
bytes
Alt-Svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
Content-Length
2268497
Expires
Tue, 22 Oct 2019 15:30:28 GMT

Redirect headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:27 GMT
server
ClientMapServer
status
302
x-frame-options
SAMEORIGIN
content-type
text/html; charset=UTF-8
location
https://r4---sn-4g5ednee.c.2mdn.net/videoplayback/id/a24f93b0836c331a/itag/342/source/doubleclick_dmm/ctier/L/acao/yes/ip/0.0.0.0/ipbits/0/expire/3713879037/sparams/acao,ctier,expire,id,ip,ipbits,itag,mip,mm,mn,ms,mv,mvi,pl,source/signature/504A329919287FA4737CA61FA8825DC9DCD2B608.01061AD6F013FE81011F2984E8A39EE5C70E39F9/key/cms1/cms_redirect/yes/mip/2a01:4f8:192:5414::2/mm/42/mn/sn-4g5ednee/ms/onc/mt/1571758061/mv/m/mvi/3/pl/41/file/file.mp4
cache-control
no-cache, must-revalidate
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
643
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
activeview
pagead2.googlesyndication.com/pcs/ Frame 5877
42 B
112 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjsvOjyySlI68lbTI_sA_KPiDmfeZzcT4LvdbeoU2WdnxaAs5XrDj6DvAhNP24BRdICwoyHYO8qbSBybYRgr8VwXJywmeS8IRsL6wi3t7JyQ&sig=Cg0ArKJSzPj2YH2aBwAlEAE&adk=3358644139&tt=1308&bs=1585%2C1200&mtos=1055,1055,1055,1055,1055&tos=1055,0,0,0,0&p=436,1140,686,1440&mcvt=1055&rs=3&ht=0&tfs=263&tls=1318&mc=1&lte=1&bas=0&bac=0&met=no&avms=nio&niot_obs=10&niot_cbk=34&md=2&lm=2&rst=1571758226681&rpt=162&isd=0&msd=0&oseid=3&xdi=0&ps=1600%2C5902&ss=1600%2C1200&pt=12&bin=1&deb=1-3-3-11-13-13-49-11-0-0-0&tvt=1313&r=v&id=osdim&vs=4&uc=11&upc=1&tgt=DIV&cl=1&cec=1&clc=1&cac=1&cd=0x0&itpl=19&v=20191021
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:818::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:28 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
status
200
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
no-cache, must-revalidate
content-type
image/gif
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
view
googleads4.g.doubleclick.net/pcs/ Frame 5877
0
311 B
Image
General
Full URL
https://googleads4.g.doubleclick.net/pcs/view?xai=AKAOjssXeW9jui1pORy2YYoN16oJIM0wh_Z-nlswOOHBa5atpIckFjCvewbUbb-Lh1EMVeN7qtFdY9lX5OsDA0FeqKcxOvwXNG-I8RQm0GS-o8nOQ37H7J9jSxASjkx6SnW4BwfEq_VfxOwi-7yBbq4&sig=Cg0ArKJSzHC4q4rQVN56EAE&urlfix=1&adurl=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.208.34 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s12-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 22 Oct 2019 15:30:28 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
0
x-xss-protection
0
ping.gif
stats-dev.brid.tv/ Frame 5877
0
345 B
Image
General
Full URL
https://stats-dev.brid.tv/ping.gif?p=14815&pr=o&b=c&pid=11615&s=undefined|undefined&os=l&m=0&apa=0&df=1&ow=14120&pub=p&e=i&aid=9261&par=b&wp=0&at=0
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.224.196.127 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-224-196-127.fra2.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 20:33:19 GMT
via
1.1 adb1b226e6965f6206603ba087bd4a0a.cloudfront.net (CloudFront)
last-modified
Tue, 04 Dec 2018 09:25:32 GMT
server
AmazonS3
age
70052
etag
"d41d8cd98f00b204e9800998ecf8427e"
x-cache
Hit from cloudfront
content-type
image/gif
status
200
cache-control
max-age=0, no-cache, no-store
x-amz-cf-pop
FRA2-C1
accept-ranges
bytes
content-length
0
x-amz-cf-id
qZ6BqkIi8X6skRl_Hxi2oa7cSxenUXS_Ag0Bb2aSe_MHo_980kOpjA==
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=60312569-8562-65c6-4952-219c4cca5cec&tv={c:rN5SwX,pingTime:1,time:1266,type:p,clog:[{piv:100,vs:i,r:,w:300,h:250,t:186}],es:0,sc:1,ha:1,gm:1,slTimes:{i:1266,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:186,wc:0.0.1600.1200,ac:1140.436.300.250,am:i,cc:1140.436.300.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[1092~100],as:[1092~300.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:96,fm:rFDXlcz+11|12|13|14|15|16|17|18|19|1a|1b|1c*.10764|1c1|1d.10764|1d1|1e.10764|1e1|1f|1g,idMap:1c*,rend:1,renddet:DIV.qs.sn,rmeas:1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:28 GMT
X-Server-Name
dt06.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=60312569-8562-65c6-4952-219c4cca5cec&tv={c:rN5SwY,pingTime:1,time:1267,type:pf,clog:[{piv:100,vs:i,r:,w:300,h:250,t:186}],es:0,sc:1,ha:1,gm:1,slTimes:{i:1267,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:186,wc:0.0.1600.1200,ac:1140.436.300.250,am:i,cc:1140.436.300.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[1093~100],as:[1093~300.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:96,fm:rFDXlcz+11|12|13|14|15|16|17|18|19|1a|1b|1c*.10764|1c1|1d.10764|1d1|1e.10764|1e1|1f|1g,idMap:1c*,rend:1,renddet:DIV.qs.sn,rmeas:1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:28 GMT
X-Server-Name
dt74.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=60312569-8562-65c6-4952-219c4cca5cec&tv={c:rN5SwY,pingTime:1,time:1267,type:c,clog:[{piv:100,vs:i,r:,w:300,h:250,t:186}],es:0,sc:1,ha:1,gm:1,slTimes:{i:1267,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:186,wc:0.0.1600.1200,ac:1140.436.300.250,am:i,cc:1140.436.300.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[1093~100],as:[1093~300.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:96,fm:rFDXlcz+11|12|13|14|15|16|17|18|19|1a|1b|1c*.10764|1c1|1d.10764|1d1|1e.10764|1e1|1f|1g,idMap:1c*,rend:1,renddet:DIV.qs.sn,rmeas:1,metricId:publ1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:28 GMT
X-Server-Name
dt24.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=60312569-8562-65c6-4952-219c4cca5cec&tv={c:rN5SwY,pingTime:1,time:1267,type:c,clog:[{piv:100,vs:i,r:,w:300,h:250,t:186}],es:0,sc:1,ha:1,gm:1,slTimes:{i:1268,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:186,wc:0.0.1600.1200,ac:1140.436.300.250,am:i,cc:1140.436.300.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[1094~100],as:[1094~300.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:96,fm:rFDXlcz+11|12|13|14|15|16|17|18|19|1a|1b|1c*.10764|1c1|1d.10764|1d1|1e.10764|1e1|1f|1g,idMap:1c*,rend:1,renddet:DIV.qs.sn,rmeas:1,metricId:grpm1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:28 GMT
X-Server-Name
dt66.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=35b2bbf3-52b8-a43e-25f5-83fc4deeee50&tv={c:rN5Sx8,pingTime:1,time:1352,type:p,clog:[{piv:100,vs:i,r:,w:2,h:2,t:292}],es:0,sc:1,ha:1,gm:1,slTimes:{i:1352,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:292,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,bkn:{piv:[1066~100],as:[1066~2.2]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:303,fm:rFDXlcz+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1d*.10764|1d1|1e.10764|1e1|1e2|1f|1g,fm2:rFDXlcz+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1d*.10764|1d1|1e.10764|1e1|1e2|1f|1g,idMap:1d*,rend:0,renddet:WINDOW,rmeas:0}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:28 GMT
X-Server-Name
dt37.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=35b2bbf3-52b8-a43e-25f5-83fc4deeee50&tv={c:rN5Sx8,pingTime:1,time:1352,type:pf,clog:[{piv:100,vs:i,r:,w:2,h:2,t:292}],es:0,sc:1,ha:1,gm:1,slTimes:{i:1352,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:292,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,bkn:{piv:[1066~100],as:[1066~2.2]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:303,fm:rFDXlcz+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1d*.10764|1d1|1e.10764|1e1|1e2|1f|1g,fm2:rFDXlcz+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1d*.10764|1d1|1e.10764|1e1|1e2|1f|1g,idMap:1d*,rend:0,renddet:WINDOW,rmeas:0}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:28 GMT
X-Server-Name
dt63.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=35b2bbf3-52b8-a43e-25f5-83fc4deeee50&tv={c:rN5Sx9,pingTime:1,time:1353,type:c,clog:[{piv:100,vs:i,r:,w:2,h:2,t:292}],es:0,sc:1,ha:1,gm:1,slTimes:{i:1353,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:292,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,bkn:{piv:[1067~100],as:[1067~2.2]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:303,fm:rFDXlcz+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1d*.10764|1d1|1e.10764|1e1|1e2|1f|1g,fm2:rFDXlcz+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1d*.10764|1d1|1e.10764|1e1|1e2|1f|1g,idMap:1d*,rend:0,renddet:WINDOW,rmeas:0,metricId:publ1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:28 GMT
X-Server-Name
dt74.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=35b2bbf3-52b8-a43e-25f5-83fc4deeee50&tv={c:rN5Sx9,pingTime:1,time:1353,type:c,clog:[{piv:100,vs:i,r:,w:2,h:2,t:292}],es:0,sc:1,ha:1,gm:1,slTimes:{i:1353,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:292,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,bkn:{piv:[1067~100],as:[1067~2.2]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:303,fm:rFDXlcz+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1d*.10764|1d1|1e.10764|1e1|1e2|1f|1g,fm2:rFDXlcz+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1d*.10764|1d1|1e.10764|1e1|1e2|1f|1g,idMap:1d*,rend:0,renddet:WINDOW,rmeas:0,metricId:grpm1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:28 GMT
X-Server-Name
dt24.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dc_oe=ChMItNHZ1pew5QIVkAaLCh08nQZoEAAYACD34546;met=1;ecn1=1;etm1=0;eid1=11;
ade.googlesyndication.com/ddm/activity/ Frame 5877
42 B
597 B
Image
General
Full URL
https://ade.googlesyndication.com/ddm/activity/dc_oe=ChMItNHZ1pew5QIVkAaLCh08nQZoEAAYACD34546;met=1;ecn1=1;etm1=0;eid1=11;
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.205.226 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s24-in-f2.1e100.net
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:28 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
cache-control
no-cache, must-revalidate
content-type
image/gif
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
protobuf.min.js
cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/external/ Frame EF32
69 KB
21 KB
XHR
General
Full URL
https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/external/protobuf.min.js
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
152.195.39.46 , United States, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
ECS (fcn/41A4) /
Resource Hash
04b075859121bd8bae2825f760da6f0a2f0a5e9c7755370a55d51c961e41354c

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:29 GMT
content-encoding
deflate
vary
Accept-Encoding
x-amz-request-id
A8B632884A513621
x-cache
HIT
status
200
content-length
21141
x-amz-id-2
LIxM34qSYgQSMFcnE5VM++HTN095A+Z4uJMIBCtIWHZQWZTGDiXjKlxTSn8vBhFTYGzXUrX0RN0=
last-modified
Mon, 12 Aug 2019 09:30:10 GMT
server
ECS (fcn/41A4)
etag
"0b2aa9f2e7a587c31a287a8c3cdc3acd"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
text/javascript
access-control-allow-origin
*
cache-control
max-age=63072000,s-maxage=63072000
accept-ranges
bytes
KFOmCnqEu92Fr1Mu4mxKKTU1Kg.woff2
fonts.gstatic.com/s/roboto/v20/ Frame EF32
11 KB
11 KB
Font
General
Full URL
https://fonts.gstatic.com/s/roboto/v20/KFOmCnqEu92Fr1Mu4mxKKTU1Kg.woff2
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
5d1bc9b443f3f81fa4b4ad4634c1bb9702194c1898e3a9de0ab5e2cdc0e9f479
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://fonts.googleapis.com/css?family=Roboto:500,300,700,400
Origin
https://www.reuters.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 11 Oct 2019 15:58:20 GMT
x-content-type-options
nosniff
last-modified
Wed, 24 Jul 2019 01:18:50 GMT
server
sffe
age
948729
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
11016
x-xss-protection
0
expires
Sat, 10 Oct 2020 15:58:20 GMT
mem5YaGs126MiZpBA-UNirkOUuhpKKSTjw.woff2
fonts.gstatic.com/s/opensans/v17/ Frame EF32
9 KB
9 KB
Font
General
Full URL
https://fonts.gstatic.com/s/opensans/v17/mem5YaGs126MiZpBA-UNirkOUuhpKKSTjw.woff2
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
b8e23a845bc6b7fd417d29182e0e38d353e64b5e12e06bb1de2b5ce063db1dcc
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://fonts.googleapis.com/css?family=Open+Sans:300italic,400italic,600italic,700italic,800italic,400,600,300,700,800
Origin
https://www.reuters.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 11 Oct 2019 14:51:43 GMT
x-content-type-options
nosniff
last-modified
Tue, 23 Jul 2019 19:30:44 GMT
server
sffe
age
952726
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
9180
x-xss-protection
0
expires
Sat, 10 Oct 2020 14:51:43 GMT
blacklist_script.js
tagan.adlightning.com/carambola/ Frame 0245
67 KB
26 KB
Script
General
Full URL
https://tagan.adlightning.com/carambola/blacklist_script.js
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.225.78.59 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-225-78-59.fra2.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
25d9fc9dab1f829f422558fdb2c7158a5a6aaeff10e2ae6186f1c208297ad6dd

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-version-id
FtarD2LS_BF9hp5iWzNqaJ7bvNOVIi_4
content-encoding
gzip
etag
"c0f662b8b5a44b01afd54345f4eb8de5"
age
887
x-cache
Hit from cloudfront
status
200
content-length
25701
x-amz-meta-git_commit
e5df4b9
last-modified
Tue, 22 Oct 2019 01:12:44 GMT
server
AmazonS3
date
Tue, 22 Oct 2019 15:15:43 GMT
content-type
application/javascript
via
1.1 04ce5a607a98db6d08257633417b84d7.cloudfront.net (CloudFront)
cache-control
max-age=900
x-amz-cf-pop
FRA2-C2
accept-ranges
bytes
x-amz-cf-id
mdZr7TcfxTMCVyKJ_KaC-UvOu1pG6oY8s0XBNz0gAXc5g2f-lHGq4g==
blocking_script.js
tagan.adlightning.com/carambola/ Frame 0245
51 KB
14 KB
Script
General
Full URL
https://tagan.adlightning.com/carambola/blocking_script.js
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.225.78.59 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-225-78-59.fra2.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
89e2a6149ffa9306be8353f88f60111c9976ef77681059262318551fc3ff1a45

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-version-id
R4ROrLSRtw9OG4KaHY69v06kGYSAlhfQ
content-encoding
gzip
etag
"c7306f799f7635ded477731fe3e0138b"
age
73488
x-cache
Hit from cloudfront
status
200
content-length
13901
x-amz-meta-git_commit
e5df4b9
last-modified
Tue, 15 Oct 2019 19:04:40 GMT
server
AmazonS3
date
Mon, 21 Oct 2019 19:05:42 GMT
content-type
application/javascript
via
1.1 04ce5a607a98db6d08257633417b84d7.cloudfront.net (CloudFront)
cache-control
max-age=86400
x-amz-cf-pop
FRA2-C2
accept-ranges
bytes
x-amz-cf-id
JlLlawdjv90bmE9UeRIN8cOompe3f7EqfZ4Yrn5dldSM9O3UoVyl9g==
jstag
carambola-d.openx.net/w/1.0/ Frame 0245
63 KB
23 KB
Script
General
Full URL
https://carambola-d.openx.net/w/1.0/jstag
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.164.0 /
Resource Hash
6f04b95dba638c2fc5b31900a05b430342118e2dcb2973583588113642a5aea4

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:29 GMT
content-encoding
gzip
server
OXGW/16.164.0
vary
Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
status
200
cache-control
max-age=3600
content-type
text/javascript
alt-svc
clear
content-length
22913
via
1.1 google
expires
Tue, 22 Oct 2019 16:30:29 GMT
SetAdsRequest
analytics.carambo.la/ Frame EF32
0
176 B
Fetch
General
Full URL
https://analytics.carambo.la/SetAdsRequest
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.174.181.134 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-35-174-181-134.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

Access-Control-Allow-Origin
*
Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:29 GMT
Cache-Control
no-cache
Connection
keep-alive
Expires
-1
blacklist_script.js
tagan.adlightning.com/carambola/ Frame 7A62
67 KB
26 KB
Script
General
Full URL
https://tagan.adlightning.com/carambola/blacklist_script.js
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.225.78.59 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-225-78-59.fra2.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
25d9fc9dab1f829f422558fdb2c7158a5a6aaeff10e2ae6186f1c208297ad6dd

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-version-id
FtarD2LS_BF9hp5iWzNqaJ7bvNOVIi_4
content-encoding
gzip
etag
"c0f662b8b5a44b01afd54345f4eb8de5"
x-amz-cf-pop
FRA2-C2
x-cache
Hit from cloudfront
status
200
content-length
25701
x-amz-meta-git_commit
e5df4b9
last-modified
Tue, 22 Oct 2019 01:12:44 GMT
server
AmazonS3
date
Tue, 22 Oct 2019 11:45:29 GMT
content-type
application/javascript
via
1.1 04ce5a607a98db6d08257633417b84d7.cloudfront.net (CloudFront)
cache-control
max-age=900
accept-ranges
bytes
x-amz-cf-id
n_W-WbvPGNrbdKyYCr_U3bbIJ2OZ0vzKIfNTyHV5MNZsC0A5DX6tmA==
blocking_script.js
tagan.adlightning.com/carambola/ Frame 7A62
51 KB
14 KB
Script
General
Full URL
https://tagan.adlightning.com/carambola/blocking_script.js
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.225.78.59 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-225-78-59.fra2.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
89e2a6149ffa9306be8353f88f60111c9976ef77681059262318551fc3ff1a45

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-version-id
R4ROrLSRtw9OG4KaHY69v06kGYSAlhfQ
content-encoding
gzip
etag
"c7306f799f7635ded477731fe3e0138b"
age
73488
x-cache
Hit from cloudfront
status
200
content-length
13901
x-amz-meta-git_commit
e5df4b9
last-modified
Tue, 15 Oct 2019 19:04:40 GMT
server
AmazonS3
date
Mon, 21 Oct 2019 19:05:42 GMT
content-type
application/javascript
via
1.1 04ce5a607a98db6d08257633417b84d7.cloudfront.net (CloudFront)
cache-control
max-age=86400
x-amz-cf-pop
FRA2-C2
accept-ranges
bytes
x-amz-cf-id
DJ96RxpjRlEKRhbpMlKHDSQbNTU1dqsAbR0TOo8ygo85nwkmUgyY9A==
showad.js
ads.pubmatic.com/AdServer/js/ Frame 7A62
39 KB
15 KB
Script
General
Full URL
https://ads.pubmatic.com/AdServer/js/showad.js
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.233.180 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-233-180.deploy.static.akamaitechnologies.com
Software
Apache/2.2.15 (CentOS) /
Resource Hash
5c2e5ba634ec3f23bea93de95ca5d970cc9905c2d01944f230e60c7b5e7d4363

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:29 GMT
Content-Encoding
gzip
Last-Modified
Fri, 26 Jul 2019 09:39:45 GMT
Server
Apache/2.2.15 (CentOS)
ETag
"13006b6-9bf6-58e925294ef26"
Vary
Accept-Encoding
P3P
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC", CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
Cache-Control
public, max-age=33287
Connection
keep-alive
Accept-Ranges
bytes
Content-Type
text/html; charset=UTF-8
Content-Length
14898
Expires
Wed, 23 Oct 2019 00:45:16 GMT
SetAdsRequest
analytics.carambo.la/ Frame EF32
0
176 B
Fetch
General
Full URL
https://analytics.carambo.la/SetAdsRequest
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.174.181.134 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-35-174-181-134.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

Access-Control-Allow-Origin
*
Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:29 GMT
Cache-Control
no-cache
Connection
keep-alive
Expires
-1
SetHbBidRequestProto
analytics.carambo.la/ Frame EF32
0
176 B
Fetch
General
Full URL
https://analytics.carambo.la/SetHbBidRequestProto
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.174.181.134 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-35-174-181-134.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Access-Control-Allow-Origin
*
Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:29 GMT
Cache-Control
no-cache
Connection
keep-alive
Expires
-1
UCookieSetPug
image6.pubmatic.com/AdServer/ Frame 7A62
24 B
329 B
Script
General
Full URL
https://image6.pubmatic.com/AdServer/UCookieSetPug?oid=2&cb=PubMatic._uidCB
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
185.64.189.115 , United Kingdom, ASN62713 (AS-PUBMATIC - PubMatic, Inc., US),
Reverse DNS
Software
/
Resource Hash
1b6dfbc0392b3e04e6f10a39a7c097635148b6bc998c13ffbda40d5b3df488c8

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:29 GMT
Cache-Control
private
Expires
Fri, 1 Nov 2019 08:08:44 GMT
P3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
Content-Length
24
Content-Type
text/html; charset=UTF-8
acj
carambola-d.openx.net/w/1.0/ Frame 0245
Redirect Chain
  • https://carambola-d.openx.net/w/1.0/acj?ai=d3a9183f-6e15-4497-bc84-3f6a64323458&o=1839218318&callback=OX_1839218318&ju=https%3A//www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astr...
  • https://carambola-d.openx.net/w/1.0/acj?cc=1&ai=d3a9183f-6e15-4497-bc84-3f6a64323458&o=1839218318&callback=OX_1839218318&ju=https%3A//www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves...
2 KB
2 KB
Script
General
Full URL
https://carambola-d.openx.net/w/1.0/acj?cc=1&ai=d3a9183f-6e15-4497-bc84-3f6a64323458&o=1839218318&callback=OX_1839218318&ju=https%3A//www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&jr=&auid=540746705&dims=&adxy=&res=1600x1200x24&plg=pm&ch=UTF-8&tz=-120&ws=300x250&ifr=1&tws=1600x1200&mt=1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.164.0 /
Resource Hash
d086866fbecbffb3459192eeccd7421b829a6a452cd470297a3df3ffbe292340

Request headers

Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:30 GMT
via
1.1 google
server
OXGW/16.164.0
vary
Accept
p3p
CP="CUR ADM OUR NOR STA NID"
status
200
cache-control
private, max-age=0, no-cache
content-type
application/json
alt-svc
clear
content-length
2248
expires
Mon, 26 Jul 1997 05:00:00 GMT

Redirect headers

date
Tue, 22 Oct 2019 15:30:29 GMT
via
1.1 google
server
OXGW/16.164.0
status
302
p3p
CP="CUR ADM OUR NOR STA NID"
location
https://carambola-d.openx.net/w/1.0/acj?cc=1&ai=d3a9183f-6e15-4497-bc84-3f6a64323458&o=1839218318&callback=OX_1839218318&ju=https%3A//www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&jr=&auid=540746705&dims=&adxy=&res=1600x1200x24&plg=pm&ch=UTF-8&tz=-120&ws=300x250&ifr=1&tws=1600x1200&mt=1
alt-svc
clear
content-length
0
pd
eu-u.openx.net/w/1.0/ Frame 5612
Redirect Chain
  • https://eu-u.openx.net/w/1.0/pd?plm=6&ph=c60c4e0c-5442-4600-876b-e4035d01b1eb
  • https://eu-u.openx.net/w/1.0/pd?cc=1&plm=6&ph=c60c4e0c-5442-4600-876b-e4035d01b1eb
0
0
Document
General
Full URL
https://eu-u.openx.net/w/1.0/pd?cc=1&plm=6&ph=c60c4e0c-5442-4600-876b-e4035d01b1eb
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.164.0 /
Resource Hash

Request headers

:method
GET
:authority
eu-u.openx.net
:scheme
https
:path
/w/1.0/pd?cc=1&plm=6&ph=c60c4e0c-5442-4600-876b-e4035d01b1eb
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
accept-encoding
gzip, deflate, br
cookie
i=b7f940e2-fbb6-09b1-3294-fad2c9f36f0a|1571758229
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5

Response headers

status
200
vary
Accept
set-cookie
i=b7f940e2-fbb6-09b1-3294-fad2c9f36f0a|1571758229; Version=1; Expires=Wed, 21-Oct-2020 15:30:30 GMT; Max-Age=31536000; Domain=.openx.net; Path=/ pd=v2|1571758230|mOgikimWiygu; Version=1; Expires=Wed, 06-Nov-2019 15:30:30 GMT; Max-Age=1296000; Domain=.openx.net; Path=/
server
OXGW/16.164.0
p3p
CP="CUR ADM OUR NOR STA NID"
date
Tue, 22 Oct 2019 15:30:30 GMT
content-type
text/html
content-length
592
via
1.1 google
alt-svc
clear

Redirect headers

status
302
set-cookie
i=b7f940e2-fbb6-09b1-3294-fad2c9f36f0a|1571758229; Version=1; Expires=Wed, 21-Oct-2020 15:30:29 GMT; Max-Age=31536000; Domain=.openx.net; Path=/
server
OXGW/16.164.0
p3p
CP="CUR ADM OUR NOR STA NID"
location
https://eu-u.openx.net/w/1.0/pd?cc=1&plm=6&ph=c60c4e0c-5442-4600-876b-e4035d01b1eb
date
Tue, 22 Oct 2019 15:30:29 GMT
content-length
0
via
1.1 google
alt-svc
clear
Cookie set showad.js
ads.pubmatic.com/AdServer/js/ Frame A9B5
0
0
Document
General
Full URL
https://ads.pubmatic.com/AdServer/js/showad.js
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.233.180 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-233-180.deploy.static.akamaitechnologies.com
Software
Apache/2.2.15 (CentOS) /
Resource Hash

Request headers

Host
ads.pubmatic.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
Sec-Fetch-Site
cross-site
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Accept-Encoding
gzip, deflate, br
Cookie
KTPCACOOKIE=YES
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5

Response headers

Last-Modified
Fri, 26 Jul 2019 09:39:45 GMT
ETag
"13006b6-9bf6-58e925294ef26"
Server
Apache/2.2.15 (CentOS)
Set-Cookie
KTPCACOOKIE=YES; domain=.pubmatic.com; path=/; max-age=7776000;
Accept-Ranges
bytes
Content-Encoding
gzip
P3P
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC", CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
Content-Length
14898
Content-Type
text/html; charset=UTF-8
Cache-Control
public, max-age=33286
Expires
Wed, 23 Oct 2019 00:45:16 GMT
Date
Tue, 22 Oct 2019 15:30:30 GMT
Connection
keep-alive
Vary
Accept-Encoding
Cookie set showad.js
ads.pubmatic.com/AdServer/js/ Frame 6842
0
0
Document
General
Full URL
https://ads.pubmatic.com/AdServer/js/showad.js
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.233.180 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-233-180.deploy.static.akamaitechnologies.com
Software
Apache/2.2.15 (CentOS) /
Resource Hash

Request headers

Host
ads.pubmatic.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
Sec-Fetch-Site
cross-site
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Accept-Encoding
gzip, deflate, br
Cookie
KTPCACOOKIE=YES
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5

Response headers

Last-Modified
Fri, 26 Jul 2019 09:39:45 GMT
ETag
"13006b6-9bf6-58e925294ef26"
Server
Apache/2.2.15 (CentOS)
Set-Cookie
KTPCACOOKIE=YES; domain=.pubmatic.com; path=/; max-age=7776000;
Accept-Ranges
bytes
Content-Encoding
gzip
P3P
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC", CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
Content-Length
14898
Content-Type
text/html; charset=UTF-8
Cache-Control
public, max-age=33286
Expires
Wed, 23 Oct 2019 00:45:16 GMT
Date
Tue, 22 Oct 2019 15:30:30 GMT
Connection
keep-alive
Vary
Accept-Encoding
AdServerServlet
sshowads.pubmatic.com/AdServer/ Frame 7A62
2 KB
2 KB
Script
General
Full URL
https://sshowads.pubmatic.com/AdServer/AdServerServlet?pubId=156612&siteId=251236&adId=2075066&kadwidth=300&kadheight=250&SAVersion=2&js=1&kdntuid=1&pageURL=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-farxiga-fda%2Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&inIframe=1&kadpageurl=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-farxiga-fda%2Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&operId=3&sec=1&kltstamp=2019-10-22%2017%3A30%3A30&timezone=2&screenResolution=1600x1200&ranreq=0.9121392798281893&pmUniAdId=0&adVisibility=2&adPosition=3076x1440&gdpr=0&dspids=%7B%7D
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
185.64.189.111 , United Kingdom, ASN62713 (AS-PUBMATIC - PubMatic, Inc., US),
Reverse DNS
Software
nginx /
Resource Hash
1f0a528714846a14f73d3fb00eeb7dcba5cd3fe8972ea1bfc767894518468dd4

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:30 GMT
Content-Encoding
gzip
Server
nginx
Transfer-Encoding
chunked
P3P
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
Cache-Control
no-store, no-cache, private
Connection
keep-alive
Content-Type
text/html; charset=utf-8
siab.js
cdn.tynt.com/ Frame D122
15 KB
5 KB
Script
General
Full URL
https://cdn.tynt.com/siab.js?uTjYfYoCUQ&_ADTIME_&$RANDOM&%%CACHEBUSTER%%&
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.16.87.26 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
4b3f0ca4c12f7e2cbcca6c51cda0e51542801315a1b8aaa63abbadb68da5628e

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:30 GMT
content-encoding
gzip
cf-cache-status
MISS
last-modified
Mon, 07 Oct 2019 18:43:10 GMT
server
cloudflare
etag
W/"5d9b873e-3c45"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=259200
cf-ray
529c8349dc51640d-FRA
expires
Fri, 25 Oct 2019 15:30:30 GMT
siab.js
cdn.tynt.com/ Frame 7A62
15 KB
6 KB
Script
General
Full URL
https://cdn.tynt.com/siab.js?{random}&_ADTIME_&
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.16.87.26 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
4b3f0ca4c12f7e2cbcca6c51cda0e51542801315a1b8aaa63abbadb68da5628e

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:30 GMT
content-encoding
gzip
cf-cache-status
HIT
last-modified
Mon, 07 Oct 2019 18:43:10 GMT
server
cloudflare
age
247609
etag
W/"5d9b873e-3c45"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=259200
cf-ray
529c8349ec6a640d-FRA
expires
Fri, 25 Oct 2019 15:30:30 GMT
AdDisplayTrackerServlet
aktrack.pubmatic.com/AdServer/ Frame 5A68
0
0
Document
General
Full URL
https://aktrack.pubmatic.com/AdServer/AdDisplayTrackerServlet?operId=1&pubId=156612&siteId=251236&adId=2075066&adType=3&adServerId=165&kefact=0.000000&kaxefact=0.000000&kadNetFrequecy=0&kadwidth=300&kadheight=250&kadsizeid=0&kltstamp=1571758230&indirectAdId=1840519&adServerOptimizerId=1&ranreq=0.9121392798281893&kpbmtpfact=0.000000&dcId=3&tldId=0&passback=30&svr=ADS22411U&ekefact=liCvXRXXAABZZPgCAPHzbI87ouO-LwC--RDjOFRl-y3Vzv_K&ekaxefact=liCvXSvXAACxu2yEH2e_sPfuUUDuC_5t784VHEl2Y4wpHizr&ekpbmtpfact=liCvXT_XAABptP7Rgk8K5FOkjHMF_N-P350c-Gt1eLcbugjF&crID=0&campaignId=0&isRTB=0&imprId=733C412A-15E0-49B3-A955-A461CCE0379A&oid=733C412A-15E0-49B3-A955-A461CCE0379A&cntryId=58&domain=reuters.com&pageURL=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-farxiga-fda%2Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&sec=1&pmc=0
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.233.180 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-233-180.deploy.static.akamaitechnologies.com
Software
/
Resource Hash

Request headers

Host
aktrack.pubmatic.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
Sec-Fetch-Site
cross-site
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Accept-Encoding
gzip, deflate, br
Cookie
KTPCACOOKIE=YES; pi=156612:2; pp=156612
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5

Response headers

Content-Type
text/html
Content-Length
0
Date
Tue, 22 Oct 2019 15:30:30 GMT
Connection
keep-alive
bFJBfaR2Or54kOaKkv7mNO.js
sc.tynt.com/script/sc/ Frame 7A62
2 KB
1 KB
Script
General
Full URL
https://sc.tynt.com/script/sc/bFJBfaR2Or54kOaKkv7mNO.js
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.16.87.26 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
0955d7f885f72563f66c56a86cf98c93cff8f70b50aafa307e9b715540130c66
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:30 GMT
content-encoding
gzip
x-content-type-options
nosniff
cf-cache-status
HIT
age
107068
status
200, 200 OK
x-xss-protection
1; mode=block
x-request-id
327f7cff-4763-4e93-bc58-87bffa84c9d2
x-runtime
0.002089
x-content-digest
575a77f733111aa22f71abcabea9559386c79873
last-modified
Sun, 20 Oct 2019 14:09:51 GMT
server
cloudflare
x-frame-options
SAMEORIGIN
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/javascript; charset=utf-8
cache-control
max-age=3600, public, s-maxage=172800
cf-ray
529c834a0cb9640d-FRA
x-rack-cache
fresh
expires
Mon, 21 Oct 2019 08:16:12 GMT
p
ic.tynt.com/b/
0
294 B
Image
General
Full URL
https://ic.tynt.com/b/p?id=bFJBfaR2Or54kOaKkv7mNO&lm=5&ts=1571758230082&dn=SIAB&iso=0&img=https%3A%2F%2Fs3.reutersmedia.net%2Fresources%2Fr%2F%3Fm%3D02%26d%3D20191021%26t%3D2%26i%3D1443247775%26w%3D1200%26r%3DLYNXMPEF9K0CN&ct=FDA%20approves%20AstraZeneca%20diabetes%20drug%20for%20treating%20heart%20failure%20risk&t=FDA%20approves%20AstraZeneca%20diabetes%20drug%20for%20treating%20heart%20failure%20risk%20-%20Reuters&cu=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-farxiga-fda-idUSKBN1X00J5&ah=https%3A%2F%2Fmobile.reuters.com%2Farticle%2Famp%2FidUSKBN1X00J5
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.183 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip183.208-100-17.static.steadfastdns.net
Software
nginx/1.14.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
204
date
Tue, 22 Oct 2019 15:30:29 GMT
server
nginx/1.14.0
p3p
policyref="/w3c/p3p.xml", CP="CUR ADM OUR NOR STA NID", CP=NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA
sic.js
cdn-sic.33across.com/1/javascripts/ Frame 7A62
447 KB
125 KB
Script
General
Full URL
https://cdn-sic.33across.com/1/javascripts/sic.js
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.16.38.14 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare / Love
Resource Hash
a89cd6ceb08d82e5d55e591af5e48663e1d4df60381d75d357f981fcf5a6931b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:30 GMT
content-encoding
gzip
cf-cache-status
HIT
last-modified
Wed, 18 Sep 2019 22:43:59 GMT
server
cloudflare
age
30
x-powered-by
Love
etag
W/"5d82b32f-6fce0"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=3600
cf-ray
529c834a4f1d636b-FRA
expires
Tue, 22 Oct 2019 16:30:30 GMT
ping.gif
stats-dev.brid.tv/ Frame 5877
0
347 B
Image
General
Full URL
https://stats-dev.brid.tv/ping.gif?p=14815&pr=o&b=c&pid=11615&s=undefined|undefined&os=l&m=0&apa=0&df=1&ow=14120&pub=p&e=vi&aid=9261&par=b&wp=0&at=0
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.224.196.127 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-224-196-127.fra2.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 20:33:19 GMT
via
1.1 adb1b226e6965f6206603ba087bd4a0a.cloudfront.net (CloudFront)
last-modified
Tue, 04 Dec 2018 09:25:32 GMT
server
AmazonS3
age
70054
etag
"d41d8cd98f00b204e9800998ecf8427e"
x-cache
Hit from cloudfront
content-type
image/gif
status
200
cache-control
max-age=0, no-cache, no-store
x-amz-cf-pop
FRA2-C1
accept-ranges
bytes
content-length
0
x-amz-cf-id
iEPIS8gK0KAE3ofP5J2RUAmbh19X32vIMuNsU5GnZRvQ5ZRvQ7yY9w==
gpt.js
securepubads.g.doubleclick.net/tag/js/ Frame 364E
46 KB
15 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/tag/js/gpt.js
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.208.34 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s12-in-f2.1e100.net
Software
sffe /
Resource Hash
13426ba13e9862a0e6f6e2c9af87cce602482e4fd64aa5419bea6d0f449e7c70
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:30 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"314 / 815 of 1000 / last-modified: 1571691975"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
14762
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:30 GMT
sic.css
cdn-sic.33across.com/1/stylesheets/ Frame 7A62
11 KB
2 KB
Stylesheet
General
Full URL
https://cdn-sic.33across.com/1/stylesheets/sic.css
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.16.38.14 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare / Love
Resource Hash
81c1d3e8b32d5f970c6f4a7e971031b77d19c5570d1416b9c81e3820875a3390

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:30 GMT
content-encoding
gzip
cf-cache-status
HIT
last-modified
Wed, 18 Sep 2019 22:43:10 GMT
server
cloudflare
age
3187
x-powered-by
Love
etag
W/"5d82b2fe-2a1b"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/css
status
200
cache-control
public, max-age=3600
cf-ray
529c834affce636b-FRA
expires
Tue, 22 Oct 2019 16:30:30 GMT
authorize
sic.33across.com/ Frame 7A62
1 KB
1 KB
Script
General
Full URL
https://sic.33across.com/authorize?gdprConsentLength=0&version=2.58.0&agent=Mozilla%2F5.0%20(Macintosh%3B%20Intel%20Mac%20OS%20X%2010_14_5)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F74.0.3729.169%20Safari%2F537.36&product=siab&userId=&sessionId=&publisherURL=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-farxiga-fda%2Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&referrerURL=&publisherId=bFJBfaR2Or54kOaKkv7mNO&publisher=reuters_3_300_B.com&displayableSizes=300x250&viewportWidth=300&viewportHeight=250&screenWidth=1600&screenHeight=1200&scrollX=0&scrollY=0&pageVisibility=visible&pageWidth=300&pageHeight=250&_=1571758230234&callback=_tynt_jp.a9m1b7v3d
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.180 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip180.208-100-17.static.steadfastdns.net
Software
/ Love
Resource Hash
af51201bc8638ff54b3acce74ebff889e1bb9ce7481051c6c7fd60b4bd52e4aa
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:29 GMT
content-encoding
gzip
x-content-type-options
nosniff
status
200, 200 OK
x-powered-by
Love
etag
W/"5d1-hCPlkmBdl8qIpo/LyHGVP+1D9B4"
vary
Accept-Encoding
access-control-allow-methods
GET, POST, PUT, DELETE
p3p
CP="NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA"
access-control-allow-origin
*
access-control-allow-credentials
true
content-type
text/javascript; charset=utf-8
access-control-allow-headers
X-Requested-With, Authorization
integrator.js
adservice.google.de/adsid/ Frame 364E
109 B
171 B
Script
General
Full URL
https://adservice.google.de/adsid/integrator.js?domain=www.reuters.com
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:800::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 22 Oct 2019 15:30:30 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status
200
cache-control
private, no-cache, no-store
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
104
x-xss-protection
0
integrator.js
adservice.google.com/adsid/ Frame 364E
109 B
171 B
Script
General
Full URL
https://adservice.google.com/adsid/integrator.js?domain=www.reuters.com
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:818::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 22 Oct 2019 15:30:30 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status
200
cache-control
private, no-cache, no-store
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
104
x-xss-protection
0
pubads_impl_2019101401.js
securepubads.g.doubleclick.net/gpt/ Frame 364E
156 KB
57 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.208.34 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s12-in-f2.1e100.net
Software
sffe /
Resource Hash
f8800772f0dd827877029d9d634a170a156ff82b6b6bdf251b62c750b73cfe93
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:30 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Mon, 14 Oct 2019 13:08:16 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
58589
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:30 GMT
v2
de.tynt.com/deb/
4 B
200 B
Script
General
Full URL
https://de.tynt.com/deb/v2?id=bFJBfaR2Or54kOaKkv7mNO&dn=SIAB&cc=1&r=
Requested by
Host: cdn.tynt.com
URL: https://cdn.tynt.com/siab.js?{random}&_ADTIME_&
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.185 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip185.208-100-17.static.steadfastdns.net
Software
/
Resource Hash
d21021784cda31eeae5c8295e047a14bda6ed5a9b5963fca9e7ceb398a9c9179

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
200
date
Tue, 22 Oct 2019 15:30:28 GMT
cache-control
max-age=86400
content-type
application/javascript
p3p
CP=NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA
content-length
4
expires
Wed, 23 Oct 2019 15:30:29 GMT
v2
de.tynt.com/deb/
4 B
200 B
Script
General
Full URL
https://de.tynt.com/deb/v2?m=xch&id=bFJBfaR2Or54kOaKkv7mNO&dn=SIAB&cc=1&r=
Requested by
Host: cdn.tynt.com
URL: https://cdn.tynt.com/siab.js?{random}&_ADTIME_&
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.185 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip185.208-100-17.static.steadfastdns.net
Software
/
Resource Hash
d21021784cda31eeae5c8295e047a14bda6ed5a9b5963fca9e7ceb398a9c9179

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
200
date
Tue, 22 Oct 2019 15:30:29 GMT
cache-control
max-age=86400
content-type
application/javascript
p3p
CP=NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA
content-length
4
expires
Wed, 23 Oct 2019 15:30:29 GMT
p
ic.tynt.com/b/
0
119 B
Image
General
Full URL
https://ic.tynt.com/b/p?id=bFJBfaR2Or54kOaKkv7mNO&lm=5&ts=1571758230082&dn=SIAB&iso=0&img=https%3A%2F%2Fs3.reutersmedia.net%2Fresources%2Fr%2F%3Fm%3D02%26d%3D20191021%26t%3D2%26i%3D1443247775%26w%3D1200%26r%3DLYNXMPEF9K0CN&ct=FDA%20approves%20AstraZeneca%20diabetes%20drug%20for%20treating%20heart%20failure%20risk&t=FDA%20approves%20AstraZeneca%20diabetes%20drug%20for%20treating%20heart%20failure%20risk%20-%20Reuters&cu=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-farxiga-fda-idUSKBN1X00J5
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.183 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip183.208-100-17.static.steadfastdns.net
Software
nginx/1.14.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
204
date
Tue, 22 Oct 2019 15:30:29 GMT
server
nginx/1.14.0
p3p
CP=NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA
bFJBfaR2Or54kOaKkv7mNO.js
sc.tynt.com/script/sc/ Frame D122
2 KB
898 B
Script
General
Full URL
https://sc.tynt.com/script/sc/bFJBfaR2Or54kOaKkv7mNO.js
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.16.87.26 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
0955d7f885f72563f66c56a86cf98c93cff8f70b50aafa307e9b715540130c66
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:30 GMT
content-encoding
gzip
x-content-type-options
nosniff
cf-cache-status
HIT
age
107068
status
200, 200 OK
x-xss-protection
1; mode=block
x-request-id
327f7cff-4763-4e93-bc58-87bffa84c9d2
x-runtime
0.002089
x-content-digest
575a77f733111aa22f71abcabea9559386c79873
last-modified
Sun, 20 Oct 2019 14:09:51 GMT
server
cloudflare
x-frame-options
SAMEORIGIN
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/javascript; charset=utf-8
cache-control
max-age=3600, public, s-maxage=172800
cf-ray
529c834cb878640d-FRA
x-rack-cache
fresh
expires
Mon, 21 Oct 2019 08:16:12 GMT
sic.js
cdn-sic.33across.com/1/javascripts/ Frame D122
447 KB
125 KB
Script
General
Full URL
https://cdn-sic.33across.com/1/javascripts/sic.js
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.16.38.14 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare / Love
Resource Hash
a89cd6ceb08d82e5d55e591af5e48663e1d4df60381d75d357f981fcf5a6931b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:30 GMT
content-encoding
gzip
cf-cache-status
HIT
last-modified
Wed, 18 Sep 2019 22:43:59 GMT
server
cloudflare
age
30
x-powered-by
Love
etag
W/"5d82b32f-6fce0"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=3600
cf-ray
529c834cd995636b-FRA
expires
Tue, 22 Oct 2019 16:30:30 GMT
gpt.js
securepubads.g.doubleclick.net/tag/js/ Frame 9B40
46 KB
15 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/tag/js/gpt.js
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.208.34 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s12-in-f2.1e100.net
Software
sffe /
Resource Hash
13426ba13e9862a0e6f6e2c9af87cce602482e4fd64aa5419bea6d0f449e7c70
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:30 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"314 / 312 of 1000 / last-modified: 1571691975"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
14762
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:30 GMT
sic.css
cdn-sic.33across.com/1/stylesheets/ Frame D122
11 KB
2 KB
Stylesheet
General
Full URL
https://cdn-sic.33across.com/1/stylesheets/sic.css
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.16.38.14 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare / Love
Resource Hash
81c1d3e8b32d5f970c6f4a7e971031b77d19c5570d1416b9c81e3820875a3390

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:30 GMT
content-encoding
gzip
cf-cache-status
HIT
last-modified
Wed, 18 Sep 2019 22:43:10 GMT
server
cloudflare
age
3187
x-powered-by
Love
etag
W/"5d82b2fe-2a1b"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/css
status
200
cache-control
public, max-age=3600
cf-ray
529c834d4a10636b-FRA
expires
Tue, 22 Oct 2019 16:30:30 GMT
authorize
sic.33across.com/ Frame D122
1 KB
1 KB
Script
General
Full URL
https://sic.33across.com/authorize?gdprConsentLength=0&version=2.58.0&agent=Mozilla%2F5.0%20(Macintosh%3B%20Intel%20Mac%20OS%20X%2010_14_5)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F74.0.3729.169%20Safari%2F537.36&product=siab&userId=&sessionId=&publisherURL=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-farxiga-fda%2Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&referrerURL=&publisherId=bFJBfaR2Or54kOaKkv7mNO&publisher=reuters_3_300_B.com&displayableSizes=300x250&viewportWidth=300&viewportHeight=250&screenWidth=1600&screenHeight=1200&scrollX=0&scrollY=0&pageVisibility=visible&pageWidth=300&pageHeight=250&_=1571758230606&callback=_tynt_jp.abytulpjw
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.180 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip180.208-100-17.static.steadfastdns.net
Software
/ Love
Resource Hash
305fd142998ce6c826bdd021ec5b0f76b3dc3d49a31a68cc65939d68ba4d2b9b
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:29 GMT
content-encoding
gzip
x-content-type-options
nosniff
status
200, 200 OK
x-powered-by
Love
etag
W/"5d1-wQiCh+IotetpLvUoWl9yZrmWc2c"
vary
Accept-Encoding
access-control-allow-methods
GET, POST, PUT, DELETE
p3p
CP="NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA"
access-control-allow-origin
*
access-control-allow-credentials
true
content-type
text/javascript; charset=utf-8
access-control-allow-headers
X-Requested-With, Authorization
p
ic.tynt.com/b/
0
119 B
Image
General
Full URL
https://ic.tynt.com/b/p?id=bFJBfaR2Or54kOaKkv7mNO&lm=5&ts=1571758230082&dn=SIAB&iso=0&img=https%3A%2F%2Fs3.reutersmedia.net%2Fresources%2Fr%2F%3Fm%3D02%26d%3D20191021%26t%3D2%26i%3D1443247775%26w%3D1200%26r%3DLYNXMPEF9K0CN&ct=FDA%20approves%20AstraZeneca%20diabetes%20drug%20for%20treating%20heart%20failure%20risk&t=FDA%20approves%20AstraZeneca%20diabetes%20drug%20for%20treating%20heart%20failure%20risk%20-%20Reuters
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.183 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip183.208-100-17.static.steadfastdns.net
Software
nginx/1.14.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
204
date
Tue, 22 Oct 2019 15:30:29 GMT
server
nginx/1.14.0
p3p
CP=NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA
integrator.js
adservice.google.de/adsid/ Frame 9B40
109 B
171 B
Script
General
Full URL
https://adservice.google.de/adsid/integrator.js?domain=www.reuters.com
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:800::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 22 Oct 2019 15:30:30 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status
200
cache-control
private, no-cache, no-store
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
104
x-xss-protection
0
integrator.js
adservice.google.com/adsid/ Frame 9B40
109 B
171 B
Script
General
Full URL
https://adservice.google.com/adsid/integrator.js?domain=www.reuters.com
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:818::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 22 Oct 2019 15:30:30 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status
200
cache-control
private, no-cache, no-store
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
104
x-xss-protection
0
pubads_impl_2019101401.js
securepubads.g.doubleclick.net/gpt/ Frame 9B40
156 KB
57 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.208.34 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s12-in-f2.1e100.net
Software
sffe /
Resource Hash
f8800772f0dd827877029d9d634a170a156ff82b6b6bdf251b62c750b73cfe93
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:30 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Mon, 14 Oct 2019 13:08:16 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
58589
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:30 GMT
jpt
ib.adnxs.com/ Frame 7A62
0
662 B
Script
General
Full URL
https://ib.adnxs.com/jpt?id=12251243&size=300x250&referrer=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-farxiga-fda%2Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&prod=SIAB&psa=0&pf=90&cc=0&ivt=18&iva=4&ivb=3&ivc=1&ivd=1&ive=0&ivp=6&osr=6&33xvis=0&callback=_tynt_jp.agcmkywsp
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.223.203 , Netherlands, ASN29990 (ASN-APPNEXUS - AppNexus, Inc, US),
Reverse DNS
317.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.13.4 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:32 GMT
X-Proxy-Origin
144.76.109.30; 144.76.109.30; 317.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.220.140:80
AN-X-Request-Uuid
ec16454c-8224-4242-8f36-ad4ff8ff3298
Server
nginx/1.13.4
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
text/html; charset=utf-8
Content-Length
0
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
jpt
ib.adnxs.com/ Frame 7A62
0
661 B
Script
General
Full URL
https://ib.adnxs.com/jpt?id=12251239&size=300x250&referrer=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-farxiga-fda%2Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&prod=SIAB&psa=0&pf=30&cc=0&ivt=18&iva=4&ivb=3&ivc=1&ivd=1&ive=0&ivp=6&osr=6&33xvis=0&callback=_tynt_jp.a5gmm06lg
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.223.203 , Netherlands, ASN29990 (ASN-APPNEXUS - AppNexus, Inc, US),
Reverse DNS
317.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.13.4 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:32 GMT
X-Proxy-Origin
144.76.109.30; 144.76.109.30; 317.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.220.42:80
AN-X-Request-Uuid
032eb50b-b25a-477e-9671-7a80487f6a21
Server
nginx/1.13.4
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
text/html; charset=utf-8
Content-Length
0
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
jpt
ib.adnxs.com/ Frame 7A62
0
662 B
Script
General
Full URL
https://ib.adnxs.com/jpt?id=12251244&size=300x250&referrer=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-farxiga-fda%2Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&prod=SIAB&psa=0&pf=30&cc=0&ivt=18&iva=4&ivb=3&ivc=1&ivd=1&ive=0&ivp=6&osr=6&33xvis=0&callback=_tynt_jp.a4g2hkkp7
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.223.203 , Netherlands, ASN29990 (ASN-APPNEXUS - AppNexus, Inc, US),
Reverse DNS
317.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.13.4 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:32 GMT
X-Proxy-Origin
144.76.109.30; 144.76.109.30; 317.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.220.169:80
AN-X-Request-Uuid
d7c60855-721c-4010-b7d0-96c3671787b9
Server
nginx/1.13.4
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
text/html; charset=utf-8
Content-Length
0
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
jstag
33across-d.openx.net/w/1.0/ Frame DF30
164 KB
56 KB
Script
General
Full URL
https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.164.0 /
Resource Hash
31f2ecad3847f247c69ad0bb9eaaa126237045c8aec2804888882ccd0cbe160a

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:30 GMT
content-encoding
gzip
server
OXGW/16.164.0
vary
Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
status
200
cache-control
max-age=3600
content-type
text/javascript
alt-svc
clear
content-length
57432
via
1.1 google
expires
Tue, 22 Oct 2019 16:30:30 GMT
jstag
33across-d.openx.net/w/1.0/ Frame 1A4A
164 KB
56 KB
Script
General
Full URL
https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.164.0 /
Resource Hash
32d36dd531eba22f72edbf7d1a8c8cb10503e80a246e4838f8e1f71600e21a7e

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:30 GMT
content-encoding
gzip
server
OXGW/16.164.0
vary
Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
status
200
cache-control
max-age=3600
content-type
text/javascript
alt-svc
clear
content-length
57431
via
1.1 google
expires
Tue, 22 Oct 2019 16:30:30 GMT
jstag
33across-d.openx.net/w/1.0/ Frame 3D30
164 KB
56 KB
Script
General
Full URL
https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.164.0 /
Resource Hash
c5f64424d53e711cb6e6e1f30078f6c613bfffcda9508856151cd6553bf50e73

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:30 GMT
content-encoding
gzip
server
OXGW/16.164.0
vary
Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
status
200
cache-control
max-age=3600
content-type
text/javascript
alt-svc
clear
content-length
57425
via
1.1 google
expires
Tue, 22 Oct 2019 16:30:30 GMT
exchange
ssc.33across.com/api/ Frame 7A62
141 B
409 B
XHR
General
Full URL
https://ssc.33across.com/api/exchange
Requested by
Host: cdn-sic.33across.com
URL: https://cdn-sic.33across.com/1/javascripts/sic.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.178 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip178.208-100-17.static.steadfastdns.net
Software
/ 33Across
Resource Hash
bdf4bfb5fcc5bc4fbd31e439afe6f1328e69a2c1a6cf9b7fe7c96f63625f74e6

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 22 Oct 2019 15:30:31 GMT
content-encoding
gzip
status
200, 200 OK
x-powered-by
33Across
vary
Accept-Encoding, Origin
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.reuters.com
access-control-allow-credentials
true
p
ic.tynt.com/b/
0
119 B
Image
General
Full URL
https://ic.tynt.com/b/p?id=bFJBfaR2Or54kOaKkv7mNO&lm=5&ts=1571758230082&dn=SIAB&iso=0&img=https%3A%2F%2Fs3.reutersmedia.net%2Fresources%2Fr%2F%3Fm%3D02%26d%3D20191021%26t%3D2%26i%3D1443247775%26w%3D1200%26r%3DLYNXMPEF9K0CN&ct=FDA%20approves%20AstraZeneca%20diabetes%20drug%20for%20treating%20heart%20failure%20risk
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.183 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip183.208-100-17.static.steadfastdns.net
Software
nginx/1.14.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
204
date
Tue, 22 Oct 2019 15:30:29 GMT
server
nginx/1.14.0
p3p
CP=NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA
jpt
ib.adnxs.com/ Frame D122
0
662 B
Script
General
Full URL
https://ib.adnxs.com/jpt?id=12251243&size=300x250&referrer=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-farxiga-fda%2Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&prod=SIAB&psa=0&pf=90&cc=0&ivt=18&iva=4&ivb=3&ivc=1&ivd=1&ive=0&ivp=6&osr=6&33xvis=0&callback=_tynt_jp.ago9f26j4
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.223.203 , Netherlands, ASN29990 (ASN-APPNEXUS - AppNexus, Inc, US),
Reverse DNS
317.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.13.4 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:32 GMT
X-Proxy-Origin
144.76.109.30; 144.76.109.30; 317.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.220.141:80
AN-X-Request-Uuid
b94acf3a-b0c9-4a2b-9fe8-43918aad9a1d
Server
nginx/1.13.4
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
text/html; charset=utf-8
Content-Length
0
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
jpt
ib.adnxs.com/ Frame D122
0
661 B
Script
General
Full URL
https://ib.adnxs.com/jpt?id=12251239&size=300x250&referrer=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-farxiga-fda%2Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&prod=SIAB&psa=0&pf=30&cc=0&ivt=18&iva=4&ivb=3&ivc=1&ivd=1&ive=0&ivp=6&osr=6&33xvis=0&callback=_tynt_jp.adpnp8nlk
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.223.203 , Netherlands, ASN29990 (ASN-APPNEXUS - AppNexus, Inc, US),
Reverse DNS
317.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.13.4 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:32 GMT
X-Proxy-Origin
144.76.109.30; 144.76.109.30; 317.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.223.44:80
AN-X-Request-Uuid
aa21380a-64a1-4250-982b-0f7b234832d3
Server
nginx/1.13.4
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
text/html; charset=utf-8
Content-Length
0
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
jpt
ib.adnxs.com/ Frame D122
0
662 B
Script
General
Full URL
https://ib.adnxs.com/jpt?id=12251244&size=300x250&referrer=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-farxiga-fda%2Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&prod=SIAB&psa=0&pf=30&cc=0&ivt=18&iva=4&ivb=3&ivc=1&ivd=1&ive=0&ivp=6&osr=6&33xvis=0&callback=_tynt_jp.ajbt0fmbf
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.223.203 , Netherlands, ASN29990 (ASN-APPNEXUS - AppNexus, Inc, US),
Reverse DNS
317.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.13.4 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:32 GMT
X-Proxy-Origin
144.76.109.30; 144.76.109.30; 317.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.222.234:80
AN-X-Request-Uuid
56c98ae0-4364-4763-a4de-28c24d988b5d
Server
nginx/1.13.4
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
text/html; charset=utf-8
Content-Length
0
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
jstag
33across-d.openx.net/w/1.0/ Frame BFEB
164 KB
56 KB
Script
General
Full URL
https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.164.0 /
Resource Hash
d76b5e252081cbd0229e62445d28250ab31aba3250e0a1b9ac195147fdd288df

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:30 GMT
content-encoding
gzip
server
OXGW/16.164.0
vary
Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
status
200
cache-control
max-age=3600
content-type
text/javascript
alt-svc
clear
content-length
57431
via
1.1 google
expires
Tue, 22 Oct 2019 16:30:30 GMT
jstag
33across-d.openx.net/w/1.0/ Frame DE48
164 KB
56 KB
Script
General
Full URL
https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.164.0 /
Resource Hash
72fb19acc0ac7cb9683c1aa84efda04e5d6998f1f107b8acc7f6fa4db0594763

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:30 GMT
content-encoding
gzip
server
OXGW/16.164.0
vary
Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
status
200
cache-control
max-age=3600
content-type
text/javascript
alt-svc
clear
content-length
57430
via
1.1 google
expires
Tue, 22 Oct 2019 16:30:30 GMT
jstag
33across-d.openx.net/w/1.0/ Frame 2FCE
164 KB
56 KB
Script
General
Full URL
https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.164.0 /
Resource Hash
34d2b20d65e2233f10489adfbbcb8ad0301200bc368e26d9df7c739cf621bbec

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:30 GMT
content-encoding
gzip
server
OXGW/16.164.0
vary
Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
status
200
cache-control
max-age=3600
content-type
text/javascript
alt-svc
clear
content-length
57432
via
1.1 google
expires
Tue, 22 Oct 2019 16:30:30 GMT
exchange
ssc.33across.com/api/ Frame D122
141 B
408 B
XHR
General
Full URL
https://ssc.33across.com/api/exchange
Requested by
Host: cdn-sic.33across.com
URL: https://cdn-sic.33across.com/1/javascripts/sic.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.178 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip178.208-100-17.static.steadfastdns.net
Software
/ 33Across
Resource Hash
d45d0bbbfb3f5e4b3dd2afb3e08a8a66c6a23c076fc18fe2cda8347e174d2499

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 22 Oct 2019 15:30:31 GMT
content-encoding
gzip
status
200, 200 OK
x-powered-by
33Across
vary
Accept-Encoding, Origin
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.reuters.com
access-control-allow-credentials
true
acj
33across-d.openx.net/w/1.0/ Frame DF30
454 B
638 B
XHR
General
Full URL
https://33across-d.openx.net/w/1.0/acj?o=283cf06c64cbac&ju=https%3A//www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&jr=&be=1&prf=0&auid=538526169&aus=300x250&bc=hb_2api&bt=5000&c.placement=bFJBfaR2Or54kOaKkv7mNO%3ASIAB%3Adesktop%3AINTL%3Atier1&c.pf=90&c.cc=0&c.33xvis=0&res=1600x1200x24&plg=pm&ch=UTF-8&tz=-120&ws=1x1&ifr=1&tws=300x250
Requested by
Host: 33across-d.openx.net
URL: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.164.0 /
Resource Hash
69d979f333fa2cb429271bedc0576c8adff7325fbce609454bb3b9b0f50f7bda

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:30 GMT
via
1.1 google
server
OXGW/16.164.0
status
200
vary
Accept
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.reuters.com
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
454
expires
Mon, 26 Jul 1997 05:00:00 GMT
acj
33across-d.openx.net/w/1.0/ Frame 1A4A
454 B
687 B
XHR
General
Full URL
https://33across-d.openx.net/w/1.0/acj?o=232373bf273aa3&ju=https%3A//www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&jr=&be=1&prf=0&auid=538526169&aus=300x250&bc=hb_2api&bt=5000&c.placement=bFJBfaR2Or54kOaKkv7mNO%3ASIAB%3Adesktop%3AINTL%3Atier2&c.pf=30&c.cc=0&c.33xvis=0&res=1600x1200x24&plg=pm&ch=UTF-8&tz=-120&ws=1x1&ifr=1&tws=300x250
Requested by
Host: 33across-d.openx.net
URL: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.164.0 /
Resource Hash
18718c46a005f0085f49b91e3bb57334f05194fe38ec5fa078bc383ea6b621cf

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:30 GMT
via
1.1 google
server
OXGW/16.164.0
status
200
vary
Accept
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.reuters.com
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
454
expires
Mon, 26 Jul 1997 05:00:00 GMT
v2
de.tynt.com/deb/
4 B
200 B
Script
General
Full URL
https://de.tynt.com/deb/v2?m=xch&id=bFJBfaR2Or54kOaKkv7mNO&dn=SIAB&cc=2&r=
Requested by
Host: cdn.tynt.com
URL: https://cdn.tynt.com/siab.js?uTjYfYoCUQ&_ADTIME_&$RANDOM&%%CACHEBUSTER%%&
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.185 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip185.208-100-17.static.steadfastdns.net
Software
/
Resource Hash
d21021784cda31eeae5c8295e047a14bda6ed5a9b5963fca9e7ceb398a9c9179

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
200
date
Tue, 22 Oct 2019 15:30:29 GMT
cache-control
max-age=86400
content-type
application/javascript
p3p
CP=NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA
content-length
4
expires
Wed, 23 Oct 2019 15:30:29 GMT
acj
33across-d.openx.net/w/1.0/ Frame 3D30
455 B
643 B
XHR
General
Full URL
https://33across-d.openx.net/w/1.0/acj?o=2c474baf89ee1c&ju=https%3A//www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&jr=&be=1&prf=0&auid=538526169&aus=300x250&bc=hb_2api&bt=5000&c.placement=bFJBfaR2Or54kOaKkv7mNO%3ASIAB%3Adesktop%3AINTL%3Atier3&c.pf=30&c.cc=0&c.33xvis=0&res=1600x1200x24&plg=pm&ch=UTF-8&tz=-120&ws=1x1&ifr=1&tws=300x250
Requested by
Host: 33across-d.openx.net
URL: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.164.0 /
Resource Hash
3cbd2e2af62a1f833e9e4712fbd5cfbf37ce806dc2ad657d0ef45ad2a97e70ca

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:31 GMT
via
1.1 google
server
OXGW/16.164.0
status
200
vary
Accept
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.reuters.com
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
455
expires
Mon, 26 Jul 1997 05:00:00 GMT
pd
eu-u.openx.net/w/1.0/ Frame E7E5
0
0
Document
General
Full URL
https://eu-u.openx.net/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.164.0 /
Resource Hash

Request headers

:method
GET
:authority
eu-u.openx.net
:scheme
https
:path
/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
accept-encoding
gzip, deflate, br
cookie
i=85571933-2a03-4b4b-8076-ed64cc930abe|1571758230
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5

Response headers

status
200
vary
Accept
set-cookie
i=85571933-2a03-4b4b-8076-ed64cc930abe|1571758230; Version=1; Expires=Wed, 21-Oct-2020 15:30:30 GMT; Max-Age=31536000; Domain=.openx.net; Path=/ pd=v2|1571758230|mOsLgqgikin0fcmWiygu; Version=1; Expires=Wed, 06-Nov-2019 15:30:30 GMT; Max-Age=1296000; Domain=.openx.net; Path=/
server
OXGW/16.164.0
p3p
CP="CUR ADM OUR NOR STA NID"
date
Tue, 22 Oct 2019 15:30:30 GMT
content-type
text/html
content-length
862
via
1.1 google
alt-svc
clear
pd
eu-u.openx.net/w/1.0/ Frame A96F
0
0
Document
General
Full URL
https://eu-u.openx.net/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.164.0 /
Resource Hash

Request headers

:method
GET
:authority
eu-u.openx.net
:scheme
https
:path
/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
accept-encoding
gzip, deflate, br
cookie
i=85571933-2a03-4b4b-8076-ed64cc930abe|1571758230
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5

Response headers

status
200
vary
Accept
set-cookie
i=85571933-2a03-4b4b-8076-ed64cc930abe|1571758230; Version=1; Expires=Wed, 21-Oct-2020 15:30:30 GMT; Max-Age=31536000; Domain=.openx.net; Path=/ pd=v2|1571758230|mOsLgqgikin0fcmWiygu; Version=1; Expires=Wed, 06-Nov-2019 15:30:30 GMT; Max-Age=1296000; Domain=.openx.net; Path=/
server
OXGW/16.164.0
p3p
CP="CUR ADM OUR NOR STA NID"
date
Tue, 22 Oct 2019 15:30:30 GMT
content-type
text/html
content-length
862
via
1.1 google
alt-svc
clear
acj
33across-d.openx.net/w/1.0/ Frame DE48
452 B
640 B
XHR
General
Full URL
https://33across-d.openx.net/w/1.0/acj?o=26ff188403d2aa&ju=https%3A//www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&jr=&be=1&prf=0&auid=538526169&aus=300x250&bc=hb_2api&bt=5000&c.placement=bFJBfaR2Or54kOaKkv7mNO%3ASIAB%3Adesktop%3AINTL%3Atier2&c.pf=30&c.cc=0&c.33xvis=0&res=1600x1200x24&plg=pm&ch=UTF-8&tz=-120&ws=1x1&ifr=1&tws=300x250
Requested by
Host: 33across-d.openx.net
URL: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.164.0 /
Resource Hash
d367274161f37f29bd349b8240af8219ae4b01e5feed186293decd0ed50cf921

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:30 GMT
via
1.1 google
server
OXGW/16.164.0
status
200
vary
Accept
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.reuters.com
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
452
expires
Mon, 26 Jul 1997 05:00:00 GMT
p
ic.tynt.com/b/
0
119 B
Image
General
Full URL
https://ic.tynt.com/b/p?id=bFJBfaR2Or54kOaKkv7mNO&lm=5&ts=1571758230082&dn=SIAB&iso=0&img=https%3A%2F%2Fs3.reutersmedia.net%2Fresources%2Fr%2F%3Fm%3D02%26d%3D20191021%26t%3D2%26i%3D1443247775%26w%3D1200%26r%3DLYNXMPEF9K0CN&ct=FDA%20approves%20AstraZeneca%20diabetes%20drug%20for%20treating%20heart%20failure%20risk
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.183 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip183.208-100-17.static.steadfastdns.net
Software
nginx/1.14.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
204
date
Tue, 22 Oct 2019 15:30:29 GMT
server
nginx/1.14.0
p3p
CP=NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA
acj
33across-d.openx.net/w/1.0/ Frame BFEB
454 B
638 B
XHR
General
Full URL
https://33across-d.openx.net/w/1.0/acj?o=287b0f6425ca66&ju=https%3A//www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&jr=&nl=17%252C24&ul=32%252C43&be=1&prf=0&auid=538526169&aus=300x250&bc=hb_2api&bt=5000&c.placement=bFJBfaR2Or54kOaKkv7mNO%3ASIAB%3Adesktop%3AINTL%3Atier1&c.pf=90&c.cc=0&c.33xvis=0&res=1600x1200x24&plg=pm&ch=UTF-8&tz=-120&ws=1x1&ifr=1&tws=300x250
Requested by
Host: 33across-d.openx.net
URL: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.164.0 /
Resource Hash
d5374dcd7f2899ba40ec2935ccd3f3363c4ecc3c7b162df79b9be0771794606a

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:30 GMT
via
1.1 google
server
OXGW/16.164.0
status
200
vary
Accept
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.reuters.com
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
454
expires
Mon, 26 Jul 1997 05:00:00 GMT
acj
33across-d.openx.net/w/1.0/ Frame 2FCE
454 B
638 B
XHR
General
Full URL
https://33across-d.openx.net/w/1.0/acj?o=2530f03522e63e&ju=https%3A//www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&jr=&nl=17%252C24&ul=32%252C43&be=1&prf=0&auid=538526169&aus=300x250&bc=hb_2api&bt=5000&c.placement=bFJBfaR2Or54kOaKkv7mNO%3ASIAB%3Adesktop%3AINTL%3Atier3&c.pf=30&c.cc=0&c.33xvis=0&res=1600x1200x24&plg=pm&ch=UTF-8&tz=-120&ws=1x1&ifr=1&tws=300x250
Requested by
Host: 33across-d.openx.net
URL: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.164.0 /
Resource Hash
2fc3d0033226745abf0f92830ca6213c6790cdc2d5601cd49a25210f4c859d85

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:30 GMT
via
1.1 google
server
OXGW/16.164.0
status
200
vary
Accept
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.reuters.com
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
454
expires
Mon, 26 Jul 1997 05:00:00 GMT
pd
eu-u.openx.net/w/1.0/ Frame 2988
0
0
Document
General
Full URL
https://eu-u.openx.net/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.164.0 /
Resource Hash

Request headers

:method
GET
:authority
eu-u.openx.net
:scheme
https
:path
/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
accept-encoding
gzip, deflate, br
cookie
i=85571933-2a03-4b4b-8076-ed64cc930abe|1571758230; pd=v2|1571758230|mOsLgqgikin0fcmWiygu
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5

Response headers

status
200
vary
Accept
set-cookie
i=85571933-2a03-4b4b-8076-ed64cc930abe|1571758230; Version=1; Expires=Wed, 21-Oct-2020 15:30:30 GMT; Max-Age=31536000; Domain=.openx.net; Path=/ pd=v2|1571758230|rskimWfcvmsHqGgqmuiynIsLomgemOgunsn0oagi; Version=1; Expires=Wed, 06-Nov-2019 15:30:30 GMT; Max-Age=1296000; Domain=.openx.net; Path=/
server
OXGW/16.164.0
p3p
CP="CUR ADM OUR NOR STA NID"
date
Tue, 22 Oct 2019 15:30:30 GMT
content-type
text/html
content-length
825
via
1.1 google
alt-svc
clear
pd
eu-u.openx.net/w/1.0/ Frame CE61
0
0
Document
General
Full URL
https://eu-u.openx.net/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.164.0 /
Resource Hash

Request headers

:method
GET
:authority
eu-u.openx.net
:scheme
https
:path
/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
accept-encoding
gzip, deflate, br
cookie
i=85571933-2a03-4b4b-8076-ed64cc930abe|1571758230; pd=v2|1571758230|mOsLgqgikin0fcmWiygu
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5

Response headers

status
200
vary
Accept
set-cookie
i=85571933-2a03-4b4b-8076-ed64cc930abe|1571758230; Version=1; Expires=Wed, 21-Oct-2020 15:30:30 GMT; Max-Age=31536000; Domain=.openx.net; Path=/ pd=v2|1571758230|rskimWfcvmsHqGgqmuiynIsLomgemOgunsn0oagi; Version=1; Expires=Wed, 06-Nov-2019 15:30:30 GMT; Max-Age=1296000; Domain=.openx.net; Path=/
server
OXGW/16.164.0
p3p
CP="CUR ADM OUR NOR STA NID"
date
Tue, 22 Oct 2019 15:30:30 GMT
content-type
text/html
content-length
825
via
1.1 google
alt-svc
clear
pd
eu-u.openx.net/w/1.0/ Frame 7275
0
0
Document
General
Full URL
https://eu-u.openx.net/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.164.0 /
Resource Hash

Request headers

:method
GET
:authority
eu-u.openx.net
:scheme
https
:path
/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
accept-encoding
gzip, deflate, br
cookie
i=85571933-2a03-4b4b-8076-ed64cc930abe|1571758230; pd=v2|1571758230|rskimWfcvmsHqGgqmuiynIsLomgemOgunsn0oagi
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5

Response headers

status
200
vary
Accept
set-cookie
i=85571933-2a03-4b4b-8076-ed64cc930abe|1571758230; Version=1; Expires=Wed, 21-Oct-2020 15:30:30 GMT; Max-Age=31536000; Domain=.openx.net; Path=/ pd=v2|1571758230|forsj8gmkimWjotufcvmsHtlqGgqmuiyfQnIsLiSomgemOgusflEnsn0oagi; Version=1; Expires=Wed, 06-Nov-2019 15:30:30 GMT; Max-Age=1296000; Domain=.openx.net; Path=/
server
OXGW/16.164.0
p3p
CP="CUR ADM OUR NOR STA NID"
date
Tue, 22 Oct 2019 15:30:30 GMT
content-type
text/html
content-length
916
via
1.1 google
alt-svc
clear
pd
eu-u.openx.net/w/1.0/ Frame B526
0
0
Document
General
Full URL
https://eu-u.openx.net/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.164.0 /
Resource Hash

Request headers

:method
GET
:authority
eu-u.openx.net
:scheme
https
:path
/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
accept-encoding
gzip, deflate, br
cookie
i=85571933-2a03-4b4b-8076-ed64cc930abe|1571758230; pd=v2|1571758230|forsj8gmkimWjotufcvmsHtlqGgqmuiyfQnIsLiSomgemOgusflEnsn0oagi
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5

Response headers

status
200
vary
Accept
set-cookie
i=85571933-2a03-4b4b-8076-ed64cc930abe|1571758230; Version=1; Expires=Wed, 21-Oct-2020 15:30:31 GMT; Max-Age=31536000; Domain=.openx.net; Path=/ pd=v2|1571758230.1|forsj8gmkimWjotufcvmsHtlqGgqmuiyfQnIsLiSomgemOgusflEnsn0oagi.gStKrF; Version=1; Expires=Wed, 06-Nov-2019 15:30:31 GMT; Max-Age=1296000; Domain=.openx.net; Path=/
server
OXGW/16.164.0
p3p
CP="CUR ADM OUR NOR STA NID"
date
Tue, 22 Oct 2019 15:30:31 GMT
content-type
text/html
content-length
446
via
1.1 google
alt-svc
clear
p
ic.tynt.com/b/
0
119 B
Image
General
Full URL
https://ic.tynt.com/b/p?id=bFJBfaR2Or54kOaKkv7mNO&lm=5&ts=1571758230082&dn=SIAB&iso=0&img=https%3A%2F%2Fs3.reutersmedia.net%2Fresources%2Fr%2F%3Fm%3D02%26d%3D20191021%26t%3D2%26i%3D1443247775%26w%3D1200%26r%3DLYNXMPEF9K0CN
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.183 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip183.208-100-17.static.steadfastdns.net
Software
nginx/1.14.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
204
date
Tue, 22 Oct 2019 15:30:30 GMT
server
nginx/1.14.0
p3p
CP=NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA
p
ic.tynt.com/b/
0
119 B
Image
General
Full URL
https://ic.tynt.com/b/p?id=bFJBfaR2Or54kOaKkv7mNO&lm=5&ts=1571758230082&dn=SIAB&iso=0
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.183 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip183.208-100-17.static.steadfastdns.net
Software
nginx/1.14.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
204
date
Tue, 22 Oct 2019 15:30:30 GMT
server
nginx/1.14.0
p3p
CP=NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=60312569-8562-65c6-4952-219c4cca5cec&tv={c:rN5Tzt,pingTime:5,time:5266,type:p,clog:[{piv:100,vs:i,r:,w:300,h:250,t:186}],es:0,sc:1,ha:1,gm:1,slTimes:{i:5266,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:186,wc:0.0.1600.1200,ac:1140.436.300.250,am:i,cc:1140.436.300.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[5092~100],as:[5092~300.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:99,fm:rFDXlcz+11|12|13|14|15|16|17|18|19|1a|1b|1c*.10764|1c1|1d.10764|1d1|1e.10764|1e1|1f|1g,idMap:1c*,rend:1,renddet:DIV.qs.sn,rmeas:1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:32 GMT
X-Server-Name
dt74.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=60312569-8562-65c6-4952-219c4cca5cec&tv={c:rN5Tzu,pingTime:5,time:5267,type:pf,clog:[{piv:100,vs:i,r:,w:300,h:250,t:186}],es:0,sc:1,ha:1,gm:1,slTimes:{i:5267,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:186,wc:0.0.1600.1200,ac:1140.436.300.250,am:i,cc:1140.436.300.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[5093~100],as:[5093~300.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:99,fm:rFDXlcz+11|12|13|14|15|16|17|18|19|1a|1b|1c*.10764|1c1|1d.10764|1d1|1e.10764|1e1|1f|1g,idMap:1c*,rend:1,renddet:DIV.qs.sn,rmeas:1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:32 GMT
X-Server-Name
dt24.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=35b2bbf3-52b8-a43e-25f5-83fc4deeee50&tv={c:rN5TzE,pingTime:5,time:5352,type:p,clog:[{piv:100,vs:i,r:,w:2,h:2,t:292}],es:0,sc:1,ha:1,gm:1,slTimes:{i:5352,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:292,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,bkn:{piv:[5066~100],as:[5066~2.2]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:170,fm:rFDXlcz+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1d*.10764|1d1|1e.10764|1e1|1e2|1f|1g,fm2:rFDXlcz+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1d*.10764|1d1|1e.10764|1e1|1e2|1f|1g,idMap:1d*,rend:0,renddet:WINDOW,rmeas:0}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:32 GMT
X-Server-Name
dt63.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=35b2bbf3-52b8-a43e-25f5-83fc4deeee50&tv={c:rN5TzE,pingTime:5,time:5352,type:pf,clog:[{piv:100,vs:i,r:,w:2,h:2,t:292}],es:0,sc:1,ha:1,gm:1,slTimes:{i:5352,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:292,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,bkn:{piv:[5067~100],as:[5067~2.2]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:170,fm:rFDXlcz+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1d*.10764|1d1|1e.10764|1e1|1e2|1f|1g,fm2:rFDXlcz+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1d*.10764|1d1|1e.10764|1e1|1e2|1f|1g,idMap:1d*,rend:0,renddet:WINDOW,rmeas:0}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:32 GMT
X-Server-Name
dt37.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
ads
securepubads.g.doubleclick.net/gampad/ Frame 364E
389 B
375 B
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=4426318550293249&correlator=1559298683795616&output=ldjh&impl=fif&adsid=NT&eid=21063637%2C21064617&vrg=2019101401&npa=1&guci=1.2.0.0.2.1.0.0&plat=1%3A536903688%2C2%3A536903688%2C8%3A134250504&sc=1&sfv=1-0-35&ecs=20191022&iu=%2F32867010%2FSIAB_300x250&sz=300x250&scp=c%3D50%26r%3D110%26d%3Dreuters_3_300_B.com%26g%3DbFJBfaR2Or54kOaKkv7mNO%26gd%3DbFJBfaR2Or54kOaKkv7mNO%253Adesktop%26cc%3D0%26pf%3D30%26ivt%3D18%26iva%3D4%26ivb%3D3%26ivc%3D1%26ivd%3D1%26ive%3D0%26ivp%3D6%26osr%3D6%26vis%3D0%26pre%3Dapnx%253At%2Cox%253A0%2Cttx%253A0%26pre_sz%3Dapnx%253A0x0%2Cox%253A0x0%2Cttx%253A0x0%26tier%3Dapnx%253A0%2Cox%253A0%2Cttx%253A0%26hb%3D0&cookie_enabled=1&cdm=www.reuters.com&bc=31&abxe=1&lmt=1571758232&dt=1571758232704&dlt=1571758230227&idt=115&ea=0&frm=23&biw=1585&bih=1200&isw=1&ish=1&oid=3&adx=-8560&ady=-6924&adk=62473835&uci=pm6sy95jub62&ifi=1&ifk=1468755215&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&nhd=3&iag=63&url=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-farxiga-fda%2Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&top=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-farxiga-fda%2Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&dssz=4&icsg=170&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=1x0&msz=300x250&ga_vid=1411604026.1571758233&ga_sid=1571758233&ga_hid=1124772357&fws=256&ohw=0
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.208.34 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s12-in-f2.1e100.net
Software
cafe /
Resource Hash
3322269d2a48264fe52f7338f6101c50f0751cfa340452e4a6cb1cf3cf206db4
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:32 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
202
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.reuters.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
pubads_impl_rendering_2019101401.js
securepubads.g.doubleclick.net/gpt/ Frame 364E
64 KB
24 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019101401.js
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.208.34 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s12-in-f2.1e100.net
Software
sffe /
Resource Hash
f123fae1ceff20dea7ee2ff8895276a22cddecc8e0ef503b5e95419e76909a54
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:32 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Mon, 14 Oct 2019 13:08:16 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
24836
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:32 GMT
container.html
tpc.googlesyndication.com/safeframe/1-0-35/html/ Frame 364E
0
0
Other
General
Full URL
https://tpc.googlesyndication.com/safeframe/1-0-35/html/container.html?n=3
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:815::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

ads
securepubads.g.doubleclick.net/gampad/ Frame 9B40
395 B
483 B
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=3229669953427334&correlator=3206861330870878&output=ldjh&impl=fif&adsid=NT&eid=21062421%2C21062452&vrg=2019101401&npa=1&guci=1.2.0.0.2.1.0.0&plat=1%3A536903688%2C2%3A536903688%2C8%3A134250504&sc=1&sfv=1-0-35&ecs=20191022&iu=%2F32867010%2FSIAB_300x250&sz=300x250&scp=c%3D50%26r%3D110%26d%3Dreuters_3_300_B.com%26g%3DbFJBfaR2Or54kOaKkv7mNO%26gd%3DbFJBfaR2Or54kOaKkv7mNO%253Adesktop%26cc%3D0%26pf%3D30%26ivt%3D18%26iva%3D4%26ivb%3D3%26ivc%3D1%26ivd%3D1%26ive%3D0%26ivp%3D6%26osr%3D6%26vis%3D0%26pre%3Dapnx%253At%2Cox%253A0%2Cttx%253A0%26pre_sz%3Dapnx%253A0x0%2Cox%253A0x0%2Cttx%253A0x0%26tier%3Dapnx%253A0%2Cox%253A0%2Cttx%253A0%26hb%3D0&cookie_enabled=1&cdm=www.reuters.com&bc=31&abxe=1&lmt=1571758232&dt=1571758232806&dlt=1571758230600&idt=130&ea=0&frm=23&biw=1585&bih=1200&isw=1&ish=1&oid=3&adx=-8560&ady=-6924&adk=62473835&uci=m3taggulhh05&ifi=1&ifk=1468755215&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&nhd=4&iag=255&url=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-farxiga-fda%2Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&top=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-astrazeneca-farxiga-fda%2Ffda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5&dssz=4&icsg=170&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=1x0&msz=300x250&ga_vid=751148189.1571758233&ga_sid=1571758233&ga_hid=1760731649&fws=256&ohw=0
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.208.34 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s12-in-f2.1e100.net
Software
cafe /
Resource Hash
9f6a538aa91f99d5e9e64bea8c4b832777bc03aaa93f2e21fe1ff1de637620a1
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:32 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
209
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.reuters.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
pubads_impl_rendering_2019101401.js
securepubads.g.doubleclick.net/gpt/ Frame 9B40
64 KB
24 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019101401.js
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.208.34 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s12-in-f2.1e100.net
Software
sffe /
Resource Hash
f123fae1ceff20dea7ee2ff8895276a22cddecc8e0ef503b5e95419e76909a54
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:30:32 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Mon, 14 Oct 2019 13:08:16 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
24836
x-xss-protection
0
expires
Tue, 22 Oct 2019 15:30:32 GMT
container.html
tpc.googlesyndication.com/safeframe/1-0-35/html/ Frame 9B40
0
0
Other
General
Full URL
https://tpc.googlesyndication.com/safeframe/1-0-35/html/container.html?n=4
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:815::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

gen_204
pagead2.googlesyndication.com/pagead/ Frame 364E
0
60 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/gen_204?id=gpt_sz&r=300x250&w=300&h=250
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:818::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:32 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
204
cache-control
no-cache, must-revalidate
content-type
image/gif
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
fpi.js
ap.lijit.com/www/delivery/ Frame 7A62
5 KB
3 KB
Script
General
Full URL
https://ap.lijit.com/www/delivery/fpi.js?{random}&_ADTIME_&z=577991&width=300&height=250
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
216.52.2.48 , United States, ASN29791 (VOXEL-DOT-NET - Internap Corporation, US),
Reverse DNS
Software
nginx /
Resource Hash
33722e58bc38ecd0e9659cfecaf653595461941b707edc0d9ee46768405597c9

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:33 GMT
Content-Encoding
gzip
Server
nginx
ETag
W/"5d83bab8-1534"
Vary
Accept-Encoding
Content-Type
text/javascript
Cache-Control
private, no-cache, no-store, must-revalidate, max-age=0
Transfer-Encoding
chunked
X-Sovrn-Pod
ap5ams1
Expires
Thu, 01 Jan 1970 00:00:01 GMT
sync
ap.lijit.com/ Frame 7A62
49 KB
16 KB
Script
General
Full URL
https://ap.lijit.com/sync
Requested by
Host: ap.lijit.com
URL: https://ap.lijit.com/www/delivery/fpi.js?{random}&_ADTIME_&z=577991&width=300&height=250
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
216.52.2.48 , United States, ASN29791 (VOXEL-DOT-NET - Internap Corporation, US),
Reverse DNS
Software
nginx /
Resource Hash
21f7d842731a7084f93bf9fcc84b01c33012804cbfbc4908eee7eb58feee155d

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:33 GMT
Content-Encoding
gzip
Last-Modified
Thu, 19 Sep 2019 17:28:34 GMT
Server
nginx
ETag
W/"5d83bac2-c373"
Vary
Accept-Encoding
Content-Type
text/javascript
Cache-Control
max-age=86400, must-revalidate
Transfer-Encoding
chunked
X-Sovrn-Pod
ap5ams1
Expires
Wed, 23 Oct 2019 15:30:33 GMT
adcfg
ap.lijit.com/ Frame 7A62
159 B
567 B
Script
General
Full URL
https://ap.lijit.com/adcfg?zoneid=577991&tid=5d8b99960fc24369bf996a8f367d10f7c598198c&mode=1&dmn=www.reuters.com
Requested by
Host: ap.lijit.com
URL: https://ap.lijit.com/sync
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
216.52.2.48 , United States, ASN29791 (VOXEL-DOT-NET - Internap Corporation, US),
Reverse DNS
Software
nginx /
Resource Hash
5be9dc15234391c668eccfdbe5e45cc1b79a76528d486f5b11cebc743d4ed5d4

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:33 GMT
Content-Encoding
gzip
Server
nginx
Transfer-Encoding
chunked
Vary
Accept-Encoding
Access-Control-Allow-Methods
GET, POST, DELETE, PUT
Content-Type
application/x-javascript
Access-Control-Allow-Origin
*
Access-Control-Allow-Credentials
true
X-Sovrn-Pod
ap5ams1
Access-Control-Allow-Headers
X-Requested-With, Content-Type
fpi.js
ap.lijit.com/www/delivery/ Frame D122
5 KB
3 KB
Script
General
Full URL
https://ap.lijit.com/www/delivery/fpi.js?{random}&_ADTIME_&z=577991&width=300&height=250
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
216.52.2.48 , United States, ASN29791 (VOXEL-DOT-NET - Internap Corporation, US),
Reverse DNS
Software
nginx /
Resource Hash
33722e58bc38ecd0e9659cfecaf653595461941b707edc0d9ee46768405597c9

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:33 GMT
Content-Encoding
gzip
Server
nginx
ETag
W/"5d83bac0-1534"
Vary
Accept-Encoding
Content-Type
text/javascript
Cache-Control
private, no-cache, no-store, must-revalidate, max-age=0
Transfer-Encoding
chunked
X-Sovrn-Pod
ap5ams1
Expires
Thu, 01 Jan 1970 00:00:01 GMT
sync
ap.lijit.com/ Frame D122
49 KB
16 KB
Script
General
Full URL
https://ap.lijit.com/sync
Requested by
Host: ap.lijit.com
URL: https://ap.lijit.com/www/delivery/fpi.js?{random}&_ADTIME_&z=577991&width=300&height=250
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
216.52.2.48 , United States, ASN29791 (VOXEL-DOT-NET - Internap Corporation, US),
Reverse DNS
Software
nginx /
Resource Hash
21f7d842731a7084f93bf9fcc84b01c33012804cbfbc4908eee7eb58feee155d

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:33 GMT
Content-Encoding
gzip
Last-Modified
Thu, 19 Sep 2019 17:28:24 GMT
Server
nginx
ETag
W/"5d83bab8-c373"
Vary
Accept-Encoding
Content-Type
text/javascript
Cache-Control
max-age=86400, must-revalidate
Transfer-Encoding
chunked
X-Sovrn-Pod
ap5ams1
Expires
Wed, 23 Oct 2019 15:30:33 GMT
adcfg
ap.lijit.com/ Frame D122
159 B
565 B
Script
General
Full URL
https://ap.lijit.com/adcfg?zoneid=577991&tid=0a49cd1ea3f14aa6b7c0e129989e4198fb82be36&mode=1&dmn=www.reuters.com
Requested by
Host: ap.lijit.com
URL: https://ap.lijit.com/sync
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
216.52.2.48 , United States, ASN29791 (VOXEL-DOT-NET - Internap Corporation, US),
Reverse DNS
Software
nginx /
Resource Hash
437c5c3d407ad7d7bd74ffa012247834a03b9d6a792327fe202d4429fa2a1b51

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Tue, 22 Oct 2019 15:30:33 GMT
Content-Encoding
gzip
Server
nginx
Transfer-Encoding
chunked
Vary
Accept-Encoding
Access-Control-Allow-Methods
GET, POST, DELETE, PUT
Content-Type
application/x-javascript
Access-Control-Allow-Origin
*
Access-Control-Allow-Credentials
true
X-Sovrn-Pod
ap5ams1
Access-Control-Allow-Headers
X-Requested-With, Content-Type
/
onetag-geo.s-onetag.com/
23 B
434 B
XHR
General
Full URL
https://onetag-geo.s-onetag.com/
Requested by
Host: beacon.s-onetag.com
URL: https://beacon.s-onetag.com/beacon.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:20eb:b000:5:ae3a:ba00:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
ad16e1b37490fca28df99d039d6373d2fee4d894fcd279d95b90ae872f4d860f

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 22 Oct 2019 15:15:56 GMT
via
1.1 1e498d046330e15095a1a2a958463bf5.cloudfront.net (CloudFront), 1.1 24c299c0a6423c6f96984a85fb014109.cloudfront.net (CloudFront)
age
846
x-amzn-requestid
23fcf373-ebb4-4df8-bb78-c9be713af666
status
200
x-cache
Hit from cloudfront
content-type
application/json
access-control-allow-origin
*
cache-control
max-age=3600
x-amz-cf-pop
FRA2-C2, FRA2-C1
x-amz-apigw-id
B-F-9HGcyK4FgXA=
content-length
23
x-amz-cf-id
XoP_LPDCRS2XeBUVMQr9T2iCFYXWg4MWn5Qn0JG-nA0jydCv5AfiUQ==
bid
ap.lijit.com/rtb/ Frame EF32
24 B
555 B
XHR
General
Full URL
https://ap.lijit.com/rtb/bid?src=prebid_prebid_2.23.0
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
216.52.2.48 , United States, ASN29791 (VOXEL-DOT-NET - Internap Corporation, US),
Reverse DNS
Software
nginx /
Resource Hash
b65aa72428b28b2eb85fa5e87df5842f39eb902fa4294eec82b8e95f9035b912

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 22 Oct 2019 15:30:35 GMT
Content-Encoding
gzip
Server
nginx
Transfer-Encoding
chunked
Vary
Accept-Encoding
Access-Control-Allow-Methods
GET, POST, DELETE, PUT
Content-Type
application/json
Access-Control-Allow-Origin
https://www.reuters.com
Access-Control-Allow-Credentials
true
X-Sovrn-Pod
ap5ams1
Access-Control-Allow-Headers
X-Requested-With, Content-Type
/
hb.emxdgt.com/ Frame EF32
0
307 B
XHR
General
Full URL
https://hb.emxdgt.com/?t=2000&ts=1571758235660&src=pbjs
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.196.104.43 Frankfurt am Main, Germany, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-18-196-104-43.eu-central-1.compute.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 22 Oct 2019 15:30:35 GMT
Content-Type
text/html
Access-Control-Allow-Origin
https://www.reuters.com
Cache-Control
no-cache
Access-Control-Allow-Credentials
true
Connection
Keep-Alive
Access-Control-Allow-Headers
security, Content-Type
Content-Length
0
mvo
tag.1rx.io/rmp/75109/0/ Frame EF32
0
270 B
XHR
General
Full URL
https://tag.1rx.io/rmp/75109/0/mvo?z=1r&hbv=2.23,2
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_256_GCM
Server
8.41.222.100 , United States, ASN26120 (RHYTHMONE - RhythmOne, LLC, US),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

Access-Control-Allow-Origin
https://www.reuters.com
Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:36 GMT
Cache-Control
private, max-age=0, no-cache, no-store
Access-Control-Allow-Credentials
true
Server
nginx
Connection
keep-alive
translator
hbopenbid.pubmatic.com/ Frame EF32
0
116 B
XHR
General
Full URL
https://hbopenbid.pubmatic.com/translator?source=prebid-client
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
185.64.189.112 , United Kingdom, ASN62713 (AS-PUBMATIC - PubMatic, Inc., US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

status
204
date
Tue, 22 Oct 2019 15:30:35 GMT
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
access-control-allow-origin
https://www.reuters.com
arj
carambola-d.openx.net/w/1.0/ Frame EF32
172 B
359 B
XHR
General
Full URL
https://carambola-d.openx.net/w/1.0/arj?ju=https%3A%2F%2Fwww.reuters.com%2F&jr=&ch=UTF-8&res=1600x1200x24&ifr=true&tz=-120&tws=1600x1200&be=1&bc=hb_pb_2.1.7&dddid=ba4571dd-03ed-4601-9bf8-85d3d9e0b259&nocache=1571758235664&x_gdpr_f=1&aus=300x250&divIds=cbola_code_45-1&auid=539874563&
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.164.0 /
Resource Hash
27acf6916d81d58e49ba56d1e757d532a5893c33435e3d63b3000fc6e62d017e

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:35 GMT
via
1.1 google
server
OXGW/16.164.0
status
200
vary
Accept
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.reuters.com
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
172
expires
Mon, 26 Jul 1997 05:00:00 GMT
ADTECH;apid=1Ae4de7574-f4e0-11e9-b9c1-121c10c2940c;cfp=1;rndc=1571758235;v=2;cmd=bid;cors=yes;alias=219b494579777dd;misc=1571758235665;bidfloor=0.05
adserver-us.adtech.advertising.com/pubapi/3.0/10334.1/4788545/0/1/ Frame EF32
Redirect Chain
  • https://adserver-us.adtech.advertising.com/pubapi/3.0/10334.1/4788545/0/1/ADTECH;v=2;cmd=bid;cors=yes;alias=219b494579777dd;misc=1571758235665;bidfloor=0.05;
  • https://adserver-us.adtech.advertising.com/pubapi/3.0/10334.1/4788545/0/1/ADTECH;cfp=1;rndc=1571758235;v=2;cmd=bid;cors=yes;alias=219b494579777dd;misc=1571758235665;bidfloor=0.05
  • https://adserver-us.adtech.advertising.com/pubapi/3.0/10334.1/4788545/0/1/ADTECH;apid=1Ae4de7574-f4e0-11e9-b9c1-121c10c2940c;cfp=1;rndc=1571758235;v=2;cmd=bid;cors=yes;alias=219b494579777dd;misc=15...
47 B
80 B
XHR
General
Full URL
https://adserver-us.adtech.advertising.com/pubapi/3.0/10334.1/4788545/0/1/ADTECH;apid=1Ae4de7574-f4e0-11e9-b9c1-121c10c2940c;cfp=1;rndc=1571758235;v=2;cmd=bid;cors=yes;alias=219b494579777dd;misc=1571758235665;bidfloor=0.05
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
152.199.21.89 , United States, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
Adtech Adserver /
Resource Hash
45e21cdf6d754d29f9ccc51af0289bc79ec13f8c820e8f523ce851255226d64c

Request headers

Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:36 GMT
server
Adtech Adserver
status
200
access-control-allow-methods
POST,GET,HEAD,OPTIONS
content-type
application/json
access-control-allow-origin
https://www.reuters.com
cache-control
no-store, no-cache
access-control-allow-credentials
true
content-length
47
expires
Mon, 15 Jun 1998 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:36 GMT
server
nginx
status
302
location
https://adserver-us.adtech.advertising.com/pubapi/3.0/10334.1/4788545/0/1/ADTECH;apid=1Ae4de7574-f4e0-11e9-b9c1-121c10c2940c;cfp=1;rndc=1571758235;v=2;cmd=bid;cors=yes;alias=219b494579777dd;misc=1571758235665;bidfloor=0.05
access-control-allow-methods
POST,GET,HEAD,OPTIONS
p3p
CP="NOI DSP DEVa OUR BUS UNI COM NAV INT"
access-control-allow-origin
https://www.reuters.com
cache-control
no-store, no-cache
access-control-allow-credentials
true
content-length
0
expires
Mon, 15 Jun 1998 00:00:00 GMT
ADTECH;apid=1Ae4dcfa82-f4e0-11e9-b74f-124c2db8624e;cfp=1;rndc=1571758235;v=2;cmd=bid;cors=yes;alias=228b0c287c48d74;misc=1571758235665;bidfloor=0.05
adserver-us.adtech.advertising.com/pubapi/3.0/10334.1/5126271/0/1/ Frame EF32
Redirect Chain
  • https://adserver-us.adtech.advertising.com/pubapi/3.0/10334.1/5126271/0/1/ADTECH;v=2;cmd=bid;cors=yes;alias=228b0c287c48d74;misc=1571758235665;bidfloor=0.05;
  • https://adserver-us.adtech.advertising.com/pubapi/3.0/10334.1/5126271/0/1/ADTECH;cfp=1;rndc=1571758235;v=2;cmd=bid;cors=yes;alias=228b0c287c48d74;misc=1571758235665;bidfloor=0.05
  • https://adserver-us.adtech.advertising.com/pubapi/3.0/10334.1/5126271/0/1/ADTECH;apid=1Ae4dcfa82-f4e0-11e9-b74f-124c2db8624e;cfp=1;rndc=1571758235;v=2;cmd=bid;cors=yes;alias=228b0c287c48d74;misc=15...
47 B
104 B
XHR
General
Full URL
https://adserver-us.adtech.advertising.com/pubapi/3.0/10334.1/5126271/0/1/ADTECH;apid=1Ae4dcfa82-f4e0-11e9-b74f-124c2db8624e;cfp=1;rndc=1571758235;v=2;cmd=bid;cors=yes;alias=228b0c287c48d74;misc=1571758235665;bidfloor=0.05
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
152.199.21.89 , United States, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
Adtech Adserver /
Resource Hash
59aad090b0a1ac926dd34c82ba3aeae5bec718f29a1d6203c622833db8719490

Request headers

Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:36 GMT
server
Adtech Adserver
status
200
access-control-allow-methods
POST,GET,HEAD,OPTIONS
content-type
application/json
access-control-allow-origin
https://www.reuters.com
cache-control
no-store, no-cache
access-control-allow-credentials
true
content-length
47
expires
Mon, 15 Jun 1998 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:36 GMT
server
nginx
status
302
location
https://adserver-us.adtech.advertising.com/pubapi/3.0/10334.1/5126271/0/1/ADTECH;apid=1Ae4dcfa82-f4e0-11e9-b74f-124c2db8624e;cfp=1;rndc=1571758235;v=2;cmd=bid;cors=yes;alias=228b0c287c48d74;misc=1571758235665;bidfloor=0.05
access-control-allow-methods
POST,GET,HEAD,OPTIONS
p3p
CP="NOI DSP DEVa OUR BUS UNI COM NAV INT"
access-control-allow-origin
https://www.reuters.com
cache-control
no-store, no-cache
access-control-allow-credentials
true
content-length
0
expires
Mon, 15 Jun 1998 00:00:00 GMT
prebid
ib.adnxs.com/ut/v3/ Frame EF32
260 B
1 KB
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.223.203 , Netherlands, ASN29990 (ASN-APPNEXUS - AppNexus, Inc, US),
Reverse DNS
317.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.13.4 /
Resource Hash
352d0165eb74e9dcc3968a6851ba280714b20d438d4d1f778405e8c8eecab5d7
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:37 GMT
X-Proxy-Origin
144.76.109.30; 144.76.109.30; 317.bm-nginx-loadbalancer.mgmt.ams1; *.adnxs.com; 185.33.220.27:80
AN-X-Request-Uuid
4d2b5005-81a8-4e12-94d9-5b3748e14709
Server
nginx/1.13.4
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
https://www.reuters.com
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json; charset=utf-8
Content-Length
260
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
v1
prg.smartadserver.com/prebid/ Frame EF32
0
1 KB
XHR
General
Full URL
https://prg.smartadserver.com/prebid/v1
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
185.86.138.32 , France, ASN201081 (SMARTADSERVER, FR),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 22 Oct 2019 15:30:34 GMT
X-SMRT-D
4%3b18%3b89
P3P
CP="BUS CUR CONo FIN IVDo ONL OUR PHY SAMo TELo"
Access-Control-Allow-Origin
https://www.reuters.com
Cache-Control
no-cache, no-store
Access-Control-Allow-Credentials
true
Content-Type
application/json
Content-Length
0
Expires
-1
dc_oe=ChMItNHZ1pew5QIVkAaLCh08nQZoEAAYACD34546;met=1;ecn1=1;etm1=0;eid1=960584;
ade.googlesyndication.com/ddm/activity/ Frame 5877
42 B
109 B
Image
General
Full URL
https://ade.googlesyndication.com/ddm/activity/dc_oe=ChMItNHZ1pew5QIVkAaLCh08nQZoEAAYACD34546;met=1;ecn1=1;etm1=0;eid1=960584;
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.205.226 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s24-in-f2.1e100.net
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-astrazeneca-farxiga-fda/fda-approves-astrazeneca-diabetes-drug-for-treating-heart-failure-risk-idUSKBN1X00J5
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 22 Oct 2019 15:30:36 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
cache-control
no-cache, must-revalidate
content-type
image/gif
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Verdicts & Comments Add Verdict or Comment

232 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

object| onformdata object| onpointerrawupdate object| analytics object| dataLayer object| google_tag_manager function| postscribe string| GoogleAnalyticsObject function| ga object| Reuters object| parallelMediaHosts object| google_tag_data object| gaplugins object| gaGlobal object| gaData object| tag object| firstScriptTag object| player function| onYouTubeIframeAPIReady function| onPlayerPlaybackQualityChange function| onPlayerReady function| onPlayerStateChange object| player2 function| onYouTubeIframeAPIReady2 function| onPlayerReady2 function| onPlayerPlaybackQualityChange2 function| onPlayerStateChange2 object| player3 function| onYouTubeIframeAPIReady3 function| onPlayerReady3 function| onPlayerPlaybackQualityChange3 function| onPlayerStateChange3 object| player4 function| onYouTubeIframeAPIReady4 function| onPlayerReady4 function| onPlayerPlaybackQualityChange4 function| onPlayerStateChange4 object| player5 function| onYouTubeIframeAPIReady5 function| onPlayerReady5 function| onPlayerPlaybackQualityChange5 function| onPlayerStateChange5 object| player7 function| onYouTubeIframeAPIReady7 function| onPlayerReady7 function| onPlayerPlaybackQualityChange7 function| onPlayerStateChange7 undefined| script object| _sf_async_config number| _sf_startpt object| _cb_shared object| __core-js_shared__ object| RTVEmbedder object| RCOM_Data function| webpackJsonp object| google_optimize object| YT object| YTConfig function| onYTReady object| core object| scrollMonitor object| gptadslots object| googletag function| admantx_callback object| evidon function| __cmp function| renderComponent function| LEIIPdd object| dgquf0a8Flags string| dgquf6a5Rnd function| LEIIPTrkFailed object| dgqufd273tc function| commonPopup boolean| dgquf92csdl boolean| dgquf92csdln string| dgqufd273genat string| dgqufd273sthash boolean| dgquf65eforceimp object| _cbm function| hj object| _hjSettings object| article_date object| author string| content_channel object| keywords object| tp boolean| dgquff87Body object| yt function| ytDomDomGetNextId object| ytEventsEventsListeners object| ytEventsEventsCounter function| _fbq function| fbq function| normalize string| dianomiContextHost function| dianomiLoadContext function| dianomiContextSetHeight function| dianomiContextSetWidth function| dianomiContextSetFloat function| dianomiContextElement function| dianomiReloadContext function| dianomiContextReady object| hjSiteSettings function| hjBootstrap object| hjBootstrapCalled string| NativeAIObject function| nativeAI string| segment_user_id object| TRUE_ANTHEM function| e number| abp object| _comscore function| getValuesGWIQ function| ___tp object| localCookieStorage object| sessionCookieStorage object| jQuery1124018534572018945528 string| __tpVersion object| nativeAIWebpackJsonp function| ns360 object| News360 object| NativeAI function| udm_ object| ns_p object| COMSCORE object| $jscomp function| MIIScriptCtrl object| fortyone object| gwiq object| lazyLoadOptions function| _extends function| LazyLoad string| article_platform string| article_edition number| _sf_endpt object| adobeDil object| adobe function| Visitor function| DIL object| s_c_il number| s_c_in string| topic_channel string| channel string| content_type string| adblock string| edition string| platform string| keyword_slug string| content_title string| inline_type string| dcontent_channel string| channel_list object| admp_vars function| getCookie object| pSUPERFLY_mab object| _cbq object| pSUPERFLY object| pSUPERFLY_video object| _cbv_strategies object| _cbv string| state object| __onetag object| __connect boolean| dgqufcc1Detect object| dgquf294Mobile object| dgqufd2731 object| dgqufd273o1 object| dgqufd273o2 object| dgqufd273o3 object| dgqufd2732 number| dgqufd273d3 object| dgqufd2734 object| dgqufd2735 boolean| dgquff99ij object| advBidxc function| _mR function| _mD object| _mnHM object| __iasPET function| iasDataHandler object| diagPixSentCodes string| TB4M82W string| T645KQG object| ggeac object| closure_memoize_cache_ object| googleToken object| googleIMState object| google_js_reporting_queue function| processGoogleToken undefined| google_measure_js_timing number| google_srt boolean| google_noFetch number| __google_ad_urls_id function| Goog_AdSense_getAdAdapterInstance function| Goog_AdSense_OsdAdapter function| googleCompanionsServicePresent function| googleGetCompanionAdSlots function| googleSetCompanionAdContents function| google_show_companion_ad function| google_show_companion_ad_in_slot function| google_get_companion_slot_params function| google_companion_error function| google_companion_loaded function| google_increment_num_ad_mouseovers string| google_ad_output string| google_flash_version boolean| google_webgl_support string| google_ad_section string| google_country string| TF6129H number| google_unique_id object| google_reactive_ads_global_state boolean| dgquf669Track object| __google_ad_urls object| ampInaboxIframes object| ampInaboxPendingMessages boolean| google_osd_loaded boolean| google_onload_fired function| Goog_Osd_UnloadAdBlock function| Goog_Osd_UpdateElementToMeasure function| google_osd_amcb object| Moat#G26 boolean| Moat#EVA object| MoatSuperV26 object| DOMlessLLDcallback_38025097 object| MoatDataJsonpRequest_38025097 object| teadsscript object| teads object| Cbola number| cbola_abTestId string| cbola_pageViewId object| __IntegralASExec object| _33Across

4 Cookies

Domain/Path Name / Value
.reuters.com/ Name: _fbp
Value: fb.1.1571758224096.1184693481
.dianomi.com/ Name: __cfduid
Value: deb5677535ddbcef6f66709a3251546701571758224
.reuters.com/ Name: _gat
Value: 1
.reuters.com/ Name: ajs_anonymous_id
Value: %221683a8f0-1630-462c-b620-08a3c6c0e14e%22

19 Console Messages

Source Level URL
Text
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
BODY ITEMS [object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
//wireapi.reuters.com/v7/feed/rcom/us/top-nav/finance?count=7
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
//wireapi.reuters.com/v7/feed/rcom/us/top-nav/finance/markets?count=7
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
//wireapi.reuters.com/v7/feed/rcom/us/top-nav/news/world?count=7
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
//wireapi.reuters.com/v7/feed/rcom/us/top-nav/politics?count=7
console-api log (Line 1)
Message:
Blocking Ads: No
console-api log (Line 1)
Message:
comscore new global fired
console-api log (Line 2)
Message:
segment identify user with traits: [object Object]
console-api warning URL: https://connect.facebook.net/en_US/fbevents.js(Line 24)
Message:
[Facebook Pixel] - Unable to parse JSON-LD tag. Malformed JSON found: ' { "@context": "http://schema.org", "@type": "NewsArticle", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://www.reuters.com/article/us-astrazeneca-farxiga-fda-idUSKBN1X00J5" }, "headline": "FDA approves AstraZeneca diabetes drug for treating heart failure risk", "url": "https://www.reuters.com/article/us-astrazeneca-farxiga-fda-idUSKBN1X00J5", "image": { "@type": "ImageObject", "url": "https://s3.reutersmedia.net/resources/r/?m=02&d=20191021&t=2&i=1443247775&w=1200&r=LYNXMPEF9K0CN", "width": "800", "height": "800" }, "thumbnailUrl": "https://s3.reutersmedia.net/resources/r/?m=02&d=20191021&t=2&i=1443247775&w=1200&r=LYNXMPEF9K0CN", "dateCreated": "2019-10-21T07:08:10+0000", "dateModified": "2019-10-21T07:08:10+0000", "datePublished": "2019-10-21T07:08:10+0000", "author": { "@type": "Person", "name": "Reuters Editorial" }, "publisher": { "@type": "Organization", "name": "Reuters", "logo": { "@type": "ImageObject", "url": "https://s3.reutersmedia.net/resources_v2/images/reuters_social_logo.png", "width": "200", "height": "200" } }, "description": 'AstraZeneca&#039;s diabetes drug Farxiga has been approved for use in the United States as a treatment to reduce the chances of hospitalisation for heart failure in adults with type-2 diabetes and other cardiovascular risks, the British drugmaker said on Monday.', "articleSection": "Homepage", "creator": ["Reuters Editorial"], "keywords": ["US","ASTRAZENECA","FARXIGA","FDA","Company News","Health / Medicine","Content produced in Bangalore","Sweden","Europe","Pharmaceuticals and Medical Research (TRBC)","Medical Regulatory Issues","Healthcare (TRBC)","United Kingdom", "Article", "Health"], "about":"Article" } '.
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
Require Evidon Consent: true consent: false undefined
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
Setup media.net with GDPR applied, user not consent
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
GPT SET NON PERSONAL
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
GPT ENABLE SERVICES
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
GPT DISPLAY!
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
GPT DISPLAY!
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
GPT DISPLAY!
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
GPT DISPLAY!
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
GPT DISPLAY!
console-api debug URL: https://static.adsafeprotected.com/sca.17.4.95.js(Line 32)
Message:
a: 0.001220703125ms

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

33across-d.openx.net
a.teads.tv
ad.doubleclick.net
ade.googlesyndication.com
ads.pubmatic.com
adserver-us.adtech.advertising.com
adservice.google.com
adservice.google.de
aktrack.pubmatic.com
analytics.carambo.la
ap.lijit.com
api.segment.io
async01.admantx.com
beacon.s-onetag.com
beacon.tru.am
c.evidon.com
carambola-d.openx.net
cdata.carambo.la
cdn-sic.33across.com
cdn.adsafeprotected.com
cdn.native.ai
cdn.segment.com
cdn.tinypass.com
cdn.tynt.com
cdneast2-xch.media.net
cdnjs.cloudflare.com
cmp.teads.mgr.consensu.org
connect.facebook.net
contextual.media.net
de.tynt.com
dfp-gateway.s-onetag.com
dpm.demdex.net
dt.adsafeprotected.com
eu-u.openx.net
evidon.mgr.consensu.org
experience.tinypass.com
fonts.googleapis.com
fonts.gstatic.com
gcdn.2mdn.net
geo.moatads.com
get.s-onetag.com
googleads4.g.doubleclick.net
gwiqcdn.globalwebindex.net
hb.emxdgt.com
hbopenbid.pubmatic.com
iabmap.evidon.com
ib.adnxs.com
ic.tynt.com
image6.pubmatic.com
inimage.carambo.la
l.betrad.com
logging.carambo.la
mab.chartbeat.com
mailview.bulletinhealthcare.com
media.carambo.la
onetag-geo.s-onetag.com
p.brid.tv
pagead2.googlesyndication.com
ping.chartbeat.net
pixel.adsafeprotected.com
pixel.watch
prg.smartadserver.com
queso-cdn.prod.reuters.tv
r4---sn-4g5ednee.c.2mdn.net
reuters.demdex.net
reutersdfpcw319687550988.s.moatpixel.com
route.carambo.la
s.mnet-ad.net
s.ytimg.com
s2.reutersmedia.net
s3.amazonaws.com
s3.reutersmedia.net
sb.scorecardresearch.com
sc.tynt.com
script.hotjar.com
securepubads.g.doubleclick.net
services.brid.tv
sic.33across.com
sope.prod.reuters.tv
ssc.33across.com
sshowads.pubmatic.com
static.adsafeprotected.com
static.chartbeat.com
static.hotjar.com
static.reuters.com
static.reutersmedia.net
stats-dev.brid.tv
stats.g.doubleclick.net
sync.teads.tv
t.teads.tv
tag.1rx.io
tagan.adlightning.com
tpc.googlesyndication.com
tru.am
utoumine.net
vars.hotjar.com
vendorlist.consensu.org
wireapi.reuters.com
www.dianomi.com
www.facebook.com
www.google-analytics.com
www.google.com
www.google.de
www.googletagmanager.com
www.googletagservices.com
www.reuters.com
www.youtube.com
xtr.carambo.la
z.moatads.com
104.16.38.14
104.16.87.26
104.18.136.13
104.244.36.20
13.224.196.127
13.225.78.59
13.225.78.91
13.225.78.96
136.243.25.83
143.204.101.128
143.204.101.13
143.204.101.40
143.204.101.7
143.204.101.90
143.204.99.83
147.75.101.51
147.75.84.99
147.75.85.103
152.195.39.46
152.199.21.89
18.196.104.43
185.33.223.203
185.64.189.111
185.64.189.112
185.64.189.115
185.86.138.32
199.166.0.26
199.166.0.32
2.18.232.7
2.18.233.180
2.18.235.40
2.18.235.93
2.19.43.224
208.100.17.178
208.100.17.180
208.100.17.183
208.100.17.185
216.52.2.48
216.58.205.226
216.58.205.230
216.58.208.34
23.45.108.200
23.62.140.165
2600:1f18:624f:b000:4319:b1c8:f4e4:70ed
2600:9000:200d:3200:1e:ef1b:aa40:93a1
2600:9000:20eb:3000:10:27b4:f500:93a1
2600:9000:20eb:3000:5:9a4c:9b00:93a1
2600:9000:20eb:b000:5:ae3a:ba00:93a1
2600:9000:2156:1000:a:52eb:a100:93a1
2600:9000:2156:b600:1f:287:d20a:ce1
2600:9000:2156:b800:18:1fcd:349:ca21
2600:9000:21f3:c800:1:af78:4c0:93a1
2606:4700:20::6819:a322
2606:4700::6810:4b33
2606:4700::6813:c797
2a00:1450:4001:45::a
2a00:1450:4001:800::2002
2a00:1450:4001:808::200e
2a00:1450:4001:80b::2003
2a00:1450:4001:815::2001
2a00:1450:4001:815::2008
2a00:1450:4001:818::2002
2a00:1450:4001:81d::2003
2a00:1450:4001:81e::200e
2a00:1450:4001:81f::200e
2a00:1450:4001:821::2004
2a00:1450:4001:821::200a
2a00:1450:400c:c04::9d
2a02:26f0:6c00:292::2c92
2a03:2880:f01c:8012:face:b00c:0:3
2a03:2880:f11c:8183:face:b00c:0:25de
2a04:4e42:3::714
3.224.94.188
34.239.9.60
34.243.82.109
34.95.120.147
35.174.181.134
35.177.169.46
35.177.181.185
35.201.93.216
52.216.136.5
52.22.183.200
52.27.125.121
52.72.190.3
52.85.183.90
52.85.183.93
52.87.16.121
54.171.105.8
54.217.204.244
54.235.136.175
66.81.204.228
69.174.55.131
8.41.222.100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